,drug_name,drug_type,Smiles
0,Ciprofibrate,4A11-Inducer,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
1,Clofibrate,4A11-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2,Clofibrate,4A11-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3,Dexamethasone,4A11-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4,Estrone,4A11-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5,Ethanol,4A11-Inducer,CCO
6,Lansoprazole,4A11-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
7,"Mercury, Metallic",4A11-Inhibitor,[Hg]
8,Phenobarbital,4A11-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
9,Rifampicin,4A11-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
10,Valproic Acid,4A11-Inducer,CCCC(CCC)C(O)=O
11,Aminophenazone,CP2CI-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
12,Buprenorphine,CP2CI-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
13,Clobazam,CP2CI-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
14,Clotiazepam,CP2CI-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
15,Cyclophosphamide,CP2CI-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
16,Dapsone,CP2CI-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
17,Dexamethasone,CP2CI-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
18,Diazepam,CP2CI-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
19,Diclofenac,CP2CI-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
20,Fluconazole,CP2CI-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
21,Ifosfamide,CP2CI-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
22,Imipramine,CP2CI-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
23,Lansoprazole,CP2CI-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
24,Lidocain,CP2CI-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
25,Mephenytoin,CP2CI-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
26,Methadone,CP2CI-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
27,Omeprazole,CP2CI-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
28,Perphenazine,CP2CI-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
29,Phenazone,CP2CI-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
30,Phenobarbital,CP2CI-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
31,Phenytoin,CP2CI-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
32,Phenytoin,CP2CI-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
33,Propofol,CP2CI-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
34,Rifampicin,CP2CI-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
35,Thalidomide,CP2CI-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
36,Tolbutamide,CP2CI-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
37,Troleandomycin,CP2CI-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
38,Valproic Acid,CP2CI-Inhibitor,CCCC(CCC)C(O)=O
39,Warfarin,CP2CI-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
40,Aldosterone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
41,Aminogluthetimide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
42,Aminophenazone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
43,Androstanolone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
44,Dexamethasone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
45,Insulin (human),Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
46,Metoclopramide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
47,Progesterone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
48,[32P]Natriumphosphat,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,OP([O-])([O-])=O
49,Cefmetazole,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O
50,Cefoperazone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O)C5=CC=C(O)C=C5)C(=O)C1=O
51,Ceftriaxone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CON=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NC(=O)C(O)=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4
52,Dactinomycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
53,Diclofenac,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
54,Docetaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
55,Docetaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
56,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
57,Estrone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
58,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
59,Hydroxycarbamide,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,NC(=O)NO
60,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
61,Mitoxantrone,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
62,Paclitaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
63,Paclitaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
64,Pancreozymin (cholecystokinin),Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
65,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
66,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
67,Technetium (99mTc) Mebrofenin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC1=C(Br)C(C)=C(NC(=O)CN(CC(O)=O)CC(O)=O)C(C)=C1
68,Telithromycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
69,Testosterone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
70,Aminogluthetimide,19A-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
71,Anastrozole,19A-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
72,Androstanolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
73,Betamethason,19A-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
74,Betamethason,19A-Substrate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
75,Bifonazole,19A-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
76,Bucladesine,19A-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
77,Buserelin,19A-Inducer,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6
78,Clofenotane,19A-Inhibitor,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
79,Clomifene,19A-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
80,Clonidine,19A-Inducer,ClC1=CC=CC(Cl)=C1NC2=NCCN2
81,Clotrimazole,19A-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
82,Cyproterone,19A-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
83,Danazol,19A-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
84,Dibutylphthalate,19A-Inducer,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
85,Diethylstilbestrol,19A-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
86,Dinoprostone,19A-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
87,Dopamine,19A-Inhibitor,NCCC1=CC(O)=C(O)C=C1
88,Econazole,19A-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
89,Ethanol,19A-Inducer,CCO
90,Etomidate,19A-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
91,Etretinate,19A-Inhibitor,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
92,Exemestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
93,Fluconazole,19A-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
94,Formestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O
95,Glutathione,19A-Inducer,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
96,Insulin (human),19A-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
97,Isoconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
98,Isoprenaline,19A-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
99,Itraconazole,19A-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
100,Letrozole,19A-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
101,Letrozole,19A-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
102,Levacetylmethadol,19A-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
103,Levonorgestrel,19A-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
104,Mefloquine,19A-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
105,Melatonin,19A-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
106,Methadone,19A-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
107,Methyltestosterone,19A-Inducer,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
108,Miconazole,19A-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
109,Nandrolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
110,Norepinephrine,19A-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
111,Oxycodone,19A-Inhibitor,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
112,Paclitaxel,19A-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
113,Phenylephrine,19A-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
114,Prasterone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
115,Raloxifene,19A-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
116,Tamoxifen,19A-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
117,Terbinafine,19A-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
118,Testosterone,19A-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
119,Tibolone,19A-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
120,Tinidazole,19A-Inhibitor,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
121,Tioconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
122,Trastuzumab,19A-Inhibitor,NCC=C
123,Troglitazone,19A-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
124,Vorozole,19A-Inhibitor,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
125,Inosine,Solute_carrier_family_28_member_3-Inhibitor,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(O)N=CN=C23
126,Mercaptopurine,Solute_carrier_family_28_member_3-Substrate,S=C1NC=NC2=C1NC=N2
127,Ribavirin,Solute_carrier_family_28_member_3-Substrate,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
128,Tioguanine,Solute_carrier_family_28_member_3-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
129,Tretinoin,Solute_carrier_family_28_member_3-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
130,Cisplatin,Probable_low_affinity_copper_uptake_protein_2-Substrate,N[Pt](N)(Cl)Cl
131,Silver,Probable_low_affinity_copper_uptake_protein_2-Inhibitor,[Ag]
132,Androstanolone,7B1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
133,Cefalexin,Multidrug_and_toxin_extrusion_protein_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
134,Chloroquine,Multidrug_and_toxin_extrusion_protein_1-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
135,Chloroquine,Multidrug_and_toxin_extrusion_protein_1-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
136,Mephenoxalone,Multidrug_and_toxin_extrusion_protein_1-Substrate,COC1=C(OC[C@H]2CNC(=O)O2)C=CC=C1
137,Metformin,Multidrug_and_toxin_extrusion_protein_1-Substrate,CN(C)C(=N)NC(N)=N
138,Trimethoprim,Multidrug_and_toxin_extrusion_protein_1-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
139,Acarbose,2E1-Inducer,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
140,Acarbose,2E1-Inhibitor,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
141,Acetic Acid,2E1-Substrate,CC(O)=O
142,Ademetionine,2E1-Inhibitor,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
143,Ademetionine,2E1-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
144,Allopurinol,2E1-Inhibitor,OC1=NC=NC2=C1C=NN2
145,Alosetron,2E1-Inhibitor,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
146,Aminophylline,2E1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
147,Amitriptyline,2E1-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
148,Amitriptyline,2E1-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
149,Azelastine,2E1-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
150,Benzocaine,2E1-Inhibitor,CCOC(=O)C1=CC=C(N)C=C1
151,Benzydamine,2E1-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
152,Bifonazole,2E1-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
153,Bromazepam,2E1-Inhibitor,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
154,Brompheniramine,2E1-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
155,Bupropion,2E1-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
156,Caffeine,2E1-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
157,Capsaicin,2E1-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
158,Carbamide,2E1-Inducer,NC(N)=O
159,Carbinoxamine,2E1-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
160,Carvedilol,2E1-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
161,Chloroform,2E1-Substrate,ClC(Cl)Cl
162,Chloroxylenol,2E1-Substrate,CC1=CC(O)=CC(C)=C1Cl
163,Chlorpromazine,2E1-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
164,Chlorzoxazone,2E1-Inhibitor,OC1=NC2=C(O1)C=CC(Cl)=C2
165,Chlorzoxazone,2E1-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
166,Cimetidine,2E1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
167,Ciprofloxacin,2E1-Inducer,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
168,Cisplatin,2E1-Substrate,N[Pt](N)(Cl)Cl
169,Cisplatin,2E1-Inducer,N[Pt](N)(Cl)Cl
170,Citalopram,2E1-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
171,Clofibrate,2E1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
172,Clomethiazole,2E1-Inhibitor,CC1=C(CCCl)SC=N1
173,Clomifene,2E1-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
174,Clotrimazole,2E1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
175,Clozapine,2E1-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
176,Colchicine,2E1-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
177,Dacarbazine,2E1-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
178,Dapsone,2E1-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
179,Desipramine,2E1-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
180,Dexfenfluramine,2E1-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
181,Dextromethorphan,2E1-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
182,Diazepam,2E1-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
183,Diclofenac,2E1-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
184,Diethyl Ether,2E1-Inducer,CCOCC
185,Diethyltoluamide,2E1-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
186,Disulfiram,2E1-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
187,Disulfiram,2E1-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
188,Dopamine,2E1-Inhibitor,NCCC1=CC(O)=C(O)C=C1
189,Dorzolamide,2E1-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
190,Econazole,2E1-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
191,Enflurane,2E1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
192,Entacapone,2E1-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
193,Estrone,2E1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
194,Eszopiclone,2E1-Substrate,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
195,Ethanol,2E1-Inducer,CCO
196,Ethanol,2E1-Inhibitor,CCO
197,Ethanol,2E1-Substrate,CCO
198,Ethosuximide,2E1-Substrate,CC[C@]1(C)CC(=O)NC1=O
199,Etoposide,2E1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
200,Etoricoxib,2E1-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
201,Felbamate,2E1-Substrate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
202,Flufenamic Acid,2E1-Inducer,OC(=O)C1=CC=CC=C1NC2=CC=CC(=C2)C(F)(F)F
203,Flumequine,2E1-Inhibitor,C[C@@H]1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O
204,Fluoxetine,2E1-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
205,Fluphenazine,2E1-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
206,Flurazepam,2E1-Inhibitor,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
207,Fluvoxamine,2E1-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
208,Folic Acid,2E1-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
209,Fomepizole,2E1-Inhibitor,CC1=CNN=C1
210,Furosemide,2E1-Substrate,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
211,Glucosamine,2E1-Substrate,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O
212,Glucose,2E1-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
213,Glycerol,2E1-Inducer,OCC(O)CO
214,Halothane,2E1-Substrate,FC(F)(F)[C@@H](Cl)Br
215,Histamine,2E1-Inducer,NCCC1=CNC=N1
216,Imipramine,2E1-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
217,Insulin (human),2E1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
218,Ipriflavone,2E1-Inducer,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
219,Isoflurane,2E1-Substrate,FC(F)O[C@@H](Cl)C(F)(F)F
220,Isoniazid,2E1-Inducer,NNC(=O)C1=CC=NC=C1
221,Isoniazid,2E1-Inhibitor,NNC(=O)C1=CC=NC=C1
222,Isoniazid,2E1-Substrate,NNC(=O)C1=CC=NC=C1
223,Isopropanol,2E1-Inducer,CC(C)O
224,Isopropanol,2E1-Inhibitor,CC(C)O
225,Isosorbide Dinitrate,2E1-Inhibitor,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
226,Itraconazole,2E1-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
227,Ketoconazole,2E1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
228,Levocarnitine,2E1-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
229,Levomepromazine,2E1-Inhibitor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
230,Medazepam,2E1-Inhibitor,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
231,Medrysone,2E1-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
232,Menadione,2E1-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
233,Meprobamate,2E1-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
234,Methazolamide,2E1-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
235,Methoxyflurane,2E1-Substrate,COC(F)(F)C(Cl)Cl
236,Metyrapone,2E1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
237,Mexiletine,2E1-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
238,Miconazole,2E1-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
239,Mitoxantrone,2E1-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
240,Mizolastine,2E1-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
241,Monoethanolamine Oleate,2E1-Substrate,CCCCCCCCC=CCCCCCCCC(O)=O
242,Nicardipine,2E1-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
243,Nicotinamide,2E1-Inhibitor,NC(=O)C1=CC=CN=C1
244,Nicotine,2E1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
245,Nicotine,2E1-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
246,Nicotine,2E1-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
247,Nifedipine,2E1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
248,Nilvadipine,2E1-Substrate,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
249,Nortriptyline,2E1-Inhibitor,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
250,Ondansetron,2E1-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
251,Oxaliplatin,2E1-Substrate,N[C@@H]1CCCC[C@H]1N
252,Pancreozymin (cholecystokinin),2E1-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
253,Paracetamol,2E1-Inducer,CC(=O)NC1=CC=C(O)C=C1
254,Paracetamol,2E1-Substrate,CC(=O)NC1=CC=C(O)C=C1
255,Paraoxon,2E1-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
256,Pargyline,2E1-Inhibitor,CN(CC#C)CC1=CC=CC=C1
257,Perazine,2E1-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
258,Phenacetin,2E1-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
259,Phenazone,2E1-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
260,Phenobarbital,2E1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
261,Phenobarbital,2E1-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
262,Phenol,2E1-Substrate,OC1=CC=CC=C1
263,Pilocarpine,2E1-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
264,Pimozide,2E1-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
265,Proguanil,2E1-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
266,Propofol,2E1-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
267,Propofol,2E1-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
268,Quinidine,2E1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
269,Retinol (vit A),2E1-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
270,Retinol (vit A),2E1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
271,Rifampicin,2E1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
272,Rifampicin,2E1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
273,Ritonavir,2E1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
274,Salicylic Acid,2E1-Inducer,OC(=O)C1=C(O)C=CC=C1
275,Selegiline,2E1-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
276,Sevoflurane,2E1-Substrate,FCOC(C(F)(F)F)C(F)(F)F
277,Sildenafil,2E1-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
278,Sodium Chloride,2E1-Inducer,[Na+].[Cl-]
279,Sodium Salicylate,2E1-Inducer,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
280,Streptozocin,2E1-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
281,Sulconazole,2E1-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
282,Sulfadiazine,2E1-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
283,Sulfanilamide,2E1-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
284,Tamoxifen,2E1-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
285,Tegafur,2E1-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
286,Tegaserod,2E1-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
287,Tenofovir Disoproxil,2E1-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
288,Thalidomide,2E1-Inducer,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
289,Theobromine,2E1-Substrate,CN1C=NC2=C1C(=O)NC(=O)N2C
290,Theophylline,2E1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
291,Thiamazole,2E1-Inhibitor,CN1C=CNC1=S
292,Thiopental,2E1-Inhibitor,CCC[C@@H](C)[C@]1(CC)C(=O)NC(S)=NC1=O
293,Thioridazine,2E1-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
294,Thiosulfate,2E1-Inhibitor,[O-]S([S-])(=O)=O
295,Thiram,2E1-Substrate,CN(C)C(=S)SSC(=S)N(C)C
296,Tibolone,2E1-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
297,Ticlopidine,2E1-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
298,Tioconazole,2E1-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
299,Tiopronin,2E1-Inhibitor,C[C@H](S)C(=O)NCC(O)=O
300,Tocopherol (vit E),2E1-Inhibitor,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
301,Trabectedin,2E1-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
302,Tranylcypromine,2E1-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
303,Tretinoin,2E1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
304,Trichloroethylene,2E1-Substrate,ClC=C(Cl)Cl
305,Trichloroethylene,2E1-Inhibitor,ClC=C(Cl)Cl
306,Trimethadione,2E1-Substrate,CN1C(=O)OC(C)(C)C1=O
307,Trospium,2E1-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
308,Ursodeoxycholic Acid,2E1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
309,Ursodeoxycholic Acid,2E1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
310,Vincamine,2E1-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
311,Voglibose,2E1-Inducer,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@H](O)[C@@H](O)[C@@H]1O
312,Zafirlukast,2E1-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
313,Zopiclone,2E1-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
314,Acetylsalicylic Acid,GST-Inducer,CC(=O)OC1=C(C=CC=C1)C(O)=O
315,Adriamycin,GST-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
316,Amyl Nitrite,GST-Substrate,CC(C)CCON=O
317,Artemisinin,GST-Inhibitor,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
318,Artemisinin,GST-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
319,Ascorbic Acid (vit C),GST-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
320,Ascorbic Acid (vit C),GST-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
321,Betacarotene,GST-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
322,Bucladesine,GST-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
323,Busulfan,GST-Substrate,CS(=O)(=O)OCCCCOS(C)(=O)=O
324,Camphora,GST-Inducer,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
325,Capsaicin,GST-Inhibitor,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
326,Carmustine,GST-Substrate,ClCCNC(=O)N(CCCl)N=O
327,Chenodeoxycholic Acid,GST-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
328,Chinin,GST-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
329,Chlorambucil,GST-Inducer,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl
330,Chloroform,GST-Inhibitor,ClC(Cl)Cl
331,Chloroquine,GST-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
332,Cisapride,GST-Inducer,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
333,Cisplatin,GST-Substrate,N[Pt](N)(Cl)Cl
334,Cisplatin,GST-Inducer,N[Pt](N)(Cl)Cl
335,Clofibrate,GST-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
336,Clomipramine,GST-Inhibitor,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
337,Cocaine,GST-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
338,Cyproterone,GST-Inducer,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
339,Dactinomycin,GST-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
340,Dicoumarol,GST-Inhibitor,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
341,Diethyl Ether,GST-Substrate,CCOCC
342,Diethylcarbamazine,GST-Inducer,CCN(CC)C(=O)N1CCN(C)CC1
343,Doxepin,GST-Inhibitor,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
344,Doxorubicin,GST-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
345,Estradiol,GST-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
346,Etacrynic Acid,GST-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
347,Etacrynic Acid,GST-Inhibitor,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
348,Finasteride,GST-Inhibitor,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
349,Flunarizine,GST-Inducer,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
350,Fosfomycin,GST-Substrate,C[C@H]1O[C@@H]1P(O)(O)=O
351,Gabapentin,GST-Inducer,NC[C@@]1(CCCCC1)CC(O)=O
352,Glucagon,GST-Inhibitor,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
353,Glyceryl Trinitrate,GST-Inducer,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O
354,Glycine,GST-Inducer,NCC(O)=O
355,Hematin,GST-Inhibitor,O[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C=C)C(C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C)=C5C=C)C(C)=C3CCC(O)=O
356,Hematin,GST-Substrate,O[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C=C)C(C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C)=C5C=C)C(C)=C3CCC(O)=O
357,Hydrocortisone,GST-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
358,Hydrogen Peroxide,GST-Inhibitor,OO
359,Hydrogen Peroxide,GST-Inducer,OO
360,Ibuprofen,GST-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
361,Imipramine,GST-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
362,Indometacin,GST-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
363,Indometacin,GST-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
364,Insulin (human),GST-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
365,Isosorbide Dinitrate,GST-Substrate,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
366,Ketoprofen,GST-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
367,Lamotrigine,GST-Inducer,NC1=NC(N)=C(N=N1)C2=C(Cl)C(Cl)=CC=C2
368,Lentinan,GST-Inhibitor,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]5O)[C@H]4O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
369,Levamisole,GST-Inducer,C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3
370,Levetiracetam,GST-Inducer,CC[C@@H](N1CCCC1=O)C(N)=O
371,Melatonin,GST-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
372,Melphalan,GST-Substrate,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
373,Melphalan,GST-Inducer,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
374,Mequinol,GST-Inducer,COC1=CC=C(O)C=C1
375,Mercaptamine,GST-Inhibitor,NCCS
376,Mersalyl,GST-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
377,Metamizole Sodium,GST-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
378,Methionine,GST-Inducer,CSCC[C@H](N)C(O)=O
379,Methyldopa (levorotatory),GST-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
380,Nabumetone,GST-Inducer,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
381,Nandrolone,GST-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
382,Nitric Oxide,GST-Inducer,N=O
383,Olanzapine,GST-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
384,Paracetamol,GST-Substrate,CC(=O)NC1=CC=C(O)C=C1
385,Paracetamol,GST-Inducer,CC(=O)NC1=CC=C(O)C=C1
386,Pentoxifylline,GST-Inducer,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
387,Perindopril,GST-Inhibitor,CCC[C@H](N[C@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC
388,Phenobarbital,GST-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
389,Phenytoin,GST-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
390,Pipamperone,GST-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
391,Polihexanide,GST-Inhibitor,Cl.CCCCCCNC(=N)NC(N)=N
392,Primaquine,GST-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
393,Progesterone,GST-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
394,Progesterone,GST-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
395,Propylthiouracil,GST-Inhibitor,CCCC1=CC(=O)NC(=S)N1
396,Propylthiouracil,GST-Inducer,CCCC1=CC(=O)NC(=S)N1
397,Pyrimethamine,GST-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
398,Retinol (vit A),GST-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
399,Rofecoxib,GST-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
400,Sodium Nitrite,GST-Inhibitor,[O-]N=O
401,Sulfobromophthalein,GST-Inhibitor,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
402,Sulindac,GST-Inducer,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
403,Tacrine,GST-Substrate,NC1=C2CCCCC2=NC3=C1C=CC=C3
404,Tadalafil,GST-Inducer,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
405,Tetracycline,GST-Inhibitor,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
406,Thiomersal,GST-Inhibitor,CC[Hg]SC1=C(C=CC=C1)C([O-])=O
407,Thiotepa,GST-Substrate,S=P(N1CC1)(N2CC2)N3CC3
408,Tiaprofenic Acid,GST-Inhibitor,C[C@@H](C(O)=O)C1=CC=C(S1)C(=O)C2=CC=CC=C2
409,Tienilic Acid,GST-Inhibitor,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
410,Tioctic Acid,GST-Inducer,OC(=O)CCCC[C@@H]1CCSS1
411,Trabectedin,GST-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
412,Trichloroethylene,GST-Substrate,ClC=C(Cl)Cl
413,Troglitazone,GST-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
414,Valproic Acid,GST-Inducer,CCCC(CCC)C(O)=O
415,Verapamil,GST-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
416,Warfarin,GST-Inducer,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
417,Adenosine,Sodiumbile_acid_cotransporter-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
418,Bosentan,Sodiumbile_acid_cotransporter-Inhibitor,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
419,Colestyramine,Sodiumbile_acid_cotransporter-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
420,Dexamethasone,Sodiumbile_acid_cotransporter-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
421,Rifampicin,Sodiumbile_acid_cotransporter-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
422,Ritonavir,Sodiumbile_acid_cotransporter-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
423,Rosuvastatin,Sodiumbile_acid_cotransporter-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
424,Aminogluthetimide,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
425,Anastrozole,Aromatase_Estrogen_synthetase-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
426,Androstanolone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
427,Betamethason,Aromatase_Estrogen_synthetase-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
428,Betamethason,Aromatase_Estrogen_synthetase-Substrate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
429,Bifonazole,Aromatase_Estrogen_synthetase-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
430,Bucladesine,Aromatase_Estrogen_synthetase-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
431,Buserelin,Aromatase_Estrogen_synthetase-Inducer,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6
432,Clofenotane,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
433,Clomifene,Aromatase_Estrogen_synthetase-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
434,Clonidine,Aromatase_Estrogen_synthetase-Inducer,ClC1=CC=CC(Cl)=C1NC2=NCCN2
435,Clotrimazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
436,Cyproterone,Aromatase_Estrogen_synthetase-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
437,Danazol,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
438,Dibutylphthalate,Aromatase_Estrogen_synthetase-Inducer,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
439,Diethylstilbestrol,Aromatase_Estrogen_synthetase-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
440,Dinoprostone,Aromatase_Estrogen_synthetase-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
441,Dopamine,Aromatase_Estrogen_synthetase-Inhibitor,NCCC1=CC(O)=C(O)C=C1
442,Econazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
443,Ethanol,Aromatase_Estrogen_synthetase-Inducer,CCO
444,Etomidate,Aromatase_Estrogen_synthetase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
445,Etretinate,Aromatase_Estrogen_synthetase-Inhibitor,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
446,Exemestane,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
447,Fluconazole,Aromatase_Estrogen_synthetase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
448,Formestane,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O
449,Glutathione,Aromatase_Estrogen_synthetase-Inducer,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
450,Insulin (human),Aromatase_Estrogen_synthetase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
451,Isoconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
452,Isoprenaline,Aromatase_Estrogen_synthetase-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
453,Itraconazole,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
454,Letrozole,Aromatase_Estrogen_synthetase-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
455,Letrozole,Aromatase_Estrogen_synthetase-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
456,Levacetylmethadol,Aromatase_Estrogen_synthetase-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
457,Levonorgestrel,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
458,Mefloquine,Aromatase_Estrogen_synthetase-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
459,Melatonin,Aromatase_Estrogen_synthetase-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
460,Methadone,Aromatase_Estrogen_synthetase-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
461,Methyltestosterone,Aromatase_Estrogen_synthetase-Inducer,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
462,Miconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
463,Nandrolone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
464,Norepinephrine,Aromatase_Estrogen_synthetase-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
465,Oxycodone,Aromatase_Estrogen_synthetase-Inhibitor,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
466,Paclitaxel,Aromatase_Estrogen_synthetase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
467,Phenylephrine,Aromatase_Estrogen_synthetase-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
468,Prasterone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
469,Raloxifene,Aromatase_Estrogen_synthetase-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
470,Tamoxifen,Aromatase_Estrogen_synthetase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
471,Terbinafine,Aromatase_Estrogen_synthetase-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
472,Testosterone,Aromatase_Estrogen_synthetase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
473,Tibolone,Aromatase_Estrogen_synthetase-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
474,Tinidazole,Aromatase_Estrogen_synthetase-Inhibitor,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
475,Tioconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
476,Trastuzumab,Aromatase_Estrogen_synthetase-Inhibitor,NCC=C
477,Troglitazone,Aromatase_Estrogen_synthetase-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
478,Vorozole,Aromatase_Estrogen_synthetase-Inhibitor,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
479,Acetylsalicylic Acid,SUL-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
480,Acetylsalicylic Acid,SUL-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
481,Adenosine,SUL-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
482,Aminobenzoic Acid,SUL-Substrate,NC1=CC=C(C=C1)C(O)=O
483,Apomorphine,SUL-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
484,Bemiparin,SUL-Substrate,C1=CC=C(C=C1)C=CC(=O)O
485,Betamethason,SUL-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
486,Budesonide,SUL-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
487,Calcitriol,SUL-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
488,Celecoxib,SUL-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
489,Celecoxib,SUL-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
490,Cholic Acid,SUL-Substrate,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
491,Clioquinol,SUL-Inhibitor,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
492,Clioquinol,SUL-Substrate,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
493,Corticotropin,SUL-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
494,Cortisone,SUL-Inhibitor,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
495,Diethyl Ether,SUL-Inducer,CCOCC
496,Digitoxin,SUL-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
497,Ephedrin,SUL-Substrate,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
498,Epinephrine,SUL-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
499,Epinephrine,SUL-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
500,Estradiol,SUL-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
501,Estradiol,SUL-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
502,Fluphenazine,SUL-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
503,Galactose,SUL-Substrate,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
504,Hydrocortisone,SUL-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
505,Hydrocortisone,SUL-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
506,Ibuprofen,SUL-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
507,Insulin (human),SUL-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
508,Methotrexate,SUL-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
509,Methyldopa (levorotatory),SUL-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
510,Minoxidil,SUL-Substrate,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
511,Naproxen,SUL-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
512,Paclitaxel,SUL-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
513,Pantoprazole,SUL-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
514,Paracetamol,SUL-Substrate,CC(=O)NC1=CC=C(O)C=C1
515,Pipamperone,SUL-Inhibitor,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
516,Progesterone,SUL-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
517,Progesterone,SUL-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
518,Promegestone,SUL-Inducer,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C
519,Pseudoephedrine,SUL-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
520,Pyridoxal Phosphate,SUL-Inhibitor,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1
521,Ritodrine,SUL-Substrate,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2
522,Salicylic Acid,SUL-Inhibitor,OC(=O)C1=C(O)C=CC=C1
523,Sodium Citrate,SUL-Inhibitor,OC(=O)CC(O)(CC(O)=O)C([O-])=O
524,Sodium Salicylate,SUL-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
525,Sulindac,SUL-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
526,Tamoxifen,SUL-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
527,Tamoxifen,SUL-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
528,Teicoplanin,SUL-Substrate,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](Cc6ccc(Oc7cc4cc(Oc8ccc2cc8Cl)c7O[C@@H]9O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]9NC(=O)C)c(Cl)c6)NC(=O)[C@H](N)c%10ccc(O)c(Oc%11cc(O)cc5c%11)c%10)c%12ccc(O)c(c%12)c%13c(O[C@H]%14O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]%14O)cc(O)cc%13[C@H](NC3=O)C(=O)O
529,Testosterone,SUL-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
530,Tibolone,SUL-Substrate,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
531,Tibolone,SUL-Inducer,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
532,Triamcinolone,SUL-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
533,Triclosan,SUL-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
534,Warfarin,SUL-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
535,Warfarin,SUL-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
536,Amiodarone,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
537,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
538,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
539,Bezafibrate,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
540,Bosentan,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
541,Bucladesine,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
542,Cerivastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
543,Chenodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
544,Ciclosporin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
545,Digoxin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
546,Enalapril,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
547,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
548,Estrone,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
549,Ezetimibe,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
550,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
551,Gemfibrozil,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
552,Ibuprofen,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
553,Indium (111In) Pentetic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN3CCN4CCN(CC(O)=O)CC(=O)O[In](OC(=O)C4)OC(=O)C3)C(=O)N[C@H](CN[C@H](C[C@H]5C=NC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)CC7=CC=CC=C7
554,Ketoconazole,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
555,Lopinavir,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
556,Lovastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
557,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
558,Phenobarbital,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
559,Prasterone,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
560,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
561,Quinidine,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
562,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
563,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
564,Rifamycin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
565,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
566,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
567,Silymarin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
568,Simvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
569,Torasemide,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
570,Ursodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
571,Ursodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
572,Acetylcholin,Methyltransferase-Inducer,CC(=O)OCC[N+](C)(C)C
573,Acetylsalicylic Acid,Methyltransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
574,Ademetionine,Methyltransferase-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
575,Angiotensinamide,Methyltransferase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
576,Argatroban,Methyltransferase-Inducer,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
577,Ascorbic Acid (vit C),Methyltransferase-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
578,Ascorbic Acid (vit C),Methyltransferase-Substrate,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
579,Azacitidine,Methyltransferase-Inhibitor,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
580,Azathioprine,Methyltransferase-Substrate,CN1C=NC(=C1SC2=C3NC=NC3=NC=N2)[N+]([O-])=O
581,Bendroflumethiazide,Methyltransferase-Inhibitor,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
582,Captopril,Methyltransferase-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
583,Chlorhexidine,Methyltransferase-Inhibitor,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1
584,Chloroquine,Methyltransferase-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
585,Chlorphenamine,Methyltransferase-Inducer,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
586,Cocaine,Methyltransferase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
587,Deanol,Methyltransferase-Substrate,CN(C)CCO
588,Decitabine,Methyltransferase-Inhibitor,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
589,Dicycloverine,Methyltransferase-Inhibitor,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
590,Diosmin,Methyltransferase-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
591,Entacapone,Methyltransferase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
592,Entacapone,Methyltransferase-Inducer,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
593,Epinephrine,Methyltransferase-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
594,Epinephrine,Methyltransferase-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
595,Estradiol,Methyltransferase-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
596,Estradiol,Methyltransferase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
597,Folic Acid,Methyltransferase-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
598,Fosfocreatine,Methyltransferase-Inhibitor,CN(CC(O)=O)C(=N)NP(O)(O)=O
599,Glucagon,Methyltransferase-Inducer,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
600,Histamine,Methyltransferase-Substrate,NCCC1=CNC=N1
601,Hydralazine,Methyltransferase-Inducer,NN=C1NN=CC2=C1C=CC=C2
602,Hydrocortisone,Methyltransferase-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
603,Imipramine,Methyltransferase-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
604,Isoprenaline,Methyltransferase-Substrate,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
605,Ketoprofen,Methyltransferase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
606,Ketotifen,Methyltransferase-Inducer,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3
607,Levodopa,Methyltransferase-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
608,Lidocain,Methyltransferase-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
609,Mepacrine,Methyltransferase-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
610,Mercaptopurine,Methyltransferase-Substrate,S=C1NC=NC2=C1NC=N2
611,Mesalazine,Methyltransferase-Inhibitor,NC1=CC(C(O)=O)=C(O)C=C1
612,Methotrexate,Methyltransferase-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
613,Methotrexate,Methyltransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
614,Methyldopa (levorotatory),Methyltransferase-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
615,Methyldopa (levorotatory),Methyltransferase-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
616,Moclobemide,Methyltransferase-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
617,Naproxen,Methyltransferase-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
618,Olsalazine,Methyltransferase-Inhibitor,OC(=O)C1=CC(=CC=C1O)N=NC2=CC(C(O)=O)=C(O)C=C2
619,Pargyline,Methyltransferase-Inhibitor,CN(CC#C)CC1=CC=CC=C1
620,Pargyline,Methyltransferase-Inducer,CN(CC#C)CC1=CC=CC=C1
621,Physostigmine,Methyltransferase-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
622,Plicamycin,Methyltransferase-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
623,Procaine,Methyltransferase-Inhibitor,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
624,Progesterone,Methyltransferase-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
625,Progesterone,Methyltransferase-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
626,Pyridoxine (vit B6),Methyltransferase-Inhibitor,CC1=C(O)C(CO)=C(CO)C=N1
627,Ribavirin,Methyltransferase-Inhibitor,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
628,Selenium Compounds,Methyltransferase-Inhibitor,[Se]
629,Tacrine,Methyltransferase-Inhibitor,NC1=C2CCCCC2=NC3=C1C=CC=C3
630,Tamoxifen,Methyltransferase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
631,Temozolomide,Methyltransferase-Inhibitor,CN1N=NC2=C(N=CN2C1=O)C(N)=O
632,Tioguanine,Methyltransferase-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
633,Tioguanine,Methyltransferase-Inducer,NC1=NC2=C(N=CN2)C(=S)N1
634,Tolcapone,Methyltransferase-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
635,Trimethoprim,Methyltransferase-Inducer,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
636,Tubocurarine,Methyltransferase-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
637,Ubidecarenone,Methyltransferase-Substrate,COC1=C(OC)C(=O)C(CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C)=C(C)C1=O
638,Varenicline,Methyltransferase-Inhibitor,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
639,Vecuronium,Methyltransferase-Inhibitor,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N@@+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6
640,Virginiamycin,Methyltransferase-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
641,Vorinostat,Methyltransferase-Inhibitor,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
642,Alfentanil,P450_HFLA-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
643,Alprazolam,P450_HFLA-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
644,Aminophenazone,P450_HFLA-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
645,Amiodarone,P450_HFLA-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
646,Amlodipine,P450_HFLA-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
647,Aprepitant,P450_HFLA-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
648,Aripiprazole,P450_HFLA-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
649,Astemizole,P450_HFLA-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
650,Atazanavir,P450_HFLA-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
651,Atazanavir,P450_HFLA-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
652,Atorvastatin,P450_HFLA-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
653,Aztreonam,P450_HFLA-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
654,Buspirone,P450_HFLA-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
655,Caffeine,P450_HFLA-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
656,Carbamazepine,P450_HFLA-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
657,Cerivastatin,P450_HFLA-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
658,Chinin,P450_HFLA-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
659,Chlorphenamine,P450_HFLA-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
660,Ciclosporin,P450_HFLA-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
661,Ciclosporin,P450_HFLA-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
662,Cimetidine,P450_HFLA-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
663,Cisapride,P450_HFLA-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
664,Clarithromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
665,Clotiapine,P450_HFLA-Substrate,CN1CCN(CC1)C2=NC3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3
666,Clotrimazole,P450_HFLA-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
667,Cocaine,P450_HFLA-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
668,Codeine,P450_HFLA-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
669,Cortisone,P450_HFLA-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
670,Cyclophosphamide,P450_HFLA-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
671,Dapsone,P450_HFLA-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
672,Dexamethasone,P450_HFLA-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
673,Dexamethasone,P450_HFLA-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
674,Dextromethorphan,P450_HFLA-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
675,Dextropropoxyphene,P450_HFLA-Inducer,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
676,Diazepam,P450_HFLA-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
677,Diltiazem,P450_HFLA-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
678,Docetaxel,P450_HFLA-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
679,Domperidone,P450_HFLA-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
680,Doxylamin,P450_HFLA-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
681,Eplerenone,P450_HFLA-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
682,Erythromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
683,Estradiol,P450_HFLA-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
684,Estriol,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
685,Ethinylestradiol,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
686,Ethosuximide,P450_HFLA-Substrate,CC[C@]1(C)CC(=O)NC1=O
687,Ethylmorphine,P450_HFLA-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
688,Felodipine,P450_HFLA-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
689,Fentanyl,P450_HFLA-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
690,Finasteride,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
691,Fluvoxamine,P450_HFLA-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
692,Glycyrrhizic Acid,P450_HFLA-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
693,Glycyrrhizic Acid,P450_HFLA-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
694,Haloperidol,P450_HFLA-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
695,Hydrocortisone,P450_HFLA-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
696,Ifosfamide,P450_HFLA-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
697,Imatinib,P450_HFLA-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
698,Imipramine,P450_HFLA-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
699,Indinavir,P450_HFLA-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
700,Indinavir,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
701,Irinotecan,P450_HFLA-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
702,Ketoconazole,P450_HFLA-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
703,Lercanidipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
704,Levacetylmethadol,P450_HFLA-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
705,Lidocain,P450_HFLA-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
706,Linopirdine,P450_HFLA-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
707,Lovastatin,P450_HFLA-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
708,Methadone,P450_HFLA-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
709,Mibefradil,P450_HFLA-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
710,Midazolam,P450_HFLA-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
711,Midazolam,P450_HFLA-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
712,Mifepristone,P450_HFLA-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
713,Nateglinide,P450_HFLA-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
714,Nefazodone,P450_HFLA-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
715,Nelfinavir,P450_HFLA-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
716,Nelfinavir,P450_HFLA-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
717,Neostigmine,P450_HFLA-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
718,Nifedipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
719,Nisoldipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
720,Nitrendipine,P450_HFLA-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
721,Norethisterone,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
722,Norfloxacin,P450_HFLA-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
723,Ondansetron,P450_HFLA-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
724,Ornidazole,P450_HFLA-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
725,Oxazepam,P450_HFLA-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
726,Oxycodone,P450_HFLA-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
727,Paclitaxel,P450_HFLA-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
728,Phenelzine,P450_HFLA-Inhibitor,NNCCC1=CC=CC=C1
729,Phenobarbital,P450_HFLA-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
730,Phenytoin,P450_HFLA-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
731,Pimozide,P450_HFLA-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
732,Pleconaril,P450_HFLA-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
733,Prasterone,P450_HFLA-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
734,Prasterone,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
735,Praziquantel,P450_HFLA-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
736,Progesterone,P450_HFLA-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
737,Progesterone,P450_HFLA-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
738,Propranolol,P450_HFLA-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
739,Quetiapine,P450_HFLA-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
740,Quinidine,P450_HFLA-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
741,Rifampicin,P450_HFLA-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
742,Rifapentine,P450_HFLA-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
743,Risperidone,P450_HFLA-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
744,Ritonavir,P450_HFLA-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
745,Ritonavir,P450_HFLA-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
746,Salmeterol,P450_HFLA-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
747,Saquinavir,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
748,Sildenafil,P450_HFLA-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
749,Simvastatin,P450_HFLA-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
750,Sirolimus,P450_HFLA-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
751,Tacrolimus,P450_HFLA-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
752,Tamoxifen,P450_HFLA-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
753,Telithromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
754,Terfenadine,P450_HFLA-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
755,Testosterone,P450_HFLA-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
756,Trazodone,P450_HFLA-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
757,Triamcinolone,P450_HFLA-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
758,Triazolam,P450_HFLA-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
759,Troglitazone,P450_HFLA-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
760,Troglitazone,P450_HFLA-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
761,Verapamil,P450_HFLA-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
762,Verapamil,P450_HFLA-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
763,Vincristine,P450_HFLA-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
764,Zalcitabine,P450_HFLA-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
765,Zaleplon,P450_HFLA-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
766,Ziprasidone,P450_HFLA-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
767,Zolpidem,P450_HFLA-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
768,Acebutolol,2D6-Inhibitor,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
769,Acetylcholin,2D6-Substrate,CC(=O)OCC[N+](C)(C)C
770,Ajmaline,2D6-Inhibitor,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
771,Ajmaline,2D6-Substrate,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
772,Almotriptan,2D6-Substrate,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
773,Alprenolol,2D6-Substrate,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
774,Amfetamine,2D6-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
775,Amfetamine,2D6-Substrate,C[C@@H](N)CC1=CC=CC=C1
776,Aminobutyric Acid,2D6-Substrate,NCCCC(O)=O
777,Aminophenazone,2D6-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
778,Amiodarone,2D6-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
779,Amiodarone,2D6-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
780,Amitriptyline,2D6-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
781,Amitriptyline,2D6-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
782,Amlodipine,2D6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
783,Amodiaquine,2D6-Inhibitor,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
784,Amprenavir,2D6-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
785,Amsacrine,2D6-Substrate,COC1=C(NC2=C3C=CC=CC3=NC4=CC=CC=C24)C=CC(NS(C)(=O)=O)=C1
786,Aprindine,2D6-Substrate,CCN(CC)CCCN([C@H]1CC2=CC=CC=C2C1)C3=CC=CC=C3
787,Aripiprazole,2D6-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
788,Aripiprazole,2D6-Inhibitor,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
789,Aripiprazole,2D6-Inducer,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
790,Artemether,2D6-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
791,Astemizole,2D6-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
792,Atomoxetine,2D6-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
793,Atomoxetine,2D6-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
794,Azelastine,2D6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
795,Azelastine,2D6-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
796,Barnidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
797,Befunolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=CC2=C1OC(=C2)C(C)=O
798,Benidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
799,Benzatropine,2D6-Substrate,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
800,Benzethonium,2D6-Substrate,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
801,Benzydamine,2D6-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
802,Bepridil,2D6-Substrate,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
803,Betaxolol,2D6-Substrate,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
804,Betaxolol,2D6-Inhibitor,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
805,Bicalutamide,2D6-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
806,Biperiden,2D6-Inhibitor,O[C@](CCN1CCCCC1)([C@@H]2C[C@H]3C[C@@H]2C=C3)C4=CC=CC=C4
807,Bisoprolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
808,Bortezomib,2D6-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
809,Bortezomib,2D6-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
810,Brompheniramine,2D6-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
811,Brompheniramine,2D6-Inhibitor,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
812,Budipine,2D6-Inhibitor,CC(C)(C)N1CC[C@](CC1)(C2=CC=CC=C2)C3=CC=CC=C3
813,Buflomedil,2D6-Substrate,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
814,Bupivacaine,2D6-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
815,Bupranolol,2D6-Substrate,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
816,Buprenorphine,2D6-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
817,Buprenorphine,2D6-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
818,Bupropion,2D6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
819,Bupropion,2D6-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
820,Buspirone,2D6-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
821,Caffeine,2D6-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
822,Capsaicin,2D6-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
823,Captopril,2D6-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
824,Carbinoxamine,2D6-Inhibitor,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
825,Carteolol,2D6-Inhibitor,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
826,Carteolol,2D6-Substrate,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
827,Carvedilol,2D6-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
828,Cefalexin,2D6-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
829,Celecoxib,2D6-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
830,Cevimeline,2D6-Substrate,CC1O[C@@]2(CS1)CN1CCC2CC1
831,Chinin,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
832,Chlordiazepoxide,2D6-Substrate,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
833,Chloroquine,2D6-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
834,Chloroquine,2D6-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
835,Chloroxylenol,2D6-Substrate,CC1=CC(O)=CC(C)=C1Cl
836,Chlorphenamine,2D6-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
837,Chlorphenamine,2D6-Inhibitor,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
838,Chlorpromazine,2D6-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
839,Chlorpromazine,2D6-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
840,Chlorzoxazone,2D6-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
841,Cibenzoline,2D6-Substrate,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
842,Ciclosporin,2D6-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
843,Cilostazol,2D6-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
844,Cimetidine,2D6-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
845,Cinacalcet,2D6-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
846,Cinacalcet,2D6-Inhibitor,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
847,Cinnarizin,2D6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
848,Cisapride,2D6-Inhibitor,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
849,Citalopram,2D6-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
850,Citalopram,2D6-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
851,Clemastine,2D6-Inhibitor,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
852,Clomipramine,2D6-Inhibitor,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
853,Clomipramine,2D6-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
854,Clotrimazole,2D6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
855,Clozapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
856,Clozapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
857,Cocaine,2D6-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
858,Cocaine,2D6-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
859,Codeine,2D6-Inhibitor,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
860,Codeine,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
861,Colecalciferol,2D6-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
862,Cyclobenzaprine,2D6-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
863,Deanol,2D6-Substrate,CN(C)CCO
864,Debrisoquine,2D6-Substrate,NC(=N)N1CCC2=C(C1)C=CC=C2
865,Delavirdine,2D6-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
866,Delavirdine,2D6-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
867,Desipramine,2D6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
868,Desipramine,2D6-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
869,Desloratadine,2D6-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
870,Desvenlafaxine,2D6-Substrate,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
871,Desvenlafaxine,2D6-Inhibitor,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
872,Dexamethasone,2D6-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
873,Dexamfetamine,2D6-Inhibitor,C[C@H](N)CC1=CC=CC=C1
874,Dexamfetamine,2D6-Substrate,C[C@H](N)CC1=CC=CC=C1
875,Dexfenfluramine,2D6-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
876,Dexfenfluramine,2D6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
877,Dexmedetomidine,2D6-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
878,Dextromethorphan,2D6-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
879,Dextromethorphan,2D6-Inhibitor,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
880,Dextropropoxyphene,2D6-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
881,Diclofenac,2D6-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
882,Diethyltoluamide,2D6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
883,Dihydrocodeine,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
884,Diltiazem,2D6-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
885,Diltiazem,2D6-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
886,Dimethyl Sulfoxide,2D6-Inhibitor,CS(C)=O
887,Diphenhydramin,2D6-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
888,Diphenhydramin,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
889,Diphenhydramine Methylbromide,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
890,Disulfiram,2D6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
891,Disulfiram,2D6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
892,Dolasetron,2D6-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
893,Dolasetron,2D6-Inhibitor,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
894,Domperidone,2D6-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
895,Donepezil,2D6-Substrate,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
896,Dopamine,2D6-Substrate,NCCC1=CC(O)=C(O)C=C1
897,Doxazosin,2D6-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
898,Doxepin,2D6-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
899,Doxepin,2D6-Inhibitor,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
900,Doxorubicin,2D6-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
901,Doxorubicin,2D6-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
902,Duloxetine,2D6-Substrate,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
903,Duloxetine,2D6-Inhibitor,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
904,Efavirenz,2D6-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
905,Eletriptan,2D6-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
906,Emetine,2D6-Substrate,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
907,Emetine,2D6-Inhibitor,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
908,Encainide,2D6-Substrate,COC1=CC=C(C=C1)C(=O)NC2=C(C=CC=C2)[C@H](C)CN3CCCCC3
909,Entacapone,2D6-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
910,Epinastine,2D6-Inhibitor,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
911,Epinastine,2D6-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
912,Escitalopram,2D6-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
913,Escitalopram,2D6-Inhibitor,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
914,Ethylmorphine,2D6-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
915,Etilamfetamine,2D6-Substrate,CCN[C@@H](C)CC1=CC=CC=C1
916,Etoricoxib,2D6-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
917,Felodipine,2D6-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
918,Fenfluramine,2D6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
919,Fesoterodine,2D6-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
920,Fexofenadine,2D6-Inhibitor,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
921,Flecainide,2D6-Substrate,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
922,Flecainide,2D6-Inhibitor,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
923,Fluconazole,2D6-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
924,Flunarizine,2D6-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
925,Fluoxetine,2D6-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
926,Fluoxetine,2D6-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
927,Fluphenazine,2D6-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
928,Fluphenazine,2D6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
929,Fluvastatin,2D6-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
930,Fluvastatin,2D6-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
931,Fluvoxamine,2D6-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
932,Fluvoxamine,2D6-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
933,Formoterol,2D6-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
934,Galantamine,2D6-Substrate,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
935,Gefitinib,2D6-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
936,Gefitinib,2D6-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
937,Gepirone,2D6-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
938,Granisetron,2D6-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
939,Granisetron,2D6-Inhibitor,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
940,Granisetron,2D6-Inducer,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
941,Guanoxan,2D6-Substrate,NC(=N)NC[C@H]1COC2=C(O1)C=CC=C2
942,Halofantrine,2D6-Inhibitor,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
943,Halofantrine,2D6-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
944,Haloperidol,2D6-Inducer,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
945,Haloperidol,2D6-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
946,Haloperidol,2D6-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
947,Halothane,2D6-Substrate,FC(F)(F)[C@@H](Cl)Br
948,Histamine,2D6-Inhibitor,NCCC1=CNC=N1
949,Hydrochloric Acid,2D6-Inhibitor,Cl
950,Hydrocodone,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
951,Hydrogen Peroxide,2D6-Substrate,OO
952,Hydromorphone,2D6-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
953,Hydroxycarbamide,2D6-Inducer,NC(=O)NO
954,Hydroxycarbamide,2D6-Inhibitor,NC(=O)NO
955,Hydroxychloroquine,2D6-Inhibitor,CCN(CCO)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
956,Hydroxyzine,2D6-Inhibitor,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
957,Idarubicin,2D6-Inhibitor,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
958,Idarubicin,2D6-Substrate,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
959,Imatinib,2D6-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
960,Imatinib,2D6-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
961,Imipramine,2D6-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
962,Imipramine,2D6-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
963,Indinavir,2D6-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
964,Indinavir,2D6-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
965,Indoramin,2D6-Substrate,O=C(N[C@H]1CCN(CC1)CCC2=CNC3=C2C=CC=C3)C4=CC=CC=C4
966,Irbesartan,2D6-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
967,Isoniazid,2D6-Inhibitor,NNC(=O)C1=CC=NC=C1
968,Itraconazole,2D6-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
969,Ketoconazole,2D6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
970,Labetalol,2D6-Inhibitor,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
971,Labetalol,2D6-Substrate,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
972,Lansoprazole,2D6-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
973,Lercanidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
974,Levodopa,2D6-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
975,Levomepromazine,2D6-Inhibitor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
976,Levomepromazine,2D6-Substrate,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
977,Lidocain,2D6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
978,Lidocain,2D6-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
979,Lisuride,2D6-Substrate,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
980,Lofepramine,2D6-Substrate,CN(CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2)CC(=O)C4=CC=C(Cl)C=C4
981,Lomustine,2D6-Substrate,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
982,Lomustine,2D6-Inhibitor,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
983,Loperamide,2D6-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
984,Lopinavir,2D6-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
985,Loratadine,2D6-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
986,Loratadine,2D6-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
987,Loratadine,2D6-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
988,Lovastatin,2D6-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
989,Manidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
990,Maprotiline,2D6-Substrate,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
991,Medrysone,2D6-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
992,Mefloquine,2D6-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
993,Melperone,2D6-Inhibitor,C[C@H]1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1
994,Memantine,2D6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
995,Mephenytoin,2D6-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
996,Mepyramine,2D6-Inhibitor,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
997,Mequitazine,2D6-Substrate,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
998,Mesoridazine,2D6-Substrate,CN1CCCC[C@H]1CCN2C3=C(SC4=C2C=C(C=C4)S(C)=O)C=CC=C3
999,Metamfetamine,2D6-Substrate,CN[C@@H](C)CC1=CC=CC=C1
1000,Metamfetamine,2D6-Inhibitor,CN[C@@H](C)CC1=CC=CC=C1
1001,Methadone,2D6-Inhibitor,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1002,Methadone,2D6-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1003,Methazolamide,2D6-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
1004,Methoxyflurane,2D6-Substrate,COC(F)(F)C(Cl)Cl
1005,Methoxyphenamine,2D6-Substrate,CN[C@@H](C)CC1=C(OC)C=CC=C1
1006,Methyldopa (levorotatory),2D6-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
1007,Methyprylon,2D6-Substrate,CCC1(CC)C(=O)NC[C@@H](C)C1=O
1008,Metoclopramide,2D6-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1009,Metoclopramide,2D6-Substrate,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1010,Metoprolol,2D6-Substrate,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
1011,Metoprolol,2D6-Inhibitor,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
1012,Mexiletine,2D6-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
1013,Mianserin,2D6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
1014,Mianserin,2D6-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
1015,Mibefradil,2D6-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
1016,Miconazole,2D6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
1017,Midodrine,2D6-Inhibitor,COC1=CC([C@H](O)CNC(=O)CN)=C(OC)C=C1
1018,Mifepristone,2D6-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
1019,Minaprine,2D6-Substrate,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3
1020,Mirtazapine,2D6-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1021,Mirtazapine,2D6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1022,Mirtazapine,2D6-Inducer,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1023,Mizolastine,2D6-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
1024,Moclobemide,2D6-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1025,Moclobemide,2D6-Inducer,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1026,Moclobemide,2D6-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1027,Morphine,2D6-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
1028,Nateglinide,2D6-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
1029,Nebivolol,2D6-Substrate,O[C@@H](CNC[C@@H](O)[C@@H]1CCC2=C(O1)C=CC(F)=C2)[C@H]3CCC4=CC(F)=CC=C4O3
1030,Nefazodone,2D6-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
1031,Nelfinavir,2D6-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
1032,Nevirapine,2D6-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
1033,Nevirapine,2D6-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
1034,Nicardipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
1035,Nicardipine,2D6-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
1036,Nicergoline,2D6-Substrate,CO[C@]12C[C@@H](COC(=O)C3=CC(Br)=CN=C3)CN(C)[C@@H]1CC4=CN(C)C5=CC=CC2=C45
1037,Nicotinamide,2D6-Inhibitor,NC(=O)C1=CC=CN=C1
1038,Nicotine,2D6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
1039,Nicotinic Acid,2D6-Inhibitor,OC(=O)C1=CC=CN=C1
1040,Nifedipine,2D6-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
1041,Nifedipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
1042,Nitrofural,2D6-Substrate,NC(=O)NN=CC1=CC=C(O1)[N+]([O-])=O
1043,Nortriptyline,2D6-Inhibitor,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
1044,Nortriptyline,2D6-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
1045,Octopamine,2D6-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
1046,Olanzapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
1047,Olanzapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
1048,Omeprazole,2D6-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
1049,Ondansetron,2D6-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
1050,Ondansetron,2D6-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
1051,Opipramol,2D6-Substrate,OCCN1CCN(CCCN2C3=C(C=CC=C3)C=CC4=C2C=CC=C4)CC1
1052,Orphenadrine (citrate),2D6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
1053,Oxamniquine,2D6-Inhibitor,CC(C)NC[C@H]1CCC2=C(N1)C=C(C(CO)=C2)[N+]([O-])=O
1054,Oxatomide,2D6-Inhibitor,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
1055,Oxatomide,2D6-Substrate,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
1056,Oxprenolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=C(OCC=C)C=CC=C1
1057,Oxybutynin,2D6-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
1058,Oxycodone,2D6-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
1059,Palonosetron,2D6-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
1060,Paracetamol,2D6-Inducer,CC(=O)NC1=CC=C(O)C=C1
1061,Paracetamol,2D6-Substrate,CC(=O)NC1=CC=C(O)C=C1
1062,Parecoxib,2D6-Inhibitor,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
1063,Paroxetine,2D6-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
1064,Paroxetine,2D6-Substrate,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
1065,Pentamidine Isethionate,2D6-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
1066,Pentoxyverine,2D6-Substrate,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
1067,Pentoxyverine,2D6-Inhibitor,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
1068,Perazine,2D6-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
1069,Perazine,2D6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
1070,Pergolide,2D6-Inhibitor,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
1071,Perhexiline,2D6-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
1072,Perhexiline,2D6-Inhibitor,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
1073,Perphenazine,2D6-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1074,Perphenazine,2D6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1075,Phenacetin,2D6-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
1076,Phenazone,2D6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1077,Phenazone,2D6-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1078,Phenformin,2D6-Substrate,NC(=N)NC(=N)NCCC1=CC=CC=C1
1079,Phentermine,2D6-Inhibitor,CC(C)(N)CC1=CC=CC=C1
1080,Pimozide,2D6-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
1081,Pindolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1082,Pindolol,2D6-Inducer,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1083,Pindolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1084,Pioglitazone,2D6-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
1085,Piperazine,2D6-Substrate,C1CNCCN1
1086,Prajmaline,2D6-Substrate,CCC[N@+]12[C@H](O)[C@@H](CC)[C@@H]3C[C@H]1[C@@H]4N(C)C5=C(C=CC=C5)[C@]46C[C@H]2[C@H]3[C@H]6O
1087,Pravastatin,2D6-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
1088,Praziquantel,2D6-Inhibitor,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
1089,Primaquine,2D6-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
1090,Procainamide,2D6-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
1091,Prochlorperazine,2D6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1092,Progesterone,2D6-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
1093,Proguanil,2D6-Inhibitor,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
1094,Promethazine,2D6-Inhibitor,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
1095,Promethazine,2D6-Substrate,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
1096,Propafenone,2D6-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
1097,Propafenone,2D6-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
1098,Propofol,2D6-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
1099,Propofol,2D6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
1100,Propranolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
1101,Propranolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
1102,Protriptyline,2D6-Substrate,CNCCC[C@H]1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
1103,Pseudoephedrine,2D6-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
1104,Pyrantel,2D6-Substrate,CN1CCCN=C1C=CC2=CC=CS2
1105,Pyrimethamine,2D6-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
1106,Quetiapine,2D6-Inhibitor,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
1107,Quetiapine,2D6-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
1108,Quinidine,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
1109,Ranitidine,2D6-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
1110,Ranitidine,2D6-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
1111,Reboxetine,2D6-Inducer,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
1112,Reboxetine,2D6-Inhibitor,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
1113,Remoxipride,2D6-Substrate,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC
1114,Rifampicin,2D6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1115,Rifampicin,2D6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1116,Rifapentine,2D6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
1117,Risperidone,2D6-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
1118,Risperidone,2D6-Inhibitor,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
1119,Ritonavir,2D6-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
1120,Ritonavir,2D6-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
1121,Rivastigmine,2D6-Inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
1122,Ropinirole,2D6-Inhibitor,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
1123,Ropivacaine,2D6-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1124,Rosiglitazone,2D6-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
1125,Roxatidine,2D6-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
1126,Rutoside,2D6-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
1127,Saquinavir,2D6-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
1128,Saquinavir,2D6-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
1129,Selegiline,2D6-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
1130,Selegiline,2D6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
1131,Sertindole,2D6-Substrate,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
1132,Sertraline,2D6-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
1133,Sertraline,2D6-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
1134,Sildenafil,2D6-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
1135,Sildenafil,2D6-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
1136,Simvastatin,2D6-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1137,Simvastatin,2D6-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1138,Ezetimibe,2D6-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
1139,Somatostatin,2D6-Inhibitor,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O
1140,Sparteine,2D6-Inhibitor,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
1141,Sparteine,2D6-Substrate,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
1142,Sulconazole,2D6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1143,Sulfanilamide,2D6-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
1144,Sulfaphenazole,2D6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
1145,Tamoxifen,2D6-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
1146,Tamoxifen,2D6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
1147,Tamsulosin,2D6-Substrate,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
1148,Tegaserod,2D6-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
1149,Tegaserod,2D6-Substrate,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
1150,Telithromycin,2D6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
1151,Terbinafine,2D6-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
1152,Terfenadine,2D6-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1153,Terfenadine,2D6-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1154,Tetrabenazine,2D6-Inhibitor,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
1155,Tetrabenazine,2D6-Substrate,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
1156,Thebacon,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@]45CCN3C
1157,Theophylline,2D6-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
1158,Thiamazole,2D6-Inhibitor,CN1C=CNC1=S
1159,Thioridazine,2D6-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
1160,Thioridazine,2D6-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
1161,Ticlopidine,2D6-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
1162,Timolol,2D6-Substrate,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
1163,Timolol,2D6-Inhibitor,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
1164,Tiotixene,2D6-Inhibitor,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
1165,Tiotropium Bromide,2D6-Substrate,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5
1166,Tolperisone,2D6-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
1167,Tolterodine,2D6-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
1168,Trabectedin,2D6-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
1169,Tramadol,2D6-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1170,Tramadol,2D6-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1171,Tranylcypromine,2D6-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
1172,Trazodone,2D6-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
1173,Trifluperidol,2D6-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC(=CC=C3)C(F)(F)F
1174,Trimipramine,2D6-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
1175,Tripelennamine,2D6-Inhibitor,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
1176,Triprolidine,2D6-Inhibitor,CC1=CC=C(C=C1)C(=C/CN2CCCC2)C3=CC=CC=N3
1177,Tropisetron,2D6-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
1178,Tropisetron,2D6-Inhibitor,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
1179,Trospium,2D6-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
1180,Venlafaxine,2D6-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
1181,Venlafaxine,2D6-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
1182,Verapamil,2D6-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
1183,Vernakalant,2D6-Substrate,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
1184,Vinblastine,2D6-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1185,Vinblastine,2D6-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1186,Vincamine,2D6-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
1187,Vinorelbine,2D6-Substrate,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
1188,Vinorelbine,2D6-Inhibitor,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
1189,Yohimbin,2D6-Inhibitor,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
1190,Yohimbin,2D6-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
1191,Zafirlukast,2D6-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
1192,Zalcitabine,2D6-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
1193,Ziprasidone,2D6-Inhibitor,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
1194,Zolpidem,2D6-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
1195,Zolpidem,2D6-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
1196,Zotepine,2D6-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
1197,Zuclopenthixol,2D6-Substrate,OCCN1CCN(CCC=C2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1
1198,Albendazole,2D6-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
1199,Amiflamine,2D6-Substrate,CC1=C(C=CC(=C1)N(C)C)CC(C)N
1200,Aminopyrine,2D6-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
1201,Amodiaquine,2D6-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
1202,Amoxapine,2D6-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
1203,Artemisinin,2D6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
1204,Avitriptan,2D6-Substrate,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
1205,Brofaromine,2D6-Substrate,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br
1206,Carbaril,2D6-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
1207,Celecoxib,2D6-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
1208,Chlorpyrifos,2D6-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
1209,Cisapride,2D6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
1210,Cyclophosphamide,2D6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
1211,Dapsone,2D6-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
1212,Dextrorphan,2D6-Substrate,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
1213,Diphenhydramine,2D6-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1214,Diprafenone,2D6-Substrate,CCC(C)(C)NCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
1215,Estradiol,2D6-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1216,Etoperidone,2D6-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
1217,Etoricoxib,2D6-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
1218,Ezlopitant,2D6-Substrate,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
1219,Fenfluramine,2D6-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
1220,Hydrocortisone,2D6-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
1221,Iloperidone,2D6-Substrate,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
1222,Ketamine,2D6-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
1223,Levacetylmethadol,2D6-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1224,Lidocaine,2D6-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
1225,m-Chlorophenylpiperazine,2D6-Substrate,C1CN(CCN1)C2=CC(=CC=C2)Cl
1226,Methiocarb,2D6-Substrate,CC1=CC(=CC(=C1SC)C)OC(=O)NC
1227,Milameline,2D6-Substrate,CN1CCC=C(C1)C=NOC
1228,Mizolastine,2D6-Substrate,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
1229,Molindone,2D6-Substrate,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
1230,Nelfinavir,2D6-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
1231,Norcodeine,2D6-Substrate,COC1=C2C3=C(CC4C5C3(CCN4)C(O2)C(C=C5)O)C=C1
1232,Omeprazole,2D6-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
1233,Orphenadrine,2D6-Substrate,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
1234,Papaverine,2D6-Substrate,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
1235,Parathion,2D6-Substrate,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
1236,Penbutolol,2D6-Substrate,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O
1237,Pentazocine,2D6-Substrate,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
1238,Pethidine,2D6-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
1239,Phenytoin,2D6-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
1240,Pinacidil,2D6-Substrate,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
1241,Praziquantel,2D6-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
1242,Pregnenolone,2D6-Substrate,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
1243,Primaquine,2D6-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
1244,Promazine,2D6-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
1245,Tauromustine,2D6-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
1246,Terguride,2D6-Substrate,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
1247,Testosterone,2D6-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1248,Tiagabine,2D6-Substrate,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
1249,Trichloromethane,2D6-Substrate,C(Cl)(Cl)Cl
1250,Troglitazone,2D6-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
1251,Valdecoxib,2D6-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
1252,Warfarin,2D6-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
1253,Yohimbine,2D6-Substrate,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
1254,Abacavir,-,NC1=NC2=C(N=CN2[C@H]3C[C@@H](CO)C=C3)C(N[C@H]4CC4)=N1
1255,Abecarnil,-,CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4
1256,Acebutolol,-,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
1257,Aceclofenac,-,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
1258,Acenocoumarol,-,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
1259,Acetanilide,-,CC(=O)NC1=CC=CC=C1
1260,Acetazolamide,-,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
1261,Acetone,-,CC(=O)C
1262,Acetylsalicylic acid,-,CC(=O)OC1=CC=CC=C1C(=O)O
1263,Adinazolam,-,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
1264,Ajmaline,-,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
1265,Alosetron,-,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
1266,Alpidem,-,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
1267,Alprazolam,-,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
1268,Ambroxol,-,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
1269,Aminoglutethimide,-,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
1270,Amlodipine,-,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
1271,Anastrozole,-,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
1272,Aniline,-,C1=CC=C(C=C1)N
1273,Anthraquinone,-,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O
1274,Apomorphine,-,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
1275,Aprepitant,-,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
1276,Argatroban,-,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
1277,Artesunate,-,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
1278,Atazanavir,-,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
1279,Atorvastatin,-,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
1280,Atovaquone,-,OC1=C([C@H]2CC[C@@H](CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O
1281,Avasimibe,-,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
1282,Azacyclonol,-,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O
1283,Azamulin,-,CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C
1284,Azapropazone,-,CCC[C@H]1C(=O)N2N(C1=O)C(=NC3=C2C=C(C)C=C3)N(C)C
1285,Azatadine,-,CN1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=CC=C3
1286,Azimilide,-,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl
1287,Azithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
1288,Barnidipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
1289,Benzbromarone,-,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
1290,Benzene,-,C1=CC=CC=C1
1291,Benzfetamine,-,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
1292,Bepridil,-,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
1293,Betamethasone,-,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
1294,Bexarotene,-,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
1295,Bezafibrate,-,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
1296,Bifluranol,-,CCC(C1=CC(=C(C=C1)O)F)C(C)C2=CC(=C(C=C2)O)F
1297,Bifonazole,-,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
1298,Biperiden,-,O[C@](CCN1CCCCC1)([C@@H]2C[C@H]3C[C@@H]2C=C3)C4=CC=CC=C4
1299,Boldenone,-,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C
1300,Bosentan,-,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
1301,Brinzolamide,-,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
1302,Bromazepam,-,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
1303,Bromocriptine,-,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
1304,Bropirimine,-,C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br
1305,Brotizolam,-,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(Br)=C4)N12
1306,Budesonide,-,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
1307,Budipine,-,CC(C)(C)N1CC[C@](CC1)(C2=CC=CC=C2)C3=CC=CC=C3
1308,Bupropion,-,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
1309,Busulfan,-,CS(=O)(=O)OCCCCOS(C)(=O)=O
1310,Calcium folinate,-,C1C(N(C2=C(N1)N=C(N=C2[O-])N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Ca+2]
1311,Candesartan,-,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
1312,Capravirine,-,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl
1313,Carbimazole,-,CCOC(=O)N1C=CN(C1=S)C
1314,Carisoprodol,-,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C
1315,Cathinone,-,CC(C(=O)C1=CC=CC=C1)N
1316,Cerivastatin,-,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
1317,Chenodeoxycholic acid,-,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
1318,Chloral hydrate,-,C(C(Cl)(Cl)Cl)(O)O
1319,Chloramphenicol,-,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
1320,Chlordiazepoxide,-,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
1321,Chlormadinone,-,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1322,Ciclosporin,-,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
1323,Cilnidipine,-,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
1324,Cilostazol,-,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
1325,Cimetidine,-,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
1326,Ciprofibrate,-,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
1327,Clemastine,-,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1328,Clindamycin,-,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
1329,Clofazimine,-,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
1330,Clofibrate,-,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
1331,Clofibric acid,-,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
1332,Clomethiazole,-,CC1=C(CCCl)SC=N1
1333,Clopidogrel,-,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
1334,Clotrimazole,-,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
1335,Cocaine,-,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
1336,Colchicine,-,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
1337,Colecalciferol,-,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
1338,Colestyramine,-,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
1339,Cortisol,-,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
1340,Cortisone,-,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
1341,Cotinine,-,CN1C(CCC1=O)C2=CN=CC=C2
1342,Coumarin,-,C1=CC=C2C(=C1)C=CC(=O)O2
1343,Cyproterone,-,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
1344,Dacarbazine,-,CN(C)N=NC1=C(N=CN1)C(N)=O
1345,Dalfopristin,-,CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C
1346,Danazol,-,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
1347,Dantrolene,-,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
1348,Daunorubicin,-,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
1349,Dazoxiben,-,C1=CC(=CC=C1C(=O)O)OCCN2C=CN=C2
1350,Desogestrel,-,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
1351,Dexloxiglumide,-,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl
1352,Dexmedetomidine,-,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
1353,Dextropropoxyphene,-,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
1354,Dicoumarol,-,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
1355,Dieldrin,-,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl
1356,Diethylcarbamazine,-,CCN(CC)C(=O)N1CCN(C)CC1
1357,Diethylstilbestrol,-,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
1358,Difloxacin,-,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F
1359,Digitoxin,-,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
1360,Digoxin,-,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
1361,Dihydralazine,-,NNC1=NN=C(NN)C2=C1C=CC=C2
1362,Dihydroergotamine,-,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
1363,Dimethyl sulfoxide,-,CS(=O)C
1364,Diosmin,-,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
1365,Dipotassium clorazepate,-,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O.[OH-].[K+].[K+]
1366,Dirithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
1367,Disopyramide,-,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
1368,Disulfamide,-,CC1=CC(=C(C=C1S(=O)(=O)N)S(=O)(=O)N)Cl
1369,Disulfiram,-,CCN(CC)C(=S)SSC(=S)N(CC)CC
1370,Ditiocarb sodium,-,CCN(CC)C(=S)[S-].[Na+]
1371,Docetaxel,-,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
1372,Dofetilide,-,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2
1373,Dorzolamide,-,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
1374,Doxycycline,-,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
1375,Dronabinol,-,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
1376,Drospirenone,-,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
1377,Dutasteride,-,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
1378,Ebastine,-,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
1379,Ebrotidine,-,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
1380,Ecabapide,-,CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC
1381,Econazole,-,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1382,Efavirenz,-,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
1383,Efonidipine,-,CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5
1384,Eletriptan,-,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
1385,Enalapril,-,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
1386,Enflurane,-,FC(F)OC(F)(F)[C@H](F)Cl
1387,Entacapone,-,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
1388,Epinephrine,-,CNC[C@H](O)C1=CC(O)=C(O)C=C1
1389,Eplerenone,-,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
1390,Eprosartan,-,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
1391,Ergotamine,-,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
1392,Erythromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1393,Estrone,-,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
1394,Ethanol,-,CCO
1395,Ethinylestradiol,-,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
1396,Ethosuximide,-,CC[C@]1(C)CC(=O)NC1=O
1397,Ethylbenzene,-,CCC1=CC=CC=C1
1398,Etomidate,-,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
1399,Etonogestrel,-,CC[C@@]12CC(=C)[C@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@@H]1CC[C@@]2(O)C#C
1400,Etoposide,-,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
1401,Everolimus,-,CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
1402,Exemestane,-,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
1403,Fadrozole,-,C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N
1404,Famotidine,-,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
1405,Felbamate,-,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
1406,Felodipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
1407,Fenofibrate,-,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
1408,Fentanyl,-,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
1409,Fexofenadine,-,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1410,Finasteride,-,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
1411,Flosequinan,-,COSC1=CN(C)C2=C(C=CC(F)=C2)C1=O
1412,Flucloxacillin,-,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
1413,Fluconazole,-,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1414,Flufenamic acid,-,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F
1415,Flunitrazepam,-,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
1416,Fluorouracil,-,FC1=CNC(=O)NC1=O
1417,Fluparoxan,-,C1C2C(CN1)OC3=C(O2)C=CC=C3F
1418,Flurazepam,-,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
1419,Flurbiprofen,-,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
1420,Flurithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1421,Flutamide,-,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
1422,Fluticasone,-,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
1423,Fosphenytoin,-,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
1424,Frovatriptan,-,CN[C@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O
1425,Furafylline,-,CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C
1426,Gallopamil,-,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
1427,Ganaxolone,-,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C
1428,Gefitinib,-,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
1429,Gemfibrozil,-,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
1430,Gestodene,-,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
1431,Glibenclamide,-,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
1432,Gliclazide,-,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
1433,Glimepiride,-,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
1434,Glyceryl trinitrate,-,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
1435,Granisetron,-,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
1436,Grepafloxacin,-,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
1437,Griseofulvin,-,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
1438,Guanabenz,-,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
1439,Hexobarbital,-,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
1440,Homochlorcyclizine,-,CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
1441,Hydralazine,-,NN=C1NN=CC2=C1C=CC=C2
1442,Hydroxychloroquine,-,CCN(CCO)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
1443,Hydroxyzine,-,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1444,Ibuprofen,-,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
1445,Ibutilide,-,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
1446,Ifosfamide,-,ClCCN[P@@]1(=O)OCCCN1CCCl
1447,Imatinib,-,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
1448,Imiquimod,-,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
1449,Indometacin,-,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
1450,Ipriflavone,-,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
1451,Irbesartan,-,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
1452,Irinotecan,-,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
1453,Isbogrel,-,C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2
1454,Isoflurane,-,FC(F)O[C@@H](Cl)C(F)(F)F
1455,Isoniazid,-,NNC(=O)C1=CC=NC=C1
1456,Isosorbide dinitrate,-,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
1457,Isradipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
1458,Itraconazole,-,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
1459,Ivermectin,-,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
1460,Josamycin,-,CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O
1461,Ketoconazole,-,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
1462,Ketoprofen,-,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
1463,Lacidipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)C=CC(=O)OC(C)(C)C)C(=O)OCC
1464,Leflunomide,-,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
1465,Letrozole,-,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
1466,Levobupivacaine,-,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1467,Levofloxacin,-,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
1468,Levomepromazine,-,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
1469,Levothyroxine sodium,-,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]
1470,Liarozole,-,C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4
1471,Lilopristone,-,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
1472,Linezolid,-,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
1473,Liothyronine,-,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
1474,Lisofylline,-,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
1475,Litoxetine,-,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2
1476,Lomustine,-,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
1477,Lopinavir,-,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
1478,Losigamone,-,COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O
1479,Lovastatin,-,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1480,Lumefantrine,-,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O
1481,Malathion,-,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
1482,Manidipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
1483,Mebendazole,-,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
1484,Medazepam,-,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
1485,Medifoxamine,-,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
1486,Medroxyprogesterone,-,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
1487,Mefenamic acid,-,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
1488,Mefloquine,-,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
1489,Mepacrine,-,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
1490,Mepyramine,-,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
1491,Methaqualone,-,CC1=C(C=CC=C1)N2C(C)=NC3=C(C=CC=C3)C2=O
1492,Methomyl,-,CC(=NOC(=O)NC)SC
1493,Methoxsalen,-,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
1494,Methoxyflurane,-,COC(F)(F)C(Cl)Cl
1495,Methylergometrine,-,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
1496,Methylphenidate,-,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
1497,Methylprednisolone,-,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
1498,Metronidazole,-,CC1=NC=C(N1CCO)[N+]([O-])=O
1499,Metyrapone,-,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
1500,Mevastatin,-,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O
1501,Mexazolam,-,CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl
1502,Mibefradil,-,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
1503,Midecamycin,-,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
1504,Mifepristone,-,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
1505,Milnacipran,-,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2
1506,Minoxidil,-,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
1507,Mitoxantrone,-,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
1508,Moclobemide,-,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1509,Montelukast,-,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
1510,Moracizine,-,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
1511,Mosapride,-,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
1512,Nafcillin,-,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O
1513,Nalidixic acid,-,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O
1514,Naproxen,-,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
1515,Nateglinide,-,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
1516,Nefazodone,-,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
1517,Nefiracetam,-,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
1518,Niclosamide,-,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
1519,Niludipine,-,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCCC)C)C
1520,Nimodipine,-,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
1521,Nimorazole,-,C1COCCN1CCN2C=NC=C2[N+](=O)[O-]
1522,Nisoldipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
1523,Nitrendipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
1524,Nitrosamine,-,NN=O
1525,Norethisterone,-,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
1526,Norfloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
1527,Ofloxacin,-,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
1528,Olopatadine,-,CN(C)CCC=C1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2
1529,Oltipraz,-,CC1=C(SSC1=S)C2=NC=CN=C2
1530,Omapatrilat,-,C1CC(N2C(C1)SCCC(C2=O)NC(=O)C(CC3=CC=CC=C3)S)C(=O)O
1531,Oxamniquine,-,CC(C)NC[C@H]1CCC2=C(N1)C=C(C(CO)=C2)[N+]([O-])=O
1532,Oxcarbazepine,-,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
1533,Oxiconazole,-,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1534,Oxodipine,-,CCOC(=O)C1=C(NC(=C(C1C2=C3C(=CC=C2)OCO3)C(=O)OC)C)C
1535,Oxprenolol,-,CC(C)NC[C@@H](O)COC1=C(OCC=C)C=CC=C1
1536,Oxybutynin,-,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
1537,Paclitaxel,-,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
1538,Pantoprazole,-,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
1539,Parecoxib,-,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
1540,Pargyline,-,CN(CC#C)CC1=CC=CC=C1
1541,Pefloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(F)=C2
1542,Pentamidine,-,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
1543,Pergolide,-,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
1544,Phenazone,-,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1545,Phencyclidine,-,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
1546,Phenobarbital,-,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
1547,Phenol,-,OC1=CC=CC=C1
1548,Phenprocoumon,-,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
1549,Phensuximide,-,CN1C(=O)C[C@@H](C1=O)C2=CC=CC=C2
1550,Phenylbutazone,-,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
1551,Pilocarpine,-,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
1552,Pimozide,-,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
1553,Pipemidic acid,-,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCNCC3)C(=O)O
1554,Piroxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
1555,Plomestane,-,CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34CC#C
1556,Pramipexole,-,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
1557,Pranidipine,-,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
1558,Prasterone,-,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
1559,Pravastatin,-,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
1560,Prednisolone,-,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
1561,Primidone,-,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
1562,Proadifen,-,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
1563,Probenecid,-,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
1564,Proguanil,-,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
1565,Propanol,-,CCCO
1566,Pyridostigmine bromide,-,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]
1567,Pyrimethamine,-,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
1568,Quercetin,-,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
1569,Quinelorane,-,CCCN1CCCC2C1CC3=CN=C(N=C3C2)N
1570,Quinine,-,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
1571,Quinupristin,-,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
1572,Rabeprazole,-,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
1573,Raloxifene,-,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
1574,Ranolazine,-,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
1575,Rebamipide,-,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
1576,Remacemide,-,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN
1577,Repaglinide,-,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
1578,Reserpine,-,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
1579,Resiquimod,-,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
1580,Rifabutin,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
1581,Rifampicin,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1582,Rifamycin,-,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1583,Rifapentine,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
1584,Riluzole,-,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
1585,Rofecoxib,-,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
1586,Rokitamycin,-,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
1587,Ropinirole,-,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
1588,Roquinimex,-,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O
1589,Rosiglitazone,-,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
1590,Rosuvastatin,-,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
1591,Roxatidine,-,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
1592,Roxithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
1593,Rupatadine,-,CC1=CC(CN2CCC(CC2)=C3/C4=C(CCC5=C3N=CC=C5)C=C(Cl)C=C4)=CN=C1
1594,Salbutamol,-,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
1595,Salicylic acid,-,C1=CC=C(C(=C1)C(=O)O)O
1596,Salmeterol,-,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
1597,Secobarbital,-,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
1598,Seratrodast,-,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
1599,Sevoflurane,-,FCOC(C(F)(F)F)C(F)(F)F
1600,Sibutramine,-,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
1601,Sirolimus,-,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
1602,Spironolactone,-,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
1603,Sufentanil,-,CCC(=O)N(C1=CC=CC=C1)[C@]2(CCN(CCC3=CC=CS3)CC2)COC
1604,Sulconazole,-,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1605,Sulfadimethoxine,-,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
1606,Sulfadimidine,-,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
1607,Sulfafurazole,-,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
1608,Sulfamethoxazole,-,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
1609,Sulfamoxole,-,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
1610,Sulfanilamide,-,NC1=CC=C(C=C1)S(N)(=O)=O
1611,Sulfaphenazole,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
1612,Sulfapyridine,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
1613,Sulfasalazine,-,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
1614,Sulfinpyrazone,-,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
1615,Sulpiride,-,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
1616,Tacrine,-,NC1=C2CCCCC2=NC3=C1C=CC=C3
1617,Tacrolimus,-,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
1618,Tadalafil,-,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
1619,Tasosartan,-,CC1=NC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5)C(C)=N1
1620,Tazanolast,-,CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2
1621,Tazofelone,-,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2
1622,Tecastemizole,-,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
1623,Tegafur,-,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
1624,Telmisartan,-,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
1625,Temazepam,-,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
1626,Teniposide,-,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
1627,Tenofovir,-,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O
1628,Tenoxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
1629,Terbinafine,-,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
1630,Testolactone,-,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C
1631,Tezosentan,-,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
1632,Thalidomide,-,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
1633,Theobromine,-,CN1C=NC2=C1C(=O)NC(=O)N2C
1634,Thiamazole,-,CN1C=CNC1=S
1635,Thiotepa,-,S=P(N1CC1)(N2CC2)N3CC3
1636,Tiabendazole,-,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
1637,Tiaramide,-,C1CN(CCN1CCO)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O
1638,Ticlopidine,-,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
1639,Tienilic acid,-,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
1640,Timoprazole,-,C1=CC=C2C(=C1)NC(=N2)S(=O)CC3=CC=CC=N3
1641,Tinidazole,-,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
1642,Tioconazole,-,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
1643,Tiotixene,-,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
1644,Tipranavir,-,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
1645,Tirilazad,-,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN5CCN(CC5)C6=CC(=NC(=N6)N7CCCC7)N8CCCC8
1646,Tocainide,-,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
1647,Tolbutamide,-,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
1648,Tolcapone,-,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
1649,Toluene,-,CC1=CC=CC=C1
1650,Topiramate,-,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
1651,Torasemide,-,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
1652,Toremifene,-,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
1653,Tranylcypromine,-,N[C@H]1C[C@@H]1C2=CC=CC=C2
1654,Trapidil,-,CCN(CC)C1=CC(=NC2=NC=NN12)C
1655,Tretinoin,-,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
1656,Trichloroethylene,-,ClC=C(Cl)Cl
1657,Trifluoperazine,-,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
1658,Trimetazidine,-,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
1659,Trimethadione,-,CN1C(=O)OC(C)(C)C1=O
1660,Trimethoprim,-,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
1661,Trimetrexate,-,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
1662,Tripelennamine,-,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
1663,Triprolidine,-,CC1=CC=C(C=C1)C(=C/CN2CCCC2)C3=CC=CC=N3
1664,Trofosfamide,-,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
1665,Troleandomycin,-,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
1666,Trospium chloride,-,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
1667,Valproic acid,-,CCCC(CCC)C(=O)O
1668,Valspodar,-,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
1669,Vanoxerine,-,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
1670,Verapamil,-,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
1671,Vesnarinone,-,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC
1672,Vinblastine,-,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1673,Vincristine,-,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1674,Vindesine,-,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
1675,Voriconazole,-,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1676,Zafirlukast,-,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
1677,Zaleplon,-,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
1678,Zaltoprofen,-,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
1679,Zatosetron,-,CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C
1680,Zidovudine,-,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
1681,Zileuton,-,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
1682,Ziprasidone,-,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
1683,Zolmitriptan,-,CN(C)CCC1=CNC2=C1C=C(C[C@H]3COC(=O)N3)C=C2
1684,Zonisamide,-,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
1685,Zopiclone,-,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
1686,Zoxazolamine,-,C1=CC2=C(C=C1Cl)N=C(O2)N
1687,Bromperidol,2D6-Substrate,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
1688,Bufuralol,2D6-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
1689,Bunitrolol,2D6-Substrate,CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
1690,Carbamazepine,2D6-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
1691,Cinnarizine,2D6-Substrate,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
1692,Demethylcitalopram,2D6-Substrate,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
1693,Fluperlapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
1694,Hydroxyamfetamine,2D6-Substrate,CC(CC1=CC=C(C=C1)O)N
1695,Norfluoxetine,2D6-Substrate,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
1696,Perospirone,2D6-Substrate,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
1697,Abiraterone,-,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O
1698,Alfentanil,-,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
1699,Amifloxacin,-,CNN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O
1700,Aranidipine,-,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
1701,Atamestane,-,CC1=CC(=O)C=C2C1(C3CCC4(C(C3CC2)CCC4=O)C)C
1702,Beclometasone,-,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
1703,Benidipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
1704,Cetirizine,-,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1705,Chlorproguanil,-,CC(C)N=C(N)N=C(N)NC1=CC(=C(C=C1)Cl)Cl
1706,Ciprofloxacin,-,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
1707,Clarithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
1708,Clonazepam,-,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
1709,Corticosterone,-,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
1710,Delapril,-,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2
1711,Desloratadine,-,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
1712,Dexamethasone,-,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
1713,Diazepam,-,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
1714,Diclofenac,-,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
1715,Domperidone,-,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
1716,Doxorubicin,-,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
1717,Emedastine,-,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
1718,Emivirine,-,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2
1719,Enoxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
1720,Ergometrine,-,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
1721,Ethotoin,-,CCN1C(=O)N[C@H](C1=O)C2=CC=CC=C2
1722,Gatifloxacin,-,COC1=C(N2CCN[C@@H](C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)[C@H]4CC4
1723,Glipizide,-,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
1724,Hydroquinidine,-,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O
1725,Isoconazole,-,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
1726,Lansoprazole,-,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
1727,Lercanidipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
1728,Levonorgestrel,-,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
1729,Lobeline,-,CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O
1730,Lomefloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
1731,Lornoxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
1732,Losartan,-,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
1733,Meloxicam,-,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
1734,Mephenytoin,-,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
1735,Mestranol,-,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC
1736,Methylphenobarbital,-,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
1737,Miconazole,-,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
1738,Midazolam,-,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
1739,Modafinil,-,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
1740,Nilutamide,-,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
1741,Nilvadipine,-,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
1742,Nordazepam,-,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
1743,Onapristone,-,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
1744,Oxomemazine,-,C[C@H](CN(C)C)CN1C2=C(C=CC=C2)S(=O)(=O)C3=C1C=CC=C3
1745,Paraxanthine,-,CN1C=NC2=C1C(=O)N(C(=O)N2)C
1746,Pentobarbital,-,CCC[C@@H](C)[C@@]1(CC)C(=O)NC(=O)NC1=O
1747,Pentoxifylline,-,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
1748,Pilsicainide,-,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
1749,Pimobendan,-,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
1750,Pioglitazone,-,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
1751,Prednisone,-,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
1752,Reboxetine,-,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
1753,Rogletimide,-,CCC1(CCC(=O)NC1=O)C2=CC=NC=C2
1754,Simvastatin,-,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1755,Stiripentol,-,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
1756,Styrene,-,C=CC1=CC=CC=C1
1757,Sulfadiazine,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
1758,Sulfadoxine,-,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
1759,Sulfamerazine,-,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
1760,Sulfamethizole,-,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
1761,Sulfatroxazole,-,CC1=C(ON=C1NS(=O)(=O)C2=CC=C(C=C2)N)C
1762,Sulindac,-,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
1763,Suprofen,-,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
1764,Tetracycline,-,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
1765,Triazolam,-,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
1766,Valsartan,-,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
1767,Vorozole,-,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
1768,Almotriptan,2D6-Inhibitor,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
1769,Alprenolol,2D6-Inhibitor,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
1770,Amoxapine,2D6-Inhibitor,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
1771,Astemizole,2D6-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
1772,Atorvastatin,2D6-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
1773,Azacyclonol,2D6-Inhibitor,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O
1774,Bepridil,2D6-Inhibitor,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
1775,Bufuralol,2D6-Inhibitor,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
1776,Bupranolol,2D6-Inhibitor,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
1777,Cathinone,2D6-Inhibitor,CC(C(=O)C1=CC=CC=C1)N
1778,Cerivastatin,2D6-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
1779,Chloramphenicol,2D6-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
1780,Debrisoquine,2D6-Inhibitor,NC(=N)N1CCC2=C(C1)C=CC=C2
1781,Dimethyl sulfoxide,2D6-Inhibitor,CS(=O)C
1782,Diphenhydramine,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1783,Erythromycin,2D6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1784,Etoperidone,2D6-Inhibitor,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
1785,Ezlopitant,2D6-Inhibitor,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
1786,Hydroquinidine,2D6-Inhibitor,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O
1787,Lidocaine,2D6-Inhibitor,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
1788,Maprotiline,2D6-Inhibitor,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
1789,Mepacrine,2D6-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
1790,Methoxsalen,2D6-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
1791,Methylphenidate,2D6-Inhibitor,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
1792,Midazolam,2D6-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
1793,Niclosamide,2D6-Inhibitor,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
1794,Orphenadrine,2D6-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
1795,Pargyline,2D6-Inhibitor,CN(CC#C)CC1=CC=CC=C1
1796,Pentamidine,2D6-Inhibitor,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
1797,Pramipexole,2D6-Inhibitor,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
1798,Proadifen,2D6-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
1799,Quercetin,2D6-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
1800,Riluzole,2D6-Inhibitor,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
1801,Seratrodast,2D6-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
1802,Sertindole,2D6-Inhibitor,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
1803,Stiripentol,2D6-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
1804,Tioconazole,2D6-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
1805,Tolperisone,2D6-Inhibitor,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
1806,Trimethoprim,2D6-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
1807,Trimipramine,2D6-Inhibitor,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
1808,Troglitazone,2D6-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
1809,Trospium chloride,2D6-Inhibitor,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
1810,Valdecoxib,2D6-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
1811,Valproic acid,2D6-Inhibitor,CCCC(CCC)C(=O)O
1812,Vincristine,2D6-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1813,Yohimbine,2D6-Inhibitor,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
1814,Zileuton,2D6-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
1815,Albendazole,-,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
1816,Amfetamine,-,C[C@@H](N)CC1=CC=CC=C1
1817,Amiflamine,-,CC1=C(C=CC(=C1)N(C)C)CC(C)N
1818,Aminopyrine,-,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
1819,Amodiaquine,-,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
1820,Amprenavir,-,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
1821,Aprindine,-,CCN(CC)CCCN([C@H]1CC2=CC=CC=C2C1)C3=CC=CC=C3
1822,Aripiprazole,-,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
1823,Artemisinin,-,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
1824,Atomoxetine,-,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
1825,Avitriptan,-,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
1826,Benzydamine,-,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
1827,Bisoprolol,-,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
1828,Bortezomib,-,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
1829,Brofaromine,-,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br
1830,Bromperidol,-,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
1831,Buflomedil,-,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
1832,Bunitrolol,-,CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
1833,Caffeine,-,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1834,Captopril,-,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
1835,Carbaril,-,CNC(=O)OC1=CC=CC2=CC=CC=C21
1836,Carteolol,-,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
1837,Carvedilol,-,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
1838,Cevimeline,-,CC1O[C@@]2(CS1)CN1CCC2CC1
1839,Chlorpyrifos,-,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
1840,Chlorzoxazone,-,OC1=NC2=C(O1)C=CC(Cl)=C2
1841,Cibenzoline,-,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
1842,Cyclobenzaprine,-,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
1843,Dapsone,-,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
1844,Dextrorphan,-,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
1845,Dihydrocodeine,-,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
1846,Diprafenone,-,CCC(C)(C)NCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
1847,Dolasetron,-,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
1848,Encainide,-,COC1=CC=C(C=C1)C(=O)NC2=C(C=CC=C2)[C@H](C)CN3CCCCC3
1849,Epinastine,-,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
1850,Escitalopram,-,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
1851,Estradiol,-,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1852,Ethylmorphine,-,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
1853,Fenfluramine,-,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
1854,Flunarizine,-,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
1855,Galantamine,-,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
1856,Gepirone,-,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
1857,Guanoxan,-,NC(=N)NC[C@H]1COC2=C(O1)C=CC=C2
1858,Halothane,-,FC(F)(F)[C@@H](Cl)Br
1859,Hydrocodone,-,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
1860,Hydroxyamfetamine,-,CC(CC1=CC=C(C=C1)O)N
1861,Iloperidone,-,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
1862,Ketamine,-,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
1863,Levacetylmethadol,-,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1864,m-Chlorophenylpiperazine,-,C1CN(CCN1)C2=CC(=CC=C2)Cl
1865,Mequitazine,-,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
1866,Metamfetamine,-,CN[C@@H](C)CC1=CC=CC=C1
1867,Methiocarb,-,CC1=CC(=CC(=C1SC)C)OC(=O)NC
1868,Milameline,-,CN1CCC=C(C1)C=NOC
1869,Minaprine,-,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3
1870,Molindone,-,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
1871,Nevirapine,-,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
1872,Norcodeine,-,COC1=C2C3=C(CC4C5C3(CCN4)C(O2)C(C=C5)O)C=C1
1873,Papaverine,-,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
1874,Parathion,-,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
1875,Penbutolol,-,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O
1876,Pentazocine,-,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
1877,Perospirone,-,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
1878,Pethidine,-,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
1879,Phenacetin,-,CCOC1=CC=C(NC(C)=O)C=C1
1880,Phenformin,-,NC(=N)NC(=N)NCCC1=CC=CC=C1
1881,Phenytoin,-,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
1882,Pinacidil,-,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
1883,Pregnenolone,-,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
1884,Procainamide,-,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
1885,Promazine,-,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
1886,Pyrantel,-,CN1CCCN=C1C=CC2=CC=CS2
1887,Quetiapine,-,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
1888,Remoxipride,-,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC
1889,Ropivacaine,-,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1890,Sildenafil,-,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
1891,Tamsulosin,-,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
1892,Tauromustine,-,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
1893,Terguride,-,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
1894,Theophylline,-,CN1C(=O)N(C)C2=C(NC=N2)C1=O
1895,Tiagabine,-,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
1896,Tolterodine,-,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
1897,Tramadol,-,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1898,Trazodone,-,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
1899,Trichloromethane,-,C(Cl)(Cl)Cl
1900,Trifluperidol,-,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC(=CC=C3)C(F)(F)F
1901,Warfarin,-,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
1902,Zotepine,-,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
1903,Zuclopenthixol,-,OCCN1CCN(CCC=C2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1
1904,Fluperlapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
1905,Lobeline,2D6-Inhibitor,CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O
1906,Norfluoxetine,2D6-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
1907,Quinine,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
1908,Bupivacaine,-,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1909,Buspirone,-,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
1910,Carbamazepine,-,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
1911,Cinnarizine,-,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
1912,Cyclophosphamide,-,ClCCN(CCCl)[P@]1(=O)NCCCO1
1913,Demethylcitalopram,-,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
1914,Donepezil,-,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
1915,Doxepin,-,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
1916,Hydrocortisone,-,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
1917,Indoramin,-,O=C(N[C@H]1CCN(CC1)CCC2=CNC3=C2C=CC=C3)C4=CC=CC=C4
1918,Lisuride,-,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
1919,Mexiletine,-,C[C@H](N)COC1=C(C)C=CC=C1C
1920,Morphine,-,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
1921,Nicotine,-,CN1CCC[C@H]1C2=CC=CN=C2
1922,Opipramol,-,OCCN1CCN(CCCN2C3=C(C=CC=C3)C=CC4=C2C=CC=C4)CC1
1923,Oxycodone,-,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
1924,Paracetamol,-,CC(=O)NC1=CC=C(O)C=C1
1925,Progesterone,-,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
1926,Testosterone,-,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1927,Clofibrate,P450_HP-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
1928,Midazolam,P450_HP-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
1929,Phenobarbital,P450_HP-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
1930,Progesterone,P450_HP-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
1931,Sodium Sulfate,P450_HP-Inducer,[O-]S([O-])(=O)=O
1932,Testosterone,P450_HP-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1933,Thiamine (vit B1),P450_HP-Inducer,CC1=NC(N)=C(C[N+]2=CSC(CCO)=C2C)C=N1
1934,Cisplatin,High_affinity_copper_uptake_protein_1-Inhibitor,N[Pt](N)(Cl)Cl
1935,Cisplatin,High_affinity_copper_uptake_protein_1-Substrate,N[Pt](N)(Cl)Cl
1936,Copper Sulfate,High_affinity_copper_uptake_protein_1-Substrate,[O-]S([O-])(=O)=O
1937,Copper Sulfate,High_affinity_copper_uptake_protein_1-Inhibitor,[O-]S([O-])(=O)=O
1938,Estradiol,High_affinity_copper_uptake_protein_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1939,Silver,High_affinity_copper_uptake_protein_1-Inhibitor,[Ag]
1940,Silver,High_affinity_copper_uptake_protein_1-Substrate,[Ag]
1941,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1C1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1942,Aldosterone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
1943,Aminogluthetimide,Steroid_11_beta_hydroxylase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
1944,Angiotensinamide,Steroid_11_beta_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
1945,Cimetidine,Steroid_11_beta_hydroxylase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
1946,Clotrimazole,Steroid_11_beta_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
1947,Corticotropin,Steroid_11_beta_hydroxylase-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
1948,Desoxycortone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
1949,Dexamethasone,Steroid_11_beta_hydroxylase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
1950,Etomidate,Steroid_11_beta_hydroxylase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
1951,Fluconazole,Steroid_11_beta_hydroxylase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1952,Hydrocortisone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
1953,Ketoconazole,Steroid_11_beta_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
1954,Metoclopramide,Steroid_11_beta_hydroxylase-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1955,Metyrapone,Steroid_11_beta_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
1956,Mibefradil,Steroid_11_beta_hydroxylase-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
1957,Miconazole,Steroid_11_beta_hydroxylase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
1958,Phenytoin,Steroid_11_beta_hydroxylase-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
1959,Spironolactone,Steroid_11_beta_hydroxylase-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
1960,Spironolactone,Steroid_11_beta_hydroxylase-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
1961,Acriflavinium Chloride,1B1-Inducer,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
1962,Amodiaquine,1B1-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
1963,Arsenic Trioxide,1B1-Inhibitor,O=[As]1=[As](=O)O1
1964,Biotin,1B1-Inducer,OC(=O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@@H]12
1965,Caffeine,1B1-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
1966,Clozapine,1B1-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
1967,Daunorubicin,1B1-Inhibitor,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
1968,Dibutylphthalate,1B1-Substrate,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
1969,Diosmectite,1B1-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
1970,Docetaxel,1B1-Inducer,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
1971,Docetaxel,1B1-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
1972,Docetaxel,1B1-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
1973,Doxorubicin,1B1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
1974,Doxycycline,1B1-Inhibitor,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
1975,Erythromycin,1B1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1976,Estradiol,1B1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1977,Estrone,1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
1978,Flutamide,1B1-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
1979,Flutamide,1B1-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
1980,Hydrocortisone,1B1-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
1981,Hydrogen Peroxide,1B1-Substrate,OO
1982,Ketoconazole,1B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
1983,Lansoprazole,1B1-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
1984,Melatonin,1B1-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
1985,Metharbital,1B1-Inducer,CCC1(CC)C(=O)NC(=O)N(C)C1=O
1986,Mitobronitol,1B1-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
1987,Mitoxantrone,1B1-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
1988,Omeprazole,1B1-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
1989,Oxaliplatin,1B1-Substrate,N[C@@H]1CCCC[C@H]1N
1990,Oxolamine,1B1-Inducer,CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2
1991,Paclitaxel,1B1-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
1992,Phenobarbital,1B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
1993,Primaquine,1B1-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
1994,Procarbazine,1B1-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
1995,Progesterone,1B1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
1996,Retinol (vit A),1B1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
1997,Rifampicin,1B1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1998,Rosuvastatin,1B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
1999,Salicylamide,1B1-Inhibitor,NC(=O)C1=C(O)C=CC=C1
2000,Tamoxifen,1B1-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2001,Testosterone,1B1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2002,Theophylline,1B1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2003,Tryptophan,1B1-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
2004,Etoposide,Proton_coupled_folate_transporter-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2005,Folic Acid,Proton_coupled_folate_transporter-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
2006,Methotrexate,Proton_coupled_folate_transporter-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2007,Pemetrexed,Proton_coupled_folate_transporter-Substrate,NC1=NC2=C(C(=O)N1)C(CCC3=CC=C(C=C3)C(=O)N[C@H](CCC(O)=O)C(O)=O)=CN2
2008,Sulfasalazine,Proton_coupled_folate_transporter-Inhibitor,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
2009,Cocaine,CP2AD-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2010,Methoxsalen,CP2AD-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
2011,Nicotine,CP2AD-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2012,Phenacetin,CP2AD-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2013,Rifampicin,CP2AD-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2014,Testosterone,CP2AD-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2015,Acetylcholin,MET-Inducer,CC(=O)OCC[N+](C)(C)C
2016,Acetylsalicylic Acid,MET-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
2017,Ademetionine,MET-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
2018,Angiotensinamide,MET-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
2019,Argatroban,MET-Inducer,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
2020,Ascorbic Acid (vit C),MET-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
2021,Ascorbic Acid (vit C),MET-Substrate,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
2022,Azacitidine,MET-Inhibitor,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
2023,Azathioprine,MET-Substrate,CN1C=NC(=C1SC2=C3NC=NC3=NC=N2)[N+]([O-])=O
2024,Bendroflumethiazide,MET-Inhibitor,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
2025,Captopril,MET-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
2026,Chlorhexidine,MET-Inhibitor,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1
2027,Chloroquine,MET-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
2028,Chlorphenamine,MET-Inducer,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
2029,Cocaine,MET-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2030,Deanol,MET-Substrate,CN(C)CCO
2031,Decitabine,MET-Inhibitor,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
2032,Dicycloverine,MET-Inhibitor,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
2033,Diosmin,MET-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
2034,Entacapone,MET-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
2035,Entacapone,MET-Inducer,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
2036,Epinephrine,MET-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
2037,Epinephrine,MET-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
2038,Estradiol,MET-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2039,Estradiol,MET-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2040,Folic Acid,MET-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
2041,Fosfocreatine,MET-Inhibitor,CN(CC(O)=O)C(=N)NP(O)(O)=O
2042,Glucagon,MET-Inducer,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
2043,Histamine,MET-Substrate,NCCC1=CNC=N1
2044,Hydralazine,MET-Inducer,NN=C1NN=CC2=C1C=CC=C2
2045,Hydrocortisone,MET-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2046,Imipramine,MET-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2047,Isoprenaline,MET-Substrate,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
2048,Ketoprofen,MET-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
2049,Ketotifen,MET-Inducer,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3
2050,Levodopa,MET-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
2051,Lidocain,MET-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2052,Mepacrine,MET-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
2053,Mercaptopurine,MET-Substrate,S=C1NC=NC2=C1NC=N2
2054,Mesalazine,MET-Inhibitor,NC1=CC(C(O)=O)=C(O)C=C1
2055,Methotrexate,MET-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2056,Methotrexate,MET-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2057,Methyldopa (levorotatory),MET-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
2058,Methyldopa (levorotatory),MET-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
2059,Moclobemide,MET-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
2060,Naproxen,MET-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
2061,Olsalazine,MET-Inhibitor,OC(=O)C1=CC(=CC=C1O)N=NC2=CC(C(O)=O)=C(O)C=C2
2062,Pargyline,MET-Inhibitor,CN(CC#C)CC1=CC=CC=C1
2063,Pargyline,MET-Inducer,CN(CC#C)CC1=CC=CC=C1
2064,Physostigmine,MET-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
2065,Plicamycin,MET-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
2066,Procaine,MET-Inhibitor,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
2067,Progesterone,MET-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2068,Progesterone,MET-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2069,Pyridoxine (vit B6),MET-Inhibitor,CC1=C(O)C(CO)=C(CO)C=N1
2070,Ribavirin,MET-Inhibitor,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
2071,Selenium Compounds,MET-Inhibitor,[Se]
2072,Tacrine,MET-Inhibitor,NC1=C2CCCCC2=NC3=C1C=CC=C3
2073,Tamoxifen,MET-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2074,Temozolomide,MET-Inhibitor,CN1N=NC2=C(N=CN2C1=O)C(N)=O
2075,Tioguanine,MET-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
2076,Tioguanine,MET-Inducer,NC1=NC2=C(N=CN2)C(=S)N1
2077,Tolcapone,MET-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
2078,Trimethoprim,MET-Inducer,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
2079,Tubocurarine,MET-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
2080,Ubidecarenone,MET-Substrate,COC1=C(OC)C(=O)C(CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C)=C(C)C1=O
2081,Varenicline,MET-Inhibitor,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
2082,Vecuronium,MET-Inhibitor,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N@@+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6
2083,Virginiamycin,MET-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
2084,Vorinostat,MET-Inhibitor,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
2085,Biotin,Monocarboxylate_transporter_1-Substrate,OC(=O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@@H]12
2086,Hydroxybutyric Acid,Monocarboxylate_transporter_1-Substrate,CCCC(O)=O
2087,Mersalyl,Monocarboxylate_transporter_1-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
2088,Milchsure,Monocarboxylate_transporter_1-Substrate,C[C@@H](O)C(O)=O
2089,Nateglinide,Monocarboxylate_transporter_1-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
2090,Nicotine,Monocarboxylate_transporter_1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
2091,Niflumic Acid,Monocarboxylate_transporter_1-Inhibitor,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
2092,Nitric Oxide,Monocarboxylate_transporter_1-Inducer,N=O
2093,Testosterone,Monocarboxylate_transporter_1-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2094,Aminohippuric Acid,Solute_carrier_family_22_member_6-Substrate,NC1=CC=C(C=C1)C(=O)NCC(O)=O
2095,Amoxicillin,Solute_carrier_family_22_member_6-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
2096,Amoxicillin,Solute_carrier_family_22_member_6-Inhibitor,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
2097,Cefaclor,Solute_carrier_family_22_member_6-Inhibitor,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3
2098,Cefazolin,Solute_carrier_family_22_member_6-Substrate,CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN4C=NN=N4)C3=O)C(O)=O)S1
2099,Cidofovir,Solute_carrier_family_22_member_6-Substrate,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
2100,Cimetidine,Solute_carrier_family_22_member_6-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2101,Famotidine,Solute_carrier_family_22_member_6-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
2102,Fluorescein,Solute_carrier_family_22_member_6-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
2103,Furosemide,Solute_carrier_family_22_member_6-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2104,Indometacin,Solute_carrier_family_22_member_6-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2105,Lumiracoxib,Solute_carrier_family_22_member_6-Inhibitor,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
2106,Meropenem,Solute_carrier_family_22_member_6-Substrate,C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@H]3CC[C@H](N3)C(=O)N(C)C)=C(N2C1=O)C(O)=O
2107,Methotrexate,Solute_carrier_family_22_member_6-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2108,Mycophenolic Acid,Solute_carrier_family_22_member_6-Substrate,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2109,Piroxicam,Solute_carrier_family_22_member_6-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
2110,Probenecid,Solute_carrier_family_22_member_6-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2111,Simvastatin,Solute_carrier_family_22_member_6-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2112,Cocaine,2A13-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2113,Methoxsalen,2A13-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
2114,Nicotine,2A13-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2115,Phenacetin,2A13-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2116,Rifampicin,2A13-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2117,Testosterone,2A13-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2118,Clofibrate,4B1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2119,Midazolam,4B1-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2120,Phenobarbital,4B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2121,Progesterone,4B1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2122,Sodium Sulfate,4B1-Inducer,[O-]S([O-])(=O)=O
2123,Testosterone,4B1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2124,Thiamine (vit B1),4B1-Inducer,CC1=NC(N)=C(C[N+]2=CSC(CCO)=C2C)C=N1
2125,Digoxin,Solute_carrier_organic_anion_transporter_family_member_4C1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
2126,Estrone,Solute_carrier_organic_anion_transporter_family_member_4C1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2127,Minoxidil,8A1-Inhibitor,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
2128,Tranylcypromine,8A1-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
2129,Aciclovir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC1=NC2=C(N=CN2COCCO)C(=O)N1
2130,Arsenic Trioxide,Canalicular_multispecific_organic_anion_transporter_1-Inducer,O=[As]1=[As](=O)O1
2131,Arsenic Trioxide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=[As]1=[As](=O)O1
2132,Azithromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
2133,Benzbromarone,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
2134,Benzylpenicillin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
2135,Bosentan,Canalicular_multispecific_organic_anion_transporter_1-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
2136,Carbamazepine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2137,Chenodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2138,Ciclosporin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2139,Ciclosporin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2140,Cimetidine,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2141,Ciprofloxacin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
2142,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,N[Pt](N)(Cl)Cl
2143,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,N[Pt](N)(Cl)Cl
2144,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,N[Pt](N)(Cl)Cl
2145,Clotrimazole,Canalicular_multispecific_organic_anion_transporter_1-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2146,Dexamethasone,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2147,Diclofenac,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2148,Doxorubicin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2149,Enoxolone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
2150,Eprosartan,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
2151,Erythromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2152,Estradiol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2153,Estradiol,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2154,Estrone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2155,Etodolac,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
2156,Etoposide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2157,Ezetimibe,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
2158,Fluorescein,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
2159,Fluorouracil,Canalicular_multispecific_organic_anion_transporter_1-Substrate,FC1=CNC(=O)NC1=O
2160,Gentamicin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CN[C@H](C)[C@@H]1CC[C@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@@H](NC)[C@@H]3O)[C@H]2O
2161,Glibenclamide,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2162,Glutathione,Canalicular_multispecific_organic_anion_transporter_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
2163,Grepafloxacin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
2164,Indinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2165,Indinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2166,Indometacin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2167,Indometacin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2168,Irinotecan,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2169,Ketoconazole,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2170,Levonorgestrel,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2171,Lopinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2172,Lopinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2173,Mesalazine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
2174,Methotrexate,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2175,Midecamycin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
2176,Mitoxantrone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
2177,Montelukast,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
2178,Mycophenolic Acid,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2179,Mycophenolic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2180,Octreotide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=CNC5=CC=CC=C45)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
2181,Paclitaxel,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
2182,Paracetamol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(=O)NC1=CC=C(O)C=C1
2183,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2184,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2185,Phenolphthalein,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC1=CC=C(C=C1)[C@@]2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
2186,Phenytoin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2187,Pravastatin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2188,Pravastatin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2189,Probenecid,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2190,Rifampicin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2191,Rifampicin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2192,Ritonavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2193,Ritonavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2194,Saquinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2195,Saquinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2196,Sulfinpyrazon,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2197,Sulfinpyrazon,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2198,Talinolol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
2199,Telithromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
2200,Ursodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2201,Valsartan,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
2202,Verapamil,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2203,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2204,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2205,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2206,Adenosine,Solute_carrier_family_12_member_2-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
2207,Bumetanide,Solute_carrier_family_12_member_2-Inhibitor,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2208,Cisplatin,Solute_carrier_family_12_member_2-Inducer,N[Pt](N)(Cl)Cl
2209,Estradiol,Solute_carrier_family_12_member_2-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2210,Furosemide,Solute_carrier_family_12_member_2-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2211,Glibenclamide,Solute_carrier_family_12_member_2-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2212,Kanamycin,Solute_carrier_family_12_member_2-Inhibitor,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
2213,Lithium,Solute_carrier_family_12_member_2-Inducer,[Li]
2214,Methoxamine,Solute_carrier_family_12_member_2-Inducer,COC1=CC([C@@H](O)[C@@H](C)N)=C(OC)C=C1
2215,Nitric Oxide,Solute_carrier_family_12_member_2-Inhibitor,N=O
2216,Nitroprusside,Solute_carrier_family_12_member_2-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
2217,Oxygen,Solute_carrier_family_12_member_2-Inducer,O=O
2218,Oxytocin,Solute_carrier_family_12_member_2-Inducer,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
2219,Phenylephrine,Solute_carrier_family_12_member_2-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
2220,Potassium Chloride,Solute_carrier_family_12_member_2-Substrate,[Cl-].[K+]
2221,Sodium Chloride,Solute_carrier_family_12_member_2-Substrate,[Na+].[Cl-]
2222,Enflurane,CP2F1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
2223,Ketoconazole,CP2F1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2224,Phenol,CP2F1-Substrate,OC1=CC=CC=C1
2225,Rifampicin,CP2F1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2226,Aminolevulinic Acid,Solute_carrier_family_15_member_2-Substrate,NCC(=O)CCC(O)=O
2227,Cefadroxil,Solute_carrier_family_15_member_2-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O
2228,Fosinopril,Solute_carrier_family_15_member_2-Substrate,CCC(=O)O[C@@H](O[P@@](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(O)=O)[C@H]3CCCCC3)C(C)C
2229,Glibenclamide,Solute_carrier_family_15_member_2-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2230,Quinapril,Solute_carrier_family_15_member_2-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=C(C[C@H]2C(O)=O)C=CC=C3
2231,Valaciclovir,Solute_carrier_family_15_member_2-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2232,Valganciclovir,Solute_carrier_family_15_member_2-Inhibitor,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2233,Bumetanide,Solute_carrier_family_22_member_7-Substrate,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2234,Erythromycin,Solute_carrier_family_22_member_7-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2235,Erythromycin,Solute_carrier_family_22_member_7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2236,Estradiol,Solute_carrier_family_22_member_7-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2237,Methotrexate,Solute_carrier_family_22_member_7-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2238,Probenecid,Solute_carrier_family_22_member_7-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2239,Ranitidine,Solute_carrier_family_22_member_7-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
2240,Theophylline,Solute_carrier_family_22_member_7-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2241,Theophylline,Solute_carrier_family_22_member_7-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2242,Amitriptyline,2B6-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2243,Amlodipine,2B6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
2244,Amprenavir,2B6-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2245,Aprobarbital,2B6-Inducer,CC(C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
2246,Artemisinin,2B6-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2247,Artemisinin,2B6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2248,Azelastine,2B6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
2249,Barnidipine,2B6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
2250,Brompheniramine,2B6-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
2251,Bupropion,2B6-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
2252,Bupropion,2B6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
2253,Capsaicin,2B6-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
2254,Carbamazepine,2B6-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2255,Carbamazepine,2B6-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2256,Carbinoxamine,2B6-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
2257,Chlorpromazine,2B6-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
2258,Cinnarizin,2B6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2259,Cisapride,2B6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
2260,Cisplatin,2B6-Inhibitor,N[Pt](N)(Cl)Cl
2261,Citalopram,2B6-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
2262,Clobazam,2B6-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2263,Clofibrate,2B6-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2264,Clomethiazole,2B6-Substrate,CC1=C(CCCl)SC=N1
2265,Clonazepam,2B6-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
2266,Clonazepam,2B6-Inhibitor,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
2267,Clopidogrel,2B6-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2268,Clopidogrel,2B6-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2269,Clotiazepam,2B6-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
2270,Clotrimazole,2B6-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2271,Clotrimazole,2B6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2272,Colchicine,2B6-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
2273,Colecalciferol,2B6-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
2274,Cyclophosphamide,2B6-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
2275,Cyclophosphamide,2B6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
2276,Desipramine,2B6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2277,Dexamethasone,2B6-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2278,Dextromethorphan,2B6-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2279,Diazepam,2B6-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2280,Diclofenac,2B6-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2281,Diethyltoluamide,2B6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
2282,Disulfiram,2B6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
2283,Disulfiram,2B6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
2284,Domperidone,2B6-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
2285,Doxorubicin,2B6-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2286,Efavirenz,2B6-Inducer,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2287,Efavirenz,2B6-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2288,Efavirenz,2B6-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2289,Epinastine,2B6-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
2290,Erythromycin,2B6-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2291,Esketamine,2B6-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
2292,Estrone,2B6-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2293,Ethanol,2B6-Inhibitor,CCO
2294,Ethinylestradiol,2B6-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2295,Ethylmorphine,2B6-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2296,Flunitrazepam,2B6-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
2297,Fluoxetine,2B6-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2298,Fluoxetine,2B6-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2299,Fluvoxamine,2B6-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
2300,Fosphenytoin,2B6-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
2301,Halothane,2B6-Substrate,FC(F)(F)[C@@H](Cl)Br
2302,Ifosfamide,2B6-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2303,Imipramine,2B6-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2304,Irinotecan,2B6-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2305,Isoflurane,2B6-Inducer,FC(F)O[C@@H](Cl)C(F)(F)F
2306,Isoflurane,2B6-Inhibitor,FC(F)O[C@@H](Cl)C(F)(F)F
2307,Isoflurane,2B6-Substrate,FC(F)O[C@@H](Cl)C(F)(F)F
2308,Ketamine,2B6-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
2309,Ketobemidone,2B6-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
2310,Ketoconazole,2B6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2311,Levoverbenone,2B6-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
2312,Lidocain,2B6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2313,Loperamide,2B6-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2314,Lopinavir,2B6-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2315,Malathion,2B6-Substrate,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
2316,Memantine,2B6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
2317,Metamizole Sodium,2B6-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
2318,Methadone,2B6-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2319,Methoxyflurane,2B6-Substrate,COC(F)(F)C(Cl)Cl
2320,Methylphenobarbital,2B6-Substrate,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
2321,Methyltestosterone,2B6-Substrate,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2322,Mexiletine,2B6-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
2323,Mianserin,2B6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
2324,Miconazole,2B6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
2325,Midazolam,2B6-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2326,Modafinil,2B6-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2327,Modafinil,2B6-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2328,Nelfinavir,2B6-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2329,Nevirapine,2B6-Inducer,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
2330,Nevirapine,2B6-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
2331,Nicardipine,2B6-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
2332,Nicotine,2B6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2333,Nifedipine,2B6-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
2334,Orphenadrine (citrate),2B6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
2335,Paroxetine,2B6-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
2336,Perhexiline,2B6-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
2337,Permethrin,2B6-Inducer,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
2338,Permethrin,2B6-Substrate,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
2339,Perphenazine,2B6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
2340,Pethidine,2B6-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2341,Phenazone,2B6-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
2342,Phenazone,2B6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
2343,Phenobarbital,2B6-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2344,Phenytoin,2B6-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2345,Primidone,2B6-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
2346,Promethazine,2B6-Substrate,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
2347,Propofol,2B6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
2348,Quinidine,2B6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2349,Retinol (vit A),2B6-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
2350,Rifampicin,2B6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2351,Rifampicin,2B6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2352,Ritonavir,2B6-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2353,Ritonavir,2B6-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2354,Ritonavir,2B6-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2355,Ropivacaine,2B6-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
2356,Roxithromycin,2B6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
2357,Selegiline,2B6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
2358,Sertraline,2B6-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
2359,Sertraline,2B6-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
2360,Sevoflurane,2B6-Substrate,FCOC(C(F)(F)F)C(F)(F)F
2361,Sulconazole,2B6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
2362,Sulfaphenazole,2B6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
2363,Sulfinpyrazon,2B6-Inducer,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2364,Tamoxifen,2B6-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2365,Tamoxifen,2B6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2366,Temazepam,2B6-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2367,Testosterone,2B6-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2368,Testosterone,2B6-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2369,Thalidomide,2B6-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
2370,Thiamazole,2B6-Inhibitor,CN1C=CNC1=S
2371,Thiotepa,2B6-Inhibitor,S=P(N1CC1)(N2CC2)N3CC3
2372,Thiram,2B6-Inducer,CN(C)C(=S)SSC(=S)N(C)C
2373,Ticlopidine,2B6-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
2374,Tramadol,2B6-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
2375,Tretinoin,2B6-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
2376,Triclosan,2B6-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
2377,Trofosfamide,2B6-Substrate,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
2378,Troglitazone,2B6-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
2379,Venlafaxine,2B6-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
2380,Verapamil,2B6-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2381,Verapamil,2B6-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2382,Zotepine,2B6-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
2383,Milchsure,Monocarboxylate_transporter_2-Substrate,C[C@@H](O)C(O)=O
2384,Testosterone,Monocarboxylate_transporter_2-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2385,Acetylcarnitine,Solute_carrier_family_22_member_5-Substrate,CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
2386,Cefepime,Solute_carrier_family_22_member_5-Inhibitor,CON=C(/C(=O)N[C@H]1[C@H]2SCC(C[N@+]3(C)CCCC3)=C(N2C1=O)C([O-])=O)C4=CSC(N)=N4
2387,Levocarnitine,Solute_carrier_family_22_member_5-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2388,Mepyramine,Solute_carrier_family_22_member_5-Substrate,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
2389,Potassium Chloride,Solute_carrier_family_22_member_5-Substrate,[Cl-].[K+]
2390,Verapamil,Solute_carrier_family_22_member_5-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2391,Bezafibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
2392,Ciprofibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
2393,Colestyramine,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
2394,Ezetimibe,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
2395,Fenofibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
2396,Gemfibrozil,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
2397,Glucose,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inducer,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2398,Insulin (human),Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2399,Metyrapone,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
2400,Retinol (vit A),Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
2401,Rifampicin,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2402,Ritonavir,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2403,Ursodeoxycholic Acid,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2404,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
2405,Ergoloid Mesylates,Solute_carrier_organic_anion_transporter_family_member_2B1-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](CC5=CNC6=CC=CC4=C56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
2406,Estrone,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2407,Fexofenadine,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
2408,Glibenclamide,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2409,Montelukast,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
2410,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2411,Ritonavir,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2412,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
2413,Testosterone,Solute_carrier_organic_anion_transporter_family_member_2B1-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2414,Histamine,Chromaffin_granule_amine_transporter-Substrate,NCCC1=CNC=N1
2415,Reserpine,Chromaffin_granule_amine_transporter-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2416,Reserpine,Chromaffin_granule_amine_transporter-Substrate,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2417,Tetrabenazine,Chromaffin_granule_amine_transporter-Inhibitor,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
2418,Sodium Bicarbonate,Electroneutral_sodium_bicarbonate_exchanger_1-Substrate,OC([O-])=O
2419,Angiotensinamide,Steroid_21_hydroxylase_21_OHase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
2420,Hydroxyprogesterone,Steroid_21_hydroxylase_21_OHase-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2421,Progesterone,Steroid_21_hydroxylase_21_OHase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2422,Alfacalcidol,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)C[C@@H](O)C3=C
2423,Ciclosporin,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2424,Ciprofibrate,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
2425,Colecalciferol,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
2426,Colestyramine,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
2427,Dexamethasone,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2428,Ebastine,CP4FB-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
2429,Chenodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_2-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2430,Estradiol,Canalicular_multispecific_organic_anion_transporter_2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2431,Etoposide,Canalicular_multispecific_organic_anion_transporter_2-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2432,Etoposide,Canalicular_multispecific_organic_anion_transporter_2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2433,Methotrexate,Canalicular_multispecific_organic_anion_transporter_2-Inhibitor,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2434,Morphine,Canalicular_multispecific_organic_anion_transporter_2-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
2435,Oxypertine,Canalicular_multispecific_organic_anion_transporter_2-Inducer,COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2
2436,Paracetamol,Canalicular_multispecific_organic_anion_transporter_2-Inducer,CC(=O)NC1=CC=C(O)C=C1
2437,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2438,Prasterone,Canalicular_multispecific_organic_anion_transporter_2-Inducer,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
2439,Bumetanide,Solute_carrier_family_12_member_1-Inhibitor,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2440,Bumetanide,Solute_carrier_family_12_member_1-Substrate,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2441,Desmopressin,Solute_carrier_family_12_member_1-Inducer,NC(=N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]2CSSCCC(=O)N[C@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O
2442,Furosemide,Solute_carrier_family_12_member_1-Inducer,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2443,Hydrochlorothiazide,Solute_carrier_family_12_member_1-Inducer,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1Cl
2444,Lithium,Solute_carrier_family_12_member_1-Inducer,[Li]
2445,Nitric Oxide,Solute_carrier_family_12_member_1-Inhibitor,N=O
2446,Potassium Chloride,Solute_carrier_family_12_member_1-Substrate,[Cl-].[K+]
2447,Sodium Chloride,Solute_carrier_family_12_member_1-Inducer,[Na+].[Cl-]
2448,Sodium Chloride,Solute_carrier_family_12_member_1-Substrate,[Na+].[Cl-]
2449,Vasopressin,Solute_carrier_family_12_member_1-Inducer,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
2450,Aminomethylbenzoic Acid,Solute_carrier_family_15_member_1-Inhibitor,NCC1=CC=C(C=C1)C(O)=O
2451,Cefaclor,Solute_carrier_family_15_member_1-Substrate,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3
2452,Cefadroxil,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O
2453,Cefalexin,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
2454,Cefixime,Solute_carrier_family_15_member_1-Substrate,NC1=NC(=CS1)C(=N/OCC(O)=O)C(=O)N[C@H]2[C@H]3SCC(C=C)=C(N3C2=O)C(O)=O
2455,Cefradine,Solute_carrier_family_15_member_1-Inhibitor,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(O)=O
2456,Cefradine,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(O)=O
2457,Ceftibuten,Solute_carrier_family_15_member_1-Substrate,NC1=NC(=CS1)C(=C/CC(O)=O)C(=O)N[C@H]2[C@@H]3SCC=C(N3C2=O)C(O)=O
2458,Cisplatin,Solute_carrier_family_15_member_1-Inducer,N[Pt](N)(Cl)Cl
2459,Deanol,Solute_carrier_family_15_member_1-Substrate,CN(C)CCO
2460,Didanosine,Solute_carrier_family_15_member_1-Substrate,OC[C@@H]1CC[C@@H](O1)N2C=NC3=C2N=CNC3=O
2461,Insulin (human),Solute_carrier_family_15_member_1-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2462,Midodrine,Solute_carrier_family_15_member_1-Substrate,COC1=CC([C@H](O)CNC(=O)CN)=C(OC)C=C1
2463,Nitrogen,Solute_carrier_family_15_member_1-Substrate,N#N
2464,Oseltamivir,Solute_carrier_family_15_member_1-Substrate,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
2465,Pancreozymin (cholecystokinin),Solute_carrier_family_15_member_1-Substrate,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
2466,Quinapril,Solute_carrier_family_15_member_1-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=C(C[C@H]2C(O)=O)C=CC=C3
2467,Sulpiride,Solute_carrier_family_15_member_1-Substrate,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
2468,Talinolol,Solute_carrier_family_15_member_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
2469,Valaciclovir,Solute_carrier_family_15_member_1-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2470,Valganciclovir,Solute_carrier_family_15_member_1-Substrate,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2471,Cimetidine,Solute_carrier_family_22_member_4-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2472,Gabapentin,Solute_carrier_family_22_member_4-Substrate,NC[C@@]1(CCCCC1)CC(O)=O
2473,Levocarnitine,Solute_carrier_family_22_member_4-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2474,Furosemide,Solute_carrier_family_12_member_5-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2475,Potassium Chloride,Solute_carrier_family_12_member_5-Substrate,[Cl-].[K+]
2476,Candesartan,Solute_carrier_family_22_member_11-Inhibitor,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
2477,Estrone,Solute_carrier_family_22_member_11-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2478,Pranlukast,Solute_carrier_family_22_member_11-Inhibitor,O=C(NC1=CC=C2C(=O)C=C(OC2=C1)C3=NN=NN3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4
2479,Dactinomycin,Solute_carrier_family_12_member_4-Inducer,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
2480,Potassium Chloride,Solute_carrier_family_12_member_4-Substrate,[Cl-].[K+]
2481,Ursodeoxycholic Acid,2W1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2482,Ursodeoxycholic Acid,2W1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2483,Calcifediol,24A-Substrate,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)CCC3=C
2484,Calcitriol,24A-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
2485,Calcitriol,24A-Substrate,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
2486,Teriparatide,24A-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC3=CNC4=C3C=CC=C4)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(O)=O
2487,Acetylcholin,Solute_carrier_family_22_member_1-Substrate,CC(=O)OCC[N+](C)(C)C
2488,Amiloride,Solute_carrier_family_22_member_1-Inhibitor,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
2489,Carvedilol,Solute_carrier_family_22_member_1-Inhibitor,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
2490,Cimetidine,Solute_carrier_family_22_member_1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2491,Cisplatin,Solute_carrier_family_22_member_1-Substrate,N[Pt](N)(Cl)Cl
2492,Dexamethasone,Solute_carrier_family_22_member_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2493,Dinoprostone,Solute_carrier_family_22_member_1-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2494,Estradiol,Solute_carrier_family_22_member_1-Inhibitor,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2495,Imatinib,Solute_carrier_family_22_member_1-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2496,Insulin (human),Solute_carrier_family_22_member_1-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2497,Lamivudine,Solute_carrier_family_22_member_1-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
2498,Metformin,Solute_carrier_family_22_member_1-Substrate,CN(C)C(=N)NC(N)=N
2499,Nicotine,Solute_carrier_family_22_member_1-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
2500,Phenformin,Solute_carrier_family_22_member_1-Inhibitor,NC(=N)NC(=N)NCCC1=CC=CC=C1
2501,Pramipexole,Solute_carrier_family_22_member_1-Substrate,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
2502,Prazosin,Solute_carrier_family_22_member_1-Inhibitor,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
2503,Quinidine,Solute_carrier_family_22_member_1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2504,Rifampicin,Solute_carrier_family_22_member_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2505,Tubocurarine,Solute_carrier_family_22_member_1-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
2506,Acetylcholin,Solute_carrier_family_22_member_3-Substrate,CC(=O)OCC[N+](C)(C)C
2507,Desipramine,Solute_carrier_family_22_member_3-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2508,Sodium Chloride,Solute_carrier_family_22_member_3-Substrate,[Na+].[Cl-]
2509,Ebastine,4F11-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
2510,Milchsure,Monocarboxylate_transporter_4-Substrate,C[C@@H](O)C(O)=O
2511,Oxypertine,Sodium_dependent_serotonin_transporter-Substrate,COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2
2512,Tryptophan,Monocarboxylate_transporter_10-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
2513,Aciclovir,Neutral_amino_acid_transporter_B0-Substrate,NC1=NC2=C(N=CN2COCCO)C(=O)N1
2514,Ganciclovir,Neutral_amino_acid_transporter_B0-Substrate,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
2515,Glycine,Neutral_amino_acid_transporter_B0-Substrate,NCC(O)=O
2516,Insulin (human),Neutral_amino_acid_transporter_B0-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2517,Levocarnitine,Neutral_amino_acid_transporter_B0-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2518,Levoglutamide,Neutral_amino_acid_transporter_B0-Substrate,N[C@@H](CCC(N)=O)C(O)=O
2519,Levoglutamide,Neutral_amino_acid_transporter_B0-Inducer,N[C@@H](CCC(N)=O)C(O)=O
2520,Nitric Oxide,Neutral_amino_acid_transporter_B0-Substrate,N=O
2521,Valaciclovir,Neutral_amino_acid_transporter_B0-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2522,Valganciclovir,Neutral_amino_acid_transporter_B0-Substrate,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2523,Aldosterone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
2524,Alfentanil,HLp2-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
2525,Alprazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
2526,Amiodarone,HLp2-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
2527,Amitriptyline,HLp2-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2528,Amlodipine,HLp2-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
2529,Amprenavir,HLp2-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2530,Aprepitant,HLp2-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
2531,Argatroban,HLp2-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
2532,Aripiprazole,HLp2-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
2533,Astemizole,HLp2-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
2534,Atazanavir,HLp2-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
2535,Atazanavir,HLp2-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
2536,Atorvastatin,HLp2-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
2537,Aztreonam,HLp2-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
2538,Beclometasone,HLp2-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2539,Buspirone,HLp2-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
2540,Caffeine,HLp2-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
2541,Carbamazepine,HLp2-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2542,Carbamazepine,HLp2-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2543,Cerivastatin,HLp2-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
2544,Chinin,HLp2-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
2545,Chloroquine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
2546,Chlorphenamine,HLp2-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
2547,Chlorpromazine,HLp2-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
2548,Ciclosporin,HLp2-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2549,Ciclosporin,HLp2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2550,Ciclosporin,HLp2-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2551,Cimetidine,HLp2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2552,Cisapride,HLp2-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
2553,Clarithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
2554,Clopidogrel,HLp2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2555,Cocaine,HLp2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2556,Cocaine,HLp2-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2557,Codeine,HLp2-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2558,Cortisone,HLp2-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
2559,Cyclobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
2560,Dapsone,HLp2-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
2561,Daunorubicin,HLp2-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
2562,Dexamethasone,HLp2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2563,Dexamethasone,HLp2-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2564,Dextromethorphan,HLp2-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2565,Diazepam,HLp2-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2566,Diethyltoluamide,HLp2-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
2567,Diltiazem,HLp2-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
2568,Diltiazem,HLp2-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
2569,Disulfiram,HLp2-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
2570,Docetaxel,HLp2-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
2571,Domperidone,HLp2-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
2572,Doxorubicin,HLp2-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2573,Doxylamin,HLp2-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
2574,Dutasteride,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
2575,Eplerenone,HLp2-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
2576,Erythromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2577,Erythromycin,HLp2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2578,Estradiol,HLp2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2579,Estrone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2580,Ethinylestradiol,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2581,Ethosuximide,HLp2-Substrate,CC[C@]1(C)CC(=O)NC1=O
2582,Etoposide,HLp2-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2583,Etoposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2584,Felodipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
2585,Fentanyl,HLp2-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
2586,Finasteride,HLp2-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
2587,Fluconazole,HLp2-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2588,Fluconazole,HLp2-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2589,Flutamide,HLp2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
2590,Fluvoxamine,HLp2-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
2591,Glycyrrhizic Acid,HLp2-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
2592,Glycyrrhizic Acid,HLp2-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
2593,Granisetron,HLp2-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
2594,Halofantrine,HLp2-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
2595,Haloperidol,HLp2-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
2596,Hydrocortisone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2597,Ifosfamide,HLp2-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2598,Imatinib,HLp2-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2599,Imatinib,HLp2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2600,Indinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2601,Indinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2602,Irinotecan,HLp2-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2603,Ketoconazole,HLp2-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2604,Ketoconazole,HLp2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2605,Ketoconazole,HLp2-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2606,Lercanidipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
2607,Levacetylmethadol,HLp2-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2608,Lidocain,HLp2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2609,Linopirdine,HLp2-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
2610,Losartan,HLp2-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
2611,Lovastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2612,Mepacrine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
2613,Mephenytoin,HLp2-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2614,Methadone,HLp2-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2615,Mibefradil,HLp2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
2616,Midazolam,HLp2-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2617,Mifepristone,HLp2-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
2618,Mifepristone,HLp2-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
2619,Modafinil,HLp2-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2620,Modafinil,HLp2-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2621,Nateglinide,HLp2-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
2622,Nefazodone,HLp2-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
2623,Nelfinavir,HLp2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2624,Nelfinavir,HLp2-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2625,Neostigmine,HLp2-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
2626,Nicardipine,HLp2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
2627,Nifedipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
2628,Nimodipine,HLp2-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
2629,Nisoldipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
2630,Nitrendipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
2631,Norethisterone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2632,Norfloxacin,HLp2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
2633,Octopamine,HLp2-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
2634,Omeprazole,HLp2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2635,Omeprazole,HLp2-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2636,Omeprazole,HLp2-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2637,Ondansetron,HLp2-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
2638,Ornidazole,HLp2-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
2639,Oxazepam,HLp2-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
2640,Oxcarbazepine,HLp2-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
2641,Oxybutynin,HLp2-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
2642,Oxycodone,HLp2-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
2643,Paclitaxel,HLp2-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
2644,Paracetamol,HLp2-Inducer,CC(=O)NC1=CC=C(O)C=C1
2645,Paracetamol,HLp2-Substrate,CC(=O)NC1=CC=C(O)C=C1
2646,Paraoxon,HLp2-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
2647,Pethidine,HLp2-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2648,Phenelzine,HLp2-Inhibitor,NNCCC1=CC=CC=C1
2649,Phenelzine,HLp2-Substrate,NNCCC1=CC=CC=C1
2650,Phenobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2651,Phenytoin,HLp2-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2652,Physostigmine,HLp2-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
2653,Pimozide,HLp2-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
2654,Pleconaril,HLp2-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
2655,Pravastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2656,Praziquantel,HLp2-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
2657,Prednisolone,HLp2-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
2658,Prednisolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
2659,Progesterone,HLp2-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2660,Propranolol,HLp2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
2661,Quetiapine,HLp2-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
2662,Ranitidine,HLp2-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
2663,Reserpine,HLp2-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2664,Rifampicin,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2665,Rifampicin,HLp2-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2666,Rifampicin,HLp2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2667,Rifapentine,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
2668,Risperidone,HLp2-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
2669,Ritonavir,HLp2-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2670,Ritonavir,HLp2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2671,Ritonavir,HLp2-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2672,Rosuvastatin,HLp2-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
2673,Salmeterol,HLp2-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
2674,Saquinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2675,Saquinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2676,Sildenafil,HLp2-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
2677,Simvastatin,HLp2-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2678,Sirolimus,HLp2-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
2679,Spironolactone,HLp2-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
2680,Sulfasalazine,HLp2-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
2681,Tacrolimus,HLp2-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
2682,Tamoxifen,HLp2-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2683,Tegafur,HLp2-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
2684,Telithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
2685,Teniposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
2686,Terfenadine,HLp2-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
2687,Testosterone,HLp2-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2688,Thalidomide,HLp2-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
2689,Tocopherol (vit E),HLp2-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
2690,Trazodone,HLp2-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
2691,Triamcinolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
2692,Triazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2693,Troglitazone,HLp2-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
2694,Troglitazone,HLp2-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
2695,Vardenafil,HLp2-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
2696,Verapamil,HLp2-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2697,Verapamil,HLp2-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2698,Vinblastine,HLp2-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2699,Vincristine,HLp2-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2700,Zalcitabine,HLp2-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
2701,Zaleplon,HLp2-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
2702,Ziprasidone,HLp2-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
2703,Zolpidem,HLp2-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
2704,Zonisamide,HLp2-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
2705,Zotepine,HLp2-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
2706,Adenosine,Equilibrative_nucleoside_transporter_1-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
2707,Amiloride,Solute_carrier_family_22_member_2-Substrate,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
2708,Bromides,Solute_carrier_family_22_member_2-Substrate,[Br-]
2709,Budesonide,Solute_carrier_family_22_member_2-Inhibitor,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
2710,Cimetidine,Solute_carrier_family_22_member_2-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2711,Cimetidine,Solute_carrier_family_22_member_2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2712,Cisplatin,Solute_carrier_family_22_member_2-Substrate,N[Pt](N)(Cl)Cl
2713,Cisplatin,Solute_carrier_family_22_member_2-Inhibitor,N[Pt](N)(Cl)Cl
2714,Dexamethasone,Solute_carrier_family_22_member_2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2715,Dinoprostone,Solute_carrier_family_22_member_2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2716,Dopamine,Solute_carrier_family_22_member_2-Substrate,NCCC1=CC(O)=C(O)C=C1
2717,Epinephrine,Solute_carrier_family_22_member_2-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
2718,Flurazepam,Solute_carrier_family_22_member_2-Inhibitor,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
2719,Gabapentin,Solute_carrier_family_22_member_2-Substrate,NC[C@@]1(CCCCC1)CC(O)=O
2720,Histamine,Solute_carrier_family_22_member_2-Substrate,NCCC1=CNC=N1
2721,Metformin,Solute_carrier_family_22_member_2-Substrate,CN(C)C(=N)NC(N)=N
2722,Mexiletine,Solute_carrier_family_22_member_2-Inhibitor,C[C@H](N)COC1=C(C)C=CC=C1C
2723,Norepinephrine,Solute_carrier_family_22_member_2-Substrate,NC[C@@H](O)C1=CC(O)=C(O)C=C1
2724,Oxaliplatin,Solute_carrier_family_22_member_2-Inhibitor,N[C@@H]1CCCC[C@H]1N
2725,Pramipexole,Solute_carrier_family_22_member_2-Substrate,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
2726,Propranolol,Solute_carrier_family_22_member_2-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
2727,Quinidine,Solute_carrier_family_22_member_2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2728,Dexamethasone,3A43-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2729,Ethosuximide,3A43-Substrate,CC[C@]1(C)CC(=O)NC1=O
2730,Oxazepam,3A43-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
2731,Phenelzine,3A43-Inhibitor,NNCCC1=CC=CC=C1
2732,Praziquantel,3A43-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
2733,Rifampicin,3A43-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2734,Rifapentine,3A43-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
2735,Testosterone,3A43-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2736,Zalcitabine,3A43-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
2737,Estrone,Solute_carrier_organic_anion_transporter_family_member_4A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2738,Budesonide,Multidrug_resistance_associated_protein_1-Inhibitor,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
2739,Celecoxib,Multidrug_resistance_associated_protein_1-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
2740,Chlorcyclizine,Multidrug_resistance_associated_protein_1-Substrate,CN1CCN(CC1)[C@@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
2741,Chlorphenamine,Multidrug_resistance_associated_protein_1-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
2742,Cisplatin,Multidrug_resistance_associated_protein_1-Substrate,N[Pt](N)(Cl)Cl
2743,Clotrimazole,Multidrug_resistance_associated_protein_1-Substrate,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2744,Clotrimazole,Multidrug_resistance_associated_protein_1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2745,Daunorubicin,Multidrug_resistance_associated_protein_1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
2746,Daunorubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
2747,Dipyridamole,Multidrug_resistance_associated_protein_1-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
2748,Disulfiram,Multidrug_resistance_associated_protein_1-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
2749,Doxorubicin,Multidrug_resistance_associated_protein_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2750,Doxorubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2751,Doxorubicin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2752,Epirubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C(=O)C2=CC=C1
2753,Estradiol,Multidrug_resistance_associated_protein_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2754,Estradiol,Multidrug_resistance_associated_protein_1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2755,Estrone,Multidrug_resistance_associated_protein_1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2756,Etacrynic Acid,Multidrug_resistance_associated_protein_1-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
2757,Ethanol,Multidrug_resistance_associated_protein_1-Inducer,CCO
2758,Etoposide,Multidrug_resistance_associated_protein_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2759,Fluorescein,Multidrug_resistance_associated_protein_1-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
2760,G-strophanthin,Multidrug_resistance_associated_protein_1-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
2761,Glibenclamide,Multidrug_resistance_associated_protein_1-Inducer,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2762,Glibenclamide,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2763,Glutathione,Multidrug_resistance_associated_protein_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
2764,Indometacin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2765,Ivermectin,Multidrug_resistance_associated_protein_1-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
2766,Ivermectin,Multidrug_resistance_associated_protein_1-Inhibitor,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
2767,Lopinavir,Multidrug_resistance_associated_protein_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2768,Lovastatin,Multidrug_resistance_associated_protein_1-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2769,Menadione,Multidrug_resistance_associated_protein_1-Inducer,CC1=CC(=O)C2=C(C=CC=C2)C1=O
2770,"Mercury, Metallic",Multidrug_resistance_associated_protein_1-Inducer,[Hg]
2771,Paracetamol,Multidrug_resistance_associated_protein_1-Inducer,CC(=O)NC1=CC=C(O)C=C1
2772,Phenytoin,Multidrug_resistance_associated_protein_1-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2773,Probenecid,Multidrug_resistance_associated_protein_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2774,Probenecid,Multidrug_resistance_associated_protein_1-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2775,Quinidine,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2776,Ritonavir,Multidrug_resistance_associated_protein_1-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2777,Rofecoxib,Multidrug_resistance_associated_protein_1-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
2778,Saquinavir,Multidrug_resistance_associated_protein_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2779,Saquinavir,Multidrug_resistance_associated_protein_1-Inducer,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2780,Silymarin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
2781,Sulfinpyrazon,Multidrug_resistance_associated_protein_1-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2782,Trastuzumab,Multidrug_resistance_associated_protein_1-Inhibitor,NCC=C
2783,Verapamil,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2784,Vinblastine,Multidrug_resistance_associated_protein_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2785,Vincristine,Multidrug_resistance_associated_protein_1-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2786,Aminophenazone,2C18-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
2787,Buprenorphine,2C18-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
2788,Clobazam,2C18-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2789,Clotiazepam,2C18-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
2790,Cyclophosphamide,2C18-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
2791,Dapsone,2C18-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
2792,Dexamethasone,2C18-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2793,Diazepam,2C18-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2794,Diclofenac,2C18-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2795,Fluconazole,2C18-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2796,Ifosfamide,2C18-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2797,Imipramine,2C18-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2798,Lansoprazole,2C18-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
2799,Lidocain,2C18-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2800,Mephenytoin,2C18-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2801,Methadone,2C18-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2802,Omeprazole,2C18-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2803,Perphenazine,2C18-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
2804,Phenazone,2C18-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
2805,Phenobarbital,2C18-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2806,Phenytoin,2C18-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2807,Phenytoin,2C18-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2808,Propofol,2C18-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
2809,Rifampicin,2C18-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2810,Thalidomide,2C18-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
2811,Tolbutamide,2C18-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
2812,Troleandomycin,2C18-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
2813,Valproic Acid,2C18-Inhibitor,CCCC(CCC)C(O)=O
2814,Warfarin,2C18-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
2815,Dextromethorphan,46A-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2816,Diclofenac,46A-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2817,Phenacetin,46A-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2818,Progesterone,46A-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2819,Testosterone,46A-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2820,Acetylsalicylic Acid,2C19-Inducer,CC(=O)OC1=C(C=CC=C1)C(O)=O
2821,Adinazolam,2C19-Substrate,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
2822,Aminogluthetimide,2C19-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
2823,Aminophenazone,2C19-Inhibitor,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
2824,Aminophenazone,2C19-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
2825,Amiodarone,2C19-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
2826,Amitriptyline,2C19-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2827,Amitriptyline,2C19-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2828,Amoxicillin,2C19-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
2829,Amprenavir,2C19-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2830,Aprepitant,2C19-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
2831,Aprepitant,2C19-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
2832,Artemether,2C19-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
2833,Artemisinin,2C19-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2834,Atomoxetine,2C19-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
2835,Azelastine,2C19-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
2836,Azelastine,2C19-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
2837,Barnidipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
2838,Benidipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
2839,Benzatropine,2C19-Substrate,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
2840,Benzethonium,2C19-Substrate,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
2841,Benzydamine,2C19-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
2842,Bicalutamide,2C19-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
2843,Bifonazole,2C19-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
2844,Bortezomib,2C19-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
2845,Bortezomib,2C19-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
2846,Bromazepam,2C19-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
2847,Brompheniramine,2C19-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
2848,Buflomedil,2C19-Substrate,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
2849,Bupivacaine,2C19-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
2850,Buprenorphine,2C19-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
2851,Capsaicin,2C19-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
2852,Carbamazepine,2C19-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2853,Carbamazepine,2C19-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2854,Carbinoxamine,2C19-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
2855,Carisoprodol,2C19-Substrate,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C
2856,Chinin,2C19-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
2857,Chinin,2C19-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
2858,Chloramphenicol,2C19-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
2859,Chloramphenicol,2C19-Substrate,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
2860,Chlormadinone,2C19-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2861,Chloroform,2C19-Substrate,ClC(Cl)Cl
2862,Chlorpropamide,2C19-Substrate,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
2863,Ciclosporin,2C19-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2864,Cilostazol,2C19-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
2865,Cimetidine,2C19-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2866,Cisapride,2C19-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
2867,Citalopram,2C19-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
2868,Citalopram,2C19-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
2869,Clarithromycin,2C19-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
2870,Clarithromycin,2C19-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
2871,Clobazam,2C19-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2872,Clomethiazole,2C19-Substrate,CC1=C(CCCl)SC=N1
2873,Clomipramine,2C19-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
2874,Clopidogrel,2C19-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2875,Clotiazepam,2C19-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
2876,Clotrimazole,2C19-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2877,Clozapine,2C19-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
2878,Clozapine,2C19-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
2879,Colecalciferol,2C19-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
2880,Cyclophosphamide,2C19-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
2881,Dapsone,2C19-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
2882,Delavirdine,2C19-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
2883,Desipramine,2C19-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2884,Desipramine,2C19-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2885,Desloratadine,2C19-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
2886,Desogestrel,2C19-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2887,Dexamethasone,2C19-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2888,Dexfenfluramine,2C19-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
2889,Dextromethorphan,2C19-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2890,Diazepam,2C19-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2891,Diazepam,2C19-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2892,Diclofenac,2C19-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2893,Diethyltoluamide,2C19-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
2894,Dimethyl Sulfoxide,2C19-Inhibitor,CS(C)=O
2895,Dopamine,2C19-Substrate,NCCC1=CC(O)=C(O)C=C1
2896,Doxazosin,2C19-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
2897,Doxepin,2C19-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
2898,Dronabinol,2C19-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
2899,Efavirenz,2C19-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2900,Entacapone,2C19-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
2901,Escitalopram,2C19-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
2902,Esomeprazole,2C19-Substrate,COC1=CC2=C([N-]C(=N2)S(=O)CC3=NC=C(C)C(OC)=C3C)C=C1
2903,Estradiol,2C19-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2904,Ethanol,2C19-Inhibitor,CCO
2905,Ethinylestradiol,2C19-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2906,Ethinylestradiol,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2907,Ethotoin,2C19-Inhibitor,CCN1C(=O)N[C@H](C1=O)C2=CC=CC=C2
2908,Etizolam,2C19-Substrate,CCC1=CC2=C(S1)N3C(C)=NN=C3CN=C2C4=C(Cl)C=CC=C4
2909,Etoricoxib,2C19-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
2910,Famotidine,2C19-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
2911,Felbamate,2C19-Inhibitor,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
2912,Fenofibrate,2C19-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
2913,Fluconazole,2C19-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2914,Flunitrazepam,2C19-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
2915,Fluoxetine,2C19-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2916,Fluoxetine,2C19-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2917,Flutamide,2C19-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
2918,Fluvoxamine,2C19-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
2919,Formoterol,2C19-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
2920,Fosamprenavir,2C19-Inhibitor,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2921,Fosphenytoin,2C19-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
2922,Fosphenytoin,2C19-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
2923,Gefitinib,2C19-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
2924,Gemfibrozil,2C19-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
2925,Glibenclamide,2C19-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2926,Gliclazide,2C19-Inhibitor,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
2927,Glipizide,2C19-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2928,Glucosamine,2C19-Substrate,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O
2929,Haloperidol,2C19-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
2930,Hexobarbital,2C19-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
2931,Ibuprofen,2C19-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
2932,Ifosfamide,2C19-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2933,Imatinib,2C19-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2934,Imipramine,2C19-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2935,Imipramine,2C19-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2936,Indinavir,2C19-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2937,Indometacin,2C19-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2938,Indometacin,2C19-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2939,Ipriflavone,2C19-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
2940,Isoniazid,2C19-Inhibitor,NNC(=O)C1=CC=NC=C1
2941,Isopropanol,2C19-Inhibitor,CC(C)O
2942,Ketobemidone,2C19-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
2943,Ketoconazole,2C19-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2944,Lafutidine,2C19-Inhibitor,O=C(CS(=O)CC1=CC=CO1)NCC=C/COC2=NC=CC(CN3CCCCC3)=C2
2945,Lansoprazole,2C19-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
2946,Lansoprazole,2C19-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
2947,Lopinavir,2C19-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2948,Loratadine,2C19-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
2949,Loratadine,2C19-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
2950,Losartan,2C19-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
2951,Lumiracoxib,2C19-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
2952,Lynestrenol,2C19-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2953,Lynestrenol,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2954,Medazepam,2C19-Substrate,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2955,Medrysone,2C19-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
2956,Melatonin,2C19-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
2957,Memantine,2C19-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
2958,Mephenytoin,2C19-Inhibitor,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2959,Mephenytoin,2C19-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2960,Meprobamate,2C19-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
2961,Mesuximide,2C19-Inhibitor,CN1C(=O)C[C@](C)(C1=O)C2=CC=CC=C2
2962,Mesuximide,2C19-Substrate,CN1C(=O)C[C@](C)(C1=O)C2=CC=CC=C2
2963,Methadone,2C19-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2964,Methazolamide,2C19-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
2965,Methylphenobarbital,2C19-Inhibitor,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
2966,Methylphenobarbital,2C19-Substrate,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
2967,Metoprolol,2C19-Substrate,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
2968,Miconazole,2C19-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
2969,Moclobemide,2C19-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
2970,Moclobemide,2C19-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
2971,Modafinil,2C19-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2972,Modafinil,2C19-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2973,Nelfinavir,2C19-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2974,Nelfinavir,2C19-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2975,Nicardipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
2976,Nicotine,2C19-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2977,Nilutamide,2C19-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
2978,Nilutamide,2C19-Substrate,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
2979,Nilvadipine,2C19-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
2980,Nordazepam,2C19-Substrate,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
2981,Norethisterone,2C19-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2982,Nortriptyline,2C19-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2983,Noscapine,2C19-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
2984,Olanzapine,2C19-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
2985,Omeprazole,2C19-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2986,Omeprazole,2C19-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2987,Omeprazole,2C19-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2988,Orphenadrine (citrate),2C19-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
2989,Oxcarbazepine,2C19-Inhibitor,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
2990,Pantoprazole,2C19-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
2991,Pantoprazole,2C19-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
2992,Paroxetine,2C19-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
2993,Pentobarbital,2C19-Substrate,CCC[C@@H](C)[C@@]1(CC)C(=O)NC(=O)NC1=O
2994,Perazine,2C19-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
2995,Perazine,2C19-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
2996,Perphenazine,2C19-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
2997,Pethidine,2C19-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2998,Phenacetin,2C19-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2999,Phenazone,2C19-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3000,Phenazone,2C19-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3001,Phenelzine,2C19-Inhibitor,NNCCC1=CC=CC=C1
3002,Phenelzine,2C19-Substrate,NNCCC1=CC=CC=C1
3003,Phenobarbital,2C19-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3004,Phenobarbital,2C19-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3005,Phensuximide,2C19-Inhibitor,CN1C(=O)C[C@@H](C1=O)C2=CC=CC=C2
3006,Phenytoin,2C19-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3007,Phenytoin,2C19-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3008,Pimozide,2C19-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
3009,Pioglitazone,2C19-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3010,Podophyllotoxin,2C19-Substrate,COC1=CC(=CC(OC)=C1OC)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=C2C=C5OCOC5=C4
3011,Praziquantel,2C19-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
3012,Primidone,2C19-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3013,Primidone,2C19-Substrate,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3014,Probenecid,2C19-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3015,Progesterone,2C19-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3016,Progesterone,2C19-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3017,Proguanil,2C19-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
3018,Promazine,2C19-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
3019,Propofol,2C19-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3020,Propranolol,2C19-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
3021,Quazepam,2C19-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
3022,Quetiapine,2C19-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
3023,Rabeprazole,2C19-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
3024,Rabeprazole,2C19-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
3025,Ranitidine,2C19-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
3026,Retinol (vit A),2C19-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
3027,Rifampicin,2C19-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3028,Rifampicin,2C19-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3029,Ritonavir,2C19-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3030,Ritonavir,2C19-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3031,Rosiglitazone,2C19-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3032,Saquinavir,2C19-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3033,Selegiline,2C19-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3034,Seratrodast,2C19-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3035,Seratrodast,2C19-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3036,Sertraline,2C19-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3037,Sertraline,2C19-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3038,Sildenafil,2C19-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3039,Sildenafil,2C19-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3040,Sulconazole,2C19-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
3041,Sulfanilamide,2C19-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
3042,Tamoxifen,2C19-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3043,Telmisartan,2C19-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
3044,Temazepam,2C19-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3045,Teniposide,2C19-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
3046,Terbinafine,2C19-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
3047,Testosterone,2C19-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3048,Tetrabenazine,2C19-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
3049,Thalidomide,2C19-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3050,Thiamazole,2C19-Inhibitor,CN1C=CNC1=S
3051,Thioridazine,2C19-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
3052,Ticlopidine,2C19-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
3053,Timolol,2C19-Substrate,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
3054,Tioconazole,2C19-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
3055,Tolbutamide,2C19-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
3056,Tolperisone,2C19-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
3057,Tolterodine,2C19-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
3058,Topiramate,2C19-Inhibitor,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
3059,Torasemide,2C19-Inhibitor,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
3060,Trabectedin,2C19-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
3061,Tranylcypromine,2C19-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
3062,Trimethadione,2C19-Substrate,CN1C(=O)OC(C)(C)C1=O
3063,Trimipramine,2C19-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3064,Troglitazone,2C19-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3065,Troglitazone,2C19-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3066,Troleandomycin,2C19-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
3067,Trospium,2C19-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
3068,Valdecoxib,2C19-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
3069,Valproic Acid,2C19-Inhibitor,CCCC(CCC)C(O)=O
3070,Valproic Acid,2C19-Substrate,CCCC(CCC)C(O)=O
3071,Venlafaxine,2C19-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
3072,Verapamil,2C19-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3073,Voriconazole,2C19-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3074,Voriconazole,2C19-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3075,Warfarin,2C19-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3076,Warfarin,2C19-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3077,Zafirlukast,2C19-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
3078,Zidovudine,2C19-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
3079,Zolpidem,2C19-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
3080,Zonisamide,2C19-Inhibitor,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
3081,Zonisamide,2C19-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
3082,Zotepine,2C19-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
3083,Oxaliplatin,Copper_transporting_ATPase_1-Substrate,N[C@@H]1CCCC[C@H]1N
3084,Amfetamine,Coumarin_7_hydroxylase-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
3085,Amlodipine,Coumarin_7_hydroxylase-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
3086,Amobarbital,Coumarin_7_hydroxylase-Inducer,CC[C@@]1(CCC(C)C)C(=O)NC(=O)NC1=O
3087,Artemisinin,Coumarin_7_hydroxylase-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
3088,Artesunate,Coumarin_7_hydroxylase-Substrate,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
3089,Azelastine,Coumarin_7_hydroxylase-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3090,Azithromycin,Coumarin_7_hydroxylase-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
3091,Buprenorphine,Coumarin_7_hydroxylase-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3092,Bupropion,Coumarin_7_hydroxylase-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
3093,Carbamazepine,Coumarin_7_hydroxylase-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3094,Chloroform,Coumarin_7_hydroxylase-Substrate,ClC(Cl)Cl
3095,Chloroxylenol,Coumarin_7_hydroxylase-Substrate,CC1=CC(O)=CC(C)=C1Cl
3096,Chlorzoxazone,Coumarin_7_hydroxylase-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
3097,Cinnarizin,Coumarin_7_hydroxylase-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3098,Cisapride,Coumarin_7_hydroxylase-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3099,Clofibrate,Coumarin_7_hydroxylase-Inhibitor,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3100,Clomethiazole,Coumarin_7_hydroxylase-Substrate,CC1=C(CCCl)SC=N1
3101,Clomifene,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
3102,Clotrimazole,Coumarin_7_hydroxylase-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3103,Clotrimazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3104,Clozapine,Coumarin_7_hydroxylase-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3105,Cocaine,Coumarin_7_hydroxylase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3106,Cyclophosphamide,Coumarin_7_hydroxylase-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3107,Desipramine,Coumarin_7_hydroxylase-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3108,Dexfenfluramine,Coumarin_7_hydroxylase-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
3109,Dexmedetomidine,Coumarin_7_hydroxylase-Substrate,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
3110,Diethyl Ether,Coumarin_7_hydroxylase-Substrate,CCOCC
3111,Diethyltoluamide,Coumarin_7_hydroxylase-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
3112,Disulfiram,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3113,Disulfiram,Coumarin_7_hydroxylase-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
3114,Dronabinol,Coumarin_7_hydroxylase-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
3115,Eletriptan,Coumarin_7_hydroxylase-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
3116,Entacapone,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3117,Flunarizine,Coumarin_7_hydroxylase-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
3118,Flunitrazepam,Coumarin_7_hydroxylase-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
3119,Fluorouracil,Coumarin_7_hydroxylase-Substrate,FC1=CNC(=O)NC1=O
3120,Fomepizole,Coumarin_7_hydroxylase-Inhibitor,CC1=CNN=C1
3121,Formoterol,Coumarin_7_hydroxylase-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3122,Halothane,Coumarin_7_hydroxylase-Substrate,FC(F)(F)[C@@H](Cl)Br
3123,Histamine,Coumarin_7_hydroxylase-Inhibitor,NCCC1=CNC=N1
3124,Ifosfamide,Coumarin_7_hydroxylase-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3125,Indigo Carmine,Coumarin_7_hydroxylase-Inhibitor,[O-]S(=O)(=O)C1=CC=C2NC(C(=O)C2=C1)=C3NC4=CC=C(C=C4C3=O)S([O-])(=O)=O
3126,Isoniazid,Coumarin_7_hydroxylase-Inhibitor,NNC(=O)C1=CC=NC=C1
3127,Isopropanol,Coumarin_7_hydroxylase-Inhibitor,CC(C)O
3128,Ketoconazole,Coumarin_7_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3129,Letrozole,Coumarin_7_hydroxylase-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
3130,Letrozole,Coumarin_7_hydroxylase-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
3131,Levoverbenone,Coumarin_7_hydroxylase-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
3132,Lidocain,Coumarin_7_hydroxylase-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3133,Medifoxamine,Coumarin_7_hydroxylase-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
3134,Memantine,Coumarin_7_hydroxylase-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
3135,Menadione,Coumarin_7_hydroxylase-Inhibitor,CC1=CC(=O)C2=C(C=CC=C2)C1=O
3136,Methoxsalen,Coumarin_7_hydroxylase-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
3137,Methoxsalen,Coumarin_7_hydroxylase-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
3138,Methoxyflurane,Coumarin_7_hydroxylase-Substrate,COC(F)(F)C(Cl)Cl
3139,Metyrapone,Coumarin_7_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
3140,Miconazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
3141,Nicotine,Coumarin_7_hydroxylase-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
3142,Nicotine,Coumarin_7_hydroxylase-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3143,Nicotinyl Alcohol (pyridylcarbinol),Coumarin_7_hydroxylase-Substrate,OCC1=CC=CN=C1
3144,Nilvadipine,Coumarin_7_hydroxylase-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3145,Norfloxacin,Coumarin_7_hydroxylase-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
3146,Orphenadrine (citrate),Coumarin_7_hydroxylase-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
3147,Paracetamol,Coumarin_7_hydroxylase-Substrate,CC(=O)NC1=CC=C(O)C=C1
3148,Perazine,Coumarin_7_hydroxylase-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3149,Phenacetin,Coumarin_7_hydroxylase-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3150,Phenazone,Coumarin_7_hydroxylase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3151,Phenobarbital,Coumarin_7_hydroxylase-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3152,Phenobarbital,Coumarin_7_hydroxylase-Inhibitor,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3153,Pilocarpine,Coumarin_7_hydroxylase-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
3154,Pilocarpine,Coumarin_7_hydroxylase-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
3155,Prednisolone,Coumarin_7_hydroxylase-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
3156,Progesterone,Coumarin_7_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3157,Propofol,Coumarin_7_hydroxylase-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3158,Rifampicin,Coumarin_7_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3159,Rifampicin,Coumarin_7_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3160,Rifampicin,Coumarin_7_hydroxylase-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3161,Rosiglitazone,Coumarin_7_hydroxylase-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3162,Roxatidine,Coumarin_7_hydroxylase-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
3163,Selegiline,Coumarin_7_hydroxylase-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3164,Seratrodast,Coumarin_7_hydroxylase-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3165,Sevoflurane,Coumarin_7_hydroxylase-Substrate,FCOC(C(F)(F)F)C(F)(F)F
3166,Sulconazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
3167,Sulfaphenazole,Coumarin_7_hydroxylase-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
3168,Tamoxifen,Coumarin_7_hydroxylase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3169,Tegafur,Coumarin_7_hydroxylase-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
3170,Thalidomide,Coumarin_7_hydroxylase-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3171,Thiamazole,Coumarin_7_hydroxylase-Inhibitor,CN1C=CNC1=S
3172,Tranylcypromine,Coumarin_7_hydroxylase-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
3173,Tretinoin,Coumarin_7_hydroxylase-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
3174,Troleandomycin,Coumarin_7_hydroxylase-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
3175,Trospium,Coumarin_7_hydroxylase-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
3176,Valproic Acid,Coumarin_7_hydroxylase-Substrate,CCCC(CCC)C(O)=O
3177,Zidovudine,Coumarin_7_hydroxylase-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
3178,Calcitriol,27B-Inhibitor,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
3179,Acetylcholin,N_acetyltransferase-Inhibitor,CC(=O)OCC[N+](C)(C)C
3180,Acetylsalicylic Acid,N_acetyltransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
3181,Adenosine,N_acetyltransferase-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
3182,Allopurinol,N_acetyltransferase-Substrate,OC1=NC=NC2=C1C=NN2
3183,Amfetamine,N_acetyltransferase-Inducer,C[C@@H](N)CC1=CC=CC=C1
3184,Aminobenzoic Acid,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)C(O)=O
3185,Aminobenzoic Acid,N_acetyltransferase-Inhibitor,NC1=CC=C(C=C1)C(O)=O
3186,Aminophylline,N_acetyltransferase-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
3187,Androstanolone,N_acetyltransferase-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
3188,Apomorphine,N_acetyltransferase-Inhibitor,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
3189,Arbekacin,N_acetyltransferase-Substrate,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
3190,Ascorbic Acid (vit C),N_acetyltransferase-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
3191,Bergapten,N_acetyltransferase-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
3192,Bromocriptine,N_acetyltransferase-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
3193,Bucladesine,N_acetyltransferase-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
3194,Caffeine,N_acetyltransferase-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
3195,Carbachol,N_acetyltransferase-Inhibitor,C[N+](C)(C)CCOC(N)=O
3196,Carmustine,N_acetyltransferase-Inhibitor,ClCCNC(=O)N(CCCl)N=O
3197,Cimetidine,N_acetyltransferase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3198,Clonazepam,N_acetyltransferase-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
3199,Clonidine,N_acetyltransferase-Inhibitor,ClC1=CC=CC(Cl)=C1NC2=NCCN2
3200,Clozapine,N_acetyltransferase-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3201,Cocaine,N_acetyltransferase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3202,Cocaine,N_acetyltransferase-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3203,Dactinomycin,N_acetyltransferase-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
3204,Desipramine,N_acetyltransferase-Inducer,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3205,Desipramine,N_acetyltransferase-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3206,Dexamfetamine,N_acetyltransferase-Inducer,C[C@H](N)CC1=CC=CC=C1
3207,Diazepam,N_acetyltransferase-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3208,Dihydralazine,N_acetyltransferase-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
3209,Dinoprostone,N_acetyltransferase-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
3210,Disulfiram,N_acetyltransferase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3211,Esketamine,N_acetyltransferase-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3212,Fluoxetine,N_acetyltransferase-Inducer,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3213,Folic Acid,N_acetyltransferase-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
3214,Folic Acid,N_acetyltransferase-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
3215,G-strophanthin,N_acetyltransferase-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
3216,Glycyrrhizic Acid,N_acetyltransferase-Inhibitor,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
3217,Haloperidol,N_acetyltransferase-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3218,Hydralazine,N_acetyltransferase-Substrate,NN=C1NN=CC2=C1C=CC=C2
3219,Hydrocortisone,N_acetyltransferase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
3220,Ibuprofen,N_acetyltransferase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3221,Ibuprofen,N_acetyltransferase-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3222,Imipramine,N_acetyltransferase-Inducer,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3223,Indometacin,N_acetyltransferase-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3224,Indometacin,N_acetyltransferase-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3225,Insulin (human),N_acetyltransferase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
3226,Iproniazide,N_acetyltransferase-Inhibitor,CC(C)NNC(=O)C1=CC=NC=C1
3227,Isoprenaline,N_acetyltransferase-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
3228,Ketamine,N_acetyltransferase-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3229,Ketoprofen,N_acetyltransferase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
3230,Levodopa,N_acetyltransferase-Inducer,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
3231,Lindane,N_acetyltransferase-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
3232,Melatonin,N_acetyltransferase-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
3233,Melatonin,N_acetyltransferase-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
3234,Mercaptamine,N_acetyltransferase-Inhibitor,NCCS
3235,Mesalazine,N_acetyltransferase-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
3236,Metamizole Sodium,N_acetyltransferase-Substrate,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
3237,Methotrexate,N_acetyltransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
3238,Metoclopramide,N_acetyltransferase-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
3239,Netilmicin,N_acetyltransferase-Substrate,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O
3240,Nicotine,N_acetyltransferase-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
3241,Norepinephrine,N_acetyltransferase-Inducer,NC[C@@H](O)C1=CC(O)=C(O)C=C1
3242,Octopamine,N_acetyltransferase-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
3243,Oxedrine,N_acetyltransferase-Inhibitor,CNC[C@@H](O)C1=CC=C(O)C=C1
3244,Paclitaxel,N_acetyltransferase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3245,Pargyline,N_acetyltransferase-Inducer,CN(CC#C)CC1=CC=CC=C1
3246,Phenazone,N_acetyltransferase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3247,Procainamide,N_acetyltransferase-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
3248,Salicylamide,N_acetyltransferase-Inhibitor,NC(=O)C1=C(O)C=CC=C1
3249,Sulfadiazine,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
3250,Sulfamethoxazole,N_acetyltransferase-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3251,Sulfapyridine,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
3252,Sulindac,N_acetyltransferase-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
3253,Sultiame,N_acetyltransferase-Inducer,NS(=O)(=O)C1=CC=C(C=C1)N2CCCCS2(=O)=O
3254,Tamoxifen,N_acetyltransferase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3255,Testosterone,N_acetyltransferase-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3256,Theophylline,N_acetyltransferase-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
3257,Tobramycin,N_acetyltransferase-Substrate,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
3258,Trichloroethylene,N_acetyltransferase-Substrate,ClC=C(Cl)Cl
3259,Warfarin,N_acetyltransferase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3260,Lovastatin,4F22-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3261,Aceclofenac,2C9-Substrate,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3262,Acenocoumarol,2C9-Inhibitor,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
3263,Acenocoumarol,2C9-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
3264,Acetylsalicylic Acid,2C9-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
3265,Adefovir Dipivoxil,2C9-Inhibitor,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C
3266,Alosetron,2C9-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
3267,Aminophenazone,2C9-Inhibitor,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3268,Amiodarone,2C9-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
3269,Amitriptyline,2C9-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3270,Amlodipine,2C9-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
3271,Amodiaquine,2C9-Inhibitor,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
3272,Amprenavir,2C9-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3273,Anastrozole,2C9-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
3274,Aprepitant,2C9-Inducer,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3275,Aprepitant,2C9-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3276,Atovaquone,2C9-Inhibitor,OC1=C([C@H]2CC[C@@H](CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O
3277,Azapropazone,2C9-Inhibitor,CCC[C@H]1C(=O)N2N(C1=O)C(=NC3=C2C=C(C)C=C3)N(C)C
3278,Azelastine,2C9-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3279,Barnidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
3280,Benidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
3281,Benzbromarone,2C9-Inhibitor,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
3282,Benzethonium,2C9-Inhibitor,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
3283,Bexarotene,2C9-Substrate,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
3284,Bicalutamide,2C9-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
3285,Bortezomib,2C9-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3286,Bortezomib,2C9-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3287,Bosentan,2C9-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
3288,Bosentan,2C9-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
3289,Brompheniramine,2C9-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
3290,Bupropion,2C9-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
3291,Caffeine,2C9-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
3292,Candesartan,2C9-Inhibitor,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
3293,Candesartan,2C9-Substrate,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
3294,Capecitabine,2C9-Inhibitor,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O
3295,Capsaicin,2C9-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
3296,Carbamazepine,2C9-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3297,Carbinoxamine,2C9-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
3298,Carvedilol,2C9-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
3299,Celecoxib,2C9-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
3300,Chinin,2C9-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
3301,Chloramphenicol,2C9-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
3302,Chlorpropamide,2C9-Substrate,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
3303,Ciclosporin,2C9-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
3304,Cimetidine,2C9-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3305,Cinnarizin,2C9-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3306,Cisapride,2C9-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3307,Clevidipine,2C9-Inhibitor,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
3308,Clopidogrel,2C9-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3309,Clopidogrel,2C9-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3310,Clotrimazole,2C9-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3311,Clozapine,2C9-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3312,Clozapine,2C9-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3313,Cocaine,2C9-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3314,Colchicine,2C9-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3315,Colchicine,2C9-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3316,Colecalciferol,2C9-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
3317,Cyamemazine,2C9-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
3318,Cyclizine,2C9-Inhibitor,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
3319,Cyclophosphamide,2C9-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3320,Cyclophosphamide,2C9-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
3321,Dapsone,2C9-Inducer,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3322,Dapsone,2C9-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3323,Delavirdine,2C9-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
3324,Desloratadine,2C9-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
3325,Desogestrel,2C9-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3326,Dexamethasone,2C9-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3327,Dexfenfluramine,2C9-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
3328,Dexibuprofen,2C9-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3329,Dexmedetomidine,2C9-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
3330,Dextromethorphan,2C9-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3331,Dextropropoxyphene,2C9-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
3332,Diazepam,2C9-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3333,Diazepam,2C9-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3334,Diclofenac,2C9-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3335,Diclofenac,2C9-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3336,Diclofenamide,2C9-Inducer,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
3337,Dicoumarol,2C9-Inhibitor,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
3338,Dicoumarol,2C9-Substrate,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
3339,Diltiazem,2C9-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3340,Diltiazem,2C9-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3341,Disulfiram,2C9-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3342,Dolasetron,2C9-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
3343,Dopamine,2C9-Substrate,NCCC1=CC(O)=C(O)C=C1
3344,Dorzolamide,2C9-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
3345,Doxepin,2C9-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
3346,Dronabinol,2C9-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
3347,Efavirenz,2C9-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
3348,Enoxolone,2C9-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
3349,Entacapone,2C9-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3350,Epinephrine,2C9-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
3351,Epoprostenol,2C9-Substrate,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2OC(C[C@H]12)=C/CCCC(O)=O
3352,Eprosartan,2C9-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
3353,Esketamine,2C9-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3354,Estradiol,2C9-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3355,Estrone,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
3356,Ethanol,2C9-Inhibitor,CCO
3357,Ethinylestradiol,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
3358,Etodolac,2C9-Substrate,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
3359,Etodolac,2C9-Inhibitor,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
3360,Etoposide,2C9-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
3361,Etoricoxib,2C9-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
3362,Felodipine,2C9-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
3363,Fenofibrate,2C9-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
3364,Flecainide,2C9-Inhibitor,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
3365,Fluconazole,2C9-Substrate,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3366,Fluconazole,2C9-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3367,Flunarizine,2C9-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
3368,Flunitrazepam,2C9-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
3369,Fluorouracil,2C9-Inhibitor,FC1=CNC(=O)NC1=O
3370,Fluoxetine,2C9-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3371,Fluoxetine,2C9-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3372,Fluphenazine,2C9-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
3373,Flurbiprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3374,Flurbiprofen,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3375,Fluvastatin,2C9-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3376,Fluvastatin,2C9-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3377,Fluvoxamine,2C9-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3378,Formoterol,2C9-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3379,Fosamprenavir,2C9-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3380,Fosphenytoin,2C9-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3381,Fosphenytoin,2C9-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3382,Gemfibrozil,2C9-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3383,Glibenclamide,2C9-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3384,Glibenclamide,2C9-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3385,Glimepiride,2C9-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
3386,Glipizide,2C9-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3387,Griseofulvin,2C9-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
3388,Halofantrine,2C9-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
3389,Haloperidol,2C9-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3390,Halothane,2C9-Substrate,FC(F)(F)[C@@H](Cl)Br
3391,Hexobarbital,2C9-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
3392,Histamine,2C9-Substrate,NCCC1=CNC=N1
3393,Histamine,2C9-Inhibitor,NCCC1=CNC=N1
3394,Hydrochloric Acid,2C9-Inhibitor,Cl
3395,Hydromorphone,2C9-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
3396,Ibuprofen,2C9-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3397,Ibuprofen,2C9-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3398,Idarubicin,2C9-Substrate,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
3399,Ifosfamide,2C9-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3400,Ifosfamide,2C9-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
3401,Imatinib,2C9-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3402,Imatinib,2C9-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3403,Indinavir,2C9-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
3404,Indometacin,2C9-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3405,Indometacin,2C9-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3406,Ipriflavone,2C9-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
3407,Irbesartan,2C9-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3408,Irbesartan,2C9-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3409,Isoniazid,2C9-Inhibitor,NNC(=O)C1=CC=NC=C1
3410,Ketamine,2C9-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3411,Ketobemidone,2C9-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
3412,Ketoconazole,2C9-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3413,Ketoprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
3414,Lansoprazole,2C9-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3415,Lansoprazole,2C9-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3416,Lansoprazole,2C9-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3417,Leflunomide,2C9-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3418,Leflunomide,2C9-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3419,Lidocain,2C9-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3420,Lopinavir,2C9-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
3421,Loratadine,2C9-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3422,Loratadine,2C9-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3423,Lornoxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
3424,Lornoxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
3425,Losartan,2C9-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3426,Losartan,2C9-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3427,Lovastatin,2C9-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3428,Lovastatin,2C9-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3429,Lumiracoxib,2C9-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
3430,Lynestrenol,2C9-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3431,Manidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
3432,Medroxyprogesterone,2C9-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
3433,Medrysone,2C9-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
3434,Mefenamic Acid,2C9-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3435,Mefenamic Acid,2C9-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3436,Meloxicam,2C9-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3437,Meloxicam,2C9-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3438,Mephenytoin,2C9-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3439,Methadone,2C9-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3440,Methazolamide,2C9-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
3441,Methoxyflurane,2C9-Substrate,COC(F)(F)C(Cl)Cl
3442,Metronidazole,2C9-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
3443,Metronidazole,2C9-Substrate,CC1=NC=C(N1CCO)[N+]([O-])=O
3444,Miconazole,2C9-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
3445,Mirtazapine,2C9-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
3446,Mizolastine,2C9-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
3447,Moclobemide,2C9-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3448,Moclobemide,2C9-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3449,Modafinil,2C9-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3450,Modafinil,2C9-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3451,Naproxen,2C9-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
3452,Nateglinide,2C9-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
3453,Nelfinavir,2C9-Inducer,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3454,Nelfinavir,2C9-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3455,Nevirapine,2C9-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
3456,Nevirapine,2C9-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
3457,Nicardipine,2C9-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3458,Nicardipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3459,Nicotine,2C9-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3460,Nifedipine,2C9-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3461,Nifedipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3462,Nilutamide,2C9-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
3463,Nilvadipine,2C9-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3464,Nimesulide,2C9-Inhibitor,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
3465,Nimesulide,2C9-Substrate,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
3466,Noscapine,2C9-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
3467,Olanzapine,2C9-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
3468,Omeprazole,2C9-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3469,Omeprazole,2C9-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3470,Ondansetron,2C9-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
3471,Orphenadrine (citrate),2C9-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
3472,Oxaprozin,2C9-Substrate,OC(=O)CCC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3
3473,Paclitaxel,2C9-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3474,Pancreozymin (cholecystokinin),2C9-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
3475,Pantoprazole,2C9-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
3476,Paracetamol,2C9-Substrate,CC(=O)NC1=CC=C(O)C=C1
3477,Parecoxib,2C9-Inhibitor,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
3478,Paroxetine,2C9-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
3479,Perazine,2C9-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3480,Perazine,2C9-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3481,Perphenazine,2C9-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3482,Phenacetin,2C9-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3483,Phenazone,2C9-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3484,Phenobarbital,2C9-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3485,Phenobarbital,2C9-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3486,Phenprocoumon,2C9-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3487,Phentermine,2C9-Inducer,CC(C)(N)CC1=CC=CC=C1
3488,Phentermine,2C9-Inhibitor,CC(C)(N)CC1=CC=CC=C1
3489,Phenylbutazone,2C9-Inhibitor,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
3490,Phenylbutazone,2C9-Substrate,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
3491,Phenytoin,2C9-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3492,Phenytoin,2C9-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3493,Phenytoin,2C9-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3494,Pioglitazone,2C9-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3495,Pioglitazone,2C9-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3496,Piroxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3497,Piroxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3498,Pranlukast,2C9-Inhibitor,O=C(NC1=CC=C2C(=O)C=C(OC2=C1)C3=NN=NN3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4
3499,Pravastatin,2C9-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
3500,Pravastatin,2C9-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
3501,Primidone,2C9-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3502,Probenecid,2C9-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3503,Progesterone,2C9-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3504,Progesterone,2C9-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3505,Proguanil,2C9-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
3506,Promethazine,2C9-Inhibitor,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
3507,Propafenone,2C9-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
3508,Propanol,2C9-Inhibitor,CCCO
3509,Propofol,2C9-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3510,Propofol,2C9-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
3511,Pyrimethamine,2C9-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
3512,Quazepam,2C9-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
3513,Quinidine,2C9-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
3514,Quinidine,2C9-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
3515,Retinol (vit A),2C9-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
3516,Rifampicin,2C9-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3517,Rifampicin,2C9-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3518,Rifapentine,2C9-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
3519,Ritonavir,2C9-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3520,Ritonavir,2C9-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3521,Rofecoxib,2C9-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
3522,Rosiglitazone,2C9-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3523,Rosiglitazone,2C9-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3524,Rosuvastatin,2C9-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
3525,Rosuvastatin,2C9-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
3526,Rutoside,2C9-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
3527,Saquinavir,2C9-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3528,Secobarbital,2C9-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
3529,Selegiline,2C9-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3530,Selegiline,2C9-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3531,Seratrodast,2C9-Inducer,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3532,Seratrodast,2C9-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3533,Seratrodast,2C9-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3534,Sertraline,2C9-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3535,Sertraline,2C9-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3536,Sildenafil,2C9-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3537,Silymarin,2C9-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
3538,Simvastatin,2C9-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3539,Ezetimibe,2C9-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
3540,Sulconazole,2C9-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
3541,Sulfadiazine,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
3542,Sulfadiazine,2C9-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
3543,Sulfadimethoxine,2C9-Inhibitor,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
3544,Sulfadimidine,2C9-Inhibitor,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
3545,Sulfafurazole,2C9-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
3546,Sulfafurazole,2C9-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
3547,Sulfamethizole,2C9-Inhibitor,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
3548,Sulfamethoxazole,2C9-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3549,Sulfamethoxazole,2C9-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3550,Trimethoprim,2C9-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
3551,Trimethoprim,2C9-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
3552,Sulfamoxole,2C9-Inhibitor,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
3553,Sulfanilamide,2C9-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
3554,Sulfaphenazole,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
3555,Sulfapyridine,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
3556,Sulfinpyrazon,2C9-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
3557,Sulfinpyrazon,2C9-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
3558,Suprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
3559,Suprofen,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
3560,Tamoxifen,2C9-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3561,Tamoxifen,2C9-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3562,Tegaserod,2C9-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
3563,Telmisartan,2C9-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
3564,Temazepam,2C9-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3565,Teniposide,2C9-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
3566,Tenofovir Disoproxil,2C9-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
3567,Tenoxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
3568,Terbinafine,2C9-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
3569,Terfenadine,2C9-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
3570,Testosterone,2C9-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3571,Tetrabenazine,2C9-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
3572,Thalidomide,2C9-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3573,Theophylline,2C9-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
3574,Thiamazole,2C9-Inhibitor,CN1C=CNC1=S
3575,Thioridazine,2C9-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
3576,Tibolone,2C9-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
3577,Ticlopidine,2C9-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
3578,Tienilic Acid,2C9-Inducer,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
3579,Tienilic Acid,2C9-Substrate,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
3580,Tioconazole,2C9-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
3581,Tolbutamide,2C9-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
3582,Tolbutamide,2C9-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
3583,Tolcapone,2C9-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
3584,Tolterodine,2C9-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
3585,Torasemide,2C9-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
3586,Trabectedin,2C9-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
3587,Tranylcypromine,2C9-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
3588,Tretinoin,2C9-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
3589,Tretinoin,2C9-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
3590,Triazolam,2C9-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
3591,Trimethadione,2C9-Substrate,CN1C(=O)OC(C)(C)C1=O
3592,Trimipramine,2C9-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3593,Troglitazone,2C9-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3594,Troglitazone,2C9-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3595,Tropisetron,2C9-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
3596,Trospium,2C9-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
3597,Valdecoxib,2C9-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
3598,Valdecoxib,2C9-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
3599,Valproic Acid,2C9-Inhibitor,CCCC(CCC)C(O)=O
3600,Valproic Acid,2C9-Substrate,CCCC(CCC)C(O)=O
3601,Valsartan,2C9-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
3602,Valsartan,2C9-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
3603,Venlafaxine,2C9-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
3604,Verapamil,2C9-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3605,Verapamil,2C9-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3606,Voriconazole,2C9-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3607,Voriconazole,2C9-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3608,Warfarin,2C9-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3609,Warfarin,2C9-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3610,Ximelagatran,2C9-Substrate,CCOC(=O)CN[C@H]([C@H]1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C=NNO
3611,Zafirlukast,2C9-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
3612,Zafirlukast,2C9-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
3613,Zalcitabine,2C9-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
3614,Zidovudine,2C9-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
3615,Zolpidem,2C9-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
3616,Zolpidem,2C9-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
3617,Zopiclone,2C9-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
3618,Acetylsalicylic acid,2C9-Substrate,CC(=O)OC1=CC=CC=C1C(=O)O
3619,Albendazole,2C9-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
3620,Aminopyrine,2C9-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
3621,Amiodarone,2C9-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
3622,Amoxapine,2C9-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
3623,Atomoxetine,2C9-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
3624,Bufuralol,2C9-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
3625,Carbaril,2C9-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
3626,Chlorpyrifos,2C9-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
3627,Clomipramine,2C9-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
3628,Delavirdine,2C9-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
3629,Disopyramide,2C9-Substrate,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
3630,Eletriptan,2C9-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
3631,Etoperidone,2C9-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
3632,Etoricoxib,2C9-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
3633,Gliclazide,2C9-Substrate,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
3634,Imipramine,2C9-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3635,Indinavir,2C9-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
3636,Levacetylmethadol,2C9-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3637,Lidocaine,2C9-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
3638,Mefenamic acid,2C9-Substrate,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
3639,Mestranol,2C9-Substrate,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC
3640,Midazolam,2C9-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
3641,Montelukast,2C9-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
3642,Morphine,2C9-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
3643,Nelfinavir,2C9-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3644,Praziquantel,2C9-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
3645,Promazine,2C9-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
3646,Pyrantel,2C9-Substrate,CN1CCCN=C1C=CC2=CC=CS2
3647,Quetiapine,2C9-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
3648,Repaglinide,2C9-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
3649,Ritonavir,2C9-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3650,Sulfinpyrazone,2C9-Substrate,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
3651,Tauromustine,2C9-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
3652,Tegafur,2C9-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
3653,Tiaramide,2C9-Substrate,C1CN(CCN1CCO)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O
3654,Tienilic acid,2C9-Substrate,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
3655,Toremifene,2C9-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
3656,Trichloromethane,2C9-Substrate,C(Cl)(Cl)Cl
3657,Valproic acid,2C9-Substrate,CCCC(CCC)C(=O)O
3658,Zaltoprofen,2C9-Substrate,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
3659,Zileuton,2C9-Substrate,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
3660,Alprenolol,-,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
3661,Astemizole,-,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
3662,Azelastine,-,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3663,Betaxolol,-,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
3664,Buprenorphine,-,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3665,Chlorphenamine,-,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
3666,Chlorpromazine,-,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
3667,Citalopram,-,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
3668,Codeine,-,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
3669,Debrisoquine,-,NC(=N)N1CCC2=C(C1)C=CC=C2
3670,Desipramine,-,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3671,Diphenhydramine,-,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
3672,Ezlopitant,-,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
3673,Flecainide,-,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
3674,Fluperlapine,-,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
3675,Fluphenazine,-,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
3676,Fluvoxamine,-,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3677,Halofantrine,-,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
3678,Labetalol,-,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
3679,Loratadine,-,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3680,Maprotiline,-,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
3681,Mizolastine,-,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
3682,Norfluoxetine,-,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
3683,Nortriptyline,-,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3684,Olanzapine,-,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
3685,Paroxetine,-,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
3686,Perhexiline,-,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
3687,Primaquine,-,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
3688,Promethazine,-,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
3689,Propafenone,-,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
3690,Propranolol,-,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
3691,Ranitidine,-,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
3692,Risperidone,-,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
3693,Saquinavir,-,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3694,Sertindole,-,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
3695,Sparteine,-,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
3696,Tegaserod,-,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
3697,Terfenadine,-,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
3698,Thioridazine,-,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
3699,Timolol,-,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
3700,Tolperisone,-,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
3701,Trimipramine,-,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3702,Yohimbine,-,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
3703,Carbamazepine,2C9-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3704,Cinnarizine,2C9-Substrate,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
3705,Mianserin,2C9-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
3706,Almotriptan,-,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
3707,Bupranolol,-,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
3708,Chloroquine,-,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
3709,Haloperidol,-,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3710,Metoclopramide,-,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
3711,Metoprolol,-,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
3712,Nicardipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3713,Nifedipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3714,Orphenadrine,-,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
3715,Pindolol,-,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
3716,Vinorelbine,-,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
3717,Amitriptyline,2C9-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3718,Astemizole,2C9-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
3719,Atazanavir,2C9-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
3720,Atorvastatin,2C9-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
3721,Buprenorphine,2C9-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3722,Cerivastatin,2C9-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
3723,Chlorpromazine,2C9-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
3724,Cilnidipine,2C9-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
3725,Citalopram,2C9-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
3726,Dexloxiglumide,2C9-Inhibitor,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl
3727,Dimethyl sulfoxide,2C9-Inhibitor,CS(=O)C
3728,Drospirenone,2C9-Inhibitor,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
3729,Escitalopram,2C9-Inhibitor,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
3730,Irinotecan,2C9-Inhibitor,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
3731,Isradipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
3732,Itraconazole,2C9-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
3733,Mefenamic acid,2C9-Inhibitor,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
3734,Mephenytoin,2C9-Inhibitor,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3735,Methoxsalen,2C9-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
3736,Midazolam,2C9-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
3737,Nateglinide,2C9-Inhibitor,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
3738,Nimodipine,2C9-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
3739,Nitrendipine,2C9-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
3740,Ondansetron,2C9-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
3741,Orphenadrine,2C9-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
3742,Parathion,2C9-Inhibitor,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
3743,Perphenazine,2C9-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3744,Phenprocoumon,2C9-Inhibitor,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3745,Proadifen,2C9-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
3746,Quercetin,2C9-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
3747,Quetiapine,2C9-Inhibitor,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
3748,Rabeprazole,2C9-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
3749,Rebamipide,2C9-Inhibitor,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
3750,Sildenafil,2C9-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3751,Sulfinpyrazone,2C9-Inhibitor,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
3752,Tenoxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
3753,Terfenadine,2C9-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
3754,Tezosentan,2C9-Inhibitor,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
3755,Tiabendazole,2C9-Inhibitor,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
3756,Tienilic acid,2C9-Inhibitor,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
3757,Valproic acid,2C9-Inhibitor,CCCC(CCC)C(=O)O
3758,Zaltoprofen,2C9-Inhibitor,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
3759,Zileuton,2C9-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
3760,Amoxapine,-,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
3761,Bufuralol,-,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
3762,Celecoxib,-,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
3763,Clomipramine,-,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
3764,Dextromethorphan,-,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3765,Etoperidone,-,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
3766,Imipramine,-,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3767,Lidocaine,-,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
3768,Mirtazapine,-,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
3769,Praziquantel,-,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
3770,Venlafaxine,-,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
3771,Carbamazepine,2C9-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3772,Norfluoxetine,2C9-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
3773,Stiripentol,2C9-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
3774,Sulfadoxine,2C9-Inhibitor,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
3775,Sulfamerazine,2C9-Inhibitor,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
3776,Sulfatroxazole,2C9-Inhibitor,CC1=C(ON=C1NS(=O)(=O)C2=CC=C(C=C2)N)C
3777,Sulindac,2C9-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
3778,Cisapride,-,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3779,Methadone,-,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3780,Mianserin,-,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
3781,Tropisetron,-,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
3782,Ketoconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3783,Meglutol,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(O)(CC(O)=O)CC(O)=O
3784,Sertaconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
3785,Terconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(C)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3786,Sodium Bicarbonate,Electrogenic_sodium_bicarbonate_cotransporter_1-Substrate,OC([O-])=O
3787,Tenidap,Electrogenic_sodium_bicarbonate_cotransporter_1-Inhibitor,NC(=O)N1C(=O)C(=C(/O)C2=CC=CS2)C3=C1C=CC(Cl)=C3
3788,Cisplatin,Copper_transporting_ATPase_2-Substrate,N[Pt](N)(Cl)Cl
3789,Cisplatin,Copper_transporting_ATPase_2-Inducer,N[Pt](N)(Cl)Cl
3790,Aminosalicylic Acid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=CC(O)=C(C=C1)C(O)=O
3791,Cisplatin,Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,N[Pt](N)(Cl)Cl
3792,Dexamethasone,Sodium_coupled_neutral_amino_acid_transporter_3-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3793,Folic Acid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
3794,Isoniazid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NNC(=O)C1=CC=NC=C1
3795,Levoglutamide,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,N[C@@H](CCC(N)=O)C(O)=O
3796,"Mercury, Metallic",Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,[Hg]
3797,Mesalazine,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
3798,Paclitaxel,Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3799,Sulfadimidine,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
3800,Sulfamethoxazole,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3801,Alfacalcidol,27A-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)C[C@@H](O)C3=C
3802,Ciclosporin,27A-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
3803,Ciprofibrate,27A-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
3804,Colecalciferol,27A-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
3805,Colestyramine,27A-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
3806,Dexamethasone,27A-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3807,Acetylsalicylic Acid,2C8-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
3808,Aminophenazone,2C8-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3809,Amiodarone,2C8-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
3810,Amitriptyline,2C8-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3811,Amitriptyline,2C8-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3812,Amlodipine,2C8-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
3813,Amodiaquine,2C8-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
3814,Amprenavir,2C8-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3815,Atorvastatin,2C8-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
3816,Bezafibrate,2C8-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
3817,Bortezomib,2C8-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3818,Brompheniramine,2C8-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
3819,Buprenorphine,2C8-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3820,Bupropion,2C8-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
3821,Caffeine,2C8-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
3822,Capsaicin,2C8-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
3823,Carbamazepine,2C8-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3824,Carbamazepine,2C8-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3825,Carbinoxamine,2C8-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
3826,Cefaloridine,2C8-Substrate,[O-]C(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)C[N+]4=CC=CC=C4
3827,Cerivastatin,2C8-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
3828,Cerivastatin,2C8-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
3829,Chinin,2C8-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
3830,Chloramphenicol,2C8-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
3831,Chloroquine,2C8-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
3832,Ciclosporin,2C8-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
3833,Cimetidine,2C8-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3834,Cisapride,2C8-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3835,Clopidogrel,2C8-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3836,Clotrimazole,2C8-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3837,Clozapine,2C8-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3838,Cocaine,2C8-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3839,Colchicine,2C8-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3840,Colchicine,2C8-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3841,Colecalciferol,2C8-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
3842,Cyamemazine,2C8-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
3843,Cyclophosphamide,2C8-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
3844,Cyclophosphamide,2C8-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3845,Dapsone,2C8-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3846,Delavirdine,2C8-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
3847,Dexamethasone,2C8-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3848,Dexmedetomidine,2C8-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
3849,Dextromethorphan,2C8-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3850,Dextropropoxyphene,2C8-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
3851,Diazepam,2C8-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3852,Diclofenac,2C8-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3853,Diclofenac,2C8-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3854,Diltiazem,2C8-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3855,Diltiazem,2C8-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3856,Disulfiram,2C8-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3857,Dolasetron,2C8-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
3858,Domperidone,2C8-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
3859,Dorzolamide,2C8-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
3860,Efavirenz,2C8-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
3861,Entacapone,2C8-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3862,Eprosartan,2C8-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
3863,Estradiol,2C8-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3864,Etoposide,2C8-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
3865,Felodipine,2C8-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
3866,Fenofibrate,2C8-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
3867,Fluconazole,2C8-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3868,Fluorouracil,2C8-Substrate,FC1=CNC(=O)NC1=O
3869,Fluoxetine,2C8-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3870,Fluoxetine,2C8-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3871,Fluphenazine,2C8-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
3872,Flurbiprofen,2C8-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3873,Flurbiprofen,2C8-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3874,Fluvastatin,2C8-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3875,Fluvastatin,2C8-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3876,Fluvoxamine,2C8-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3877,Formoterol,2C8-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3878,Fosamprenavir,2C8-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3879,Fosphenytoin,2C8-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3880,Fosphenytoin,2C8-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3881,Gemfibrozil,2C8-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3882,Gemfibrozil,2C8-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3883,Glimepiride,2C8-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
3884,Glipizide,2C8-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3885,Griseofulvin,2C8-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
3886,Halofantrine,2C8-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
3887,Halothane,2C8-Substrate,FC(F)(F)[C@@H](Cl)Br
3888,Hydrocortisone,2C8-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
3889,Ibuprofen,2C8-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3890,Ibuprofen,2C8-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3891,Ifosfamide,2C8-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
3892,Ifosfamide,2C8-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3893,Imatinib,2C8-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3894,Imatinib,2C8-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3895,Indinavir,2C8-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
3896,Indometacin,2C8-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3897,Indometacin,2C8-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3898,Ipriflavone,2C8-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
3899,Irbesartan,2C8-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3900,Irbesartan,2C8-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3901,Isoniazid,2C8-Inhibitor,NNC(=O)C1=CC=NC=C1
3902,Ketamine,2C8-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3903,Ketobemidone,2C8-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
3904,Ketoconazole,2C8-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3905,Ketoprofen,2C8-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
3906,Lansoprazole,2C8-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3907,Lansoprazole,2C8-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3908,Leflunomide,2C8-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3909,Leflunomide,2C8-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3910,Lidocain,2C8-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3911,Loperamide,2C8-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3912,Loratadine,2C8-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3913,Losartan,2C8-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3914,Losartan,2C8-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3915,Lovastatin,2C8-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3916,Medroxyprogesterone,2C8-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
3917,Mefenamic Acid,2C8-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3918,Mefenamic Acid,2C8-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3919,Meloxicam,2C8-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3920,Meloxicam,2C8-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3921,Mephenytoin,2C8-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3922,Methadone,2C8-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3923,Metronidazole,2C8-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
3924,Mirtazapine,2C8-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
3925,Mometasone,2C8-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
3926,Montelukast,2C8-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
3927,Morphine,2C8-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
3928,Naloxone,2C8-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
3929,Naproxen,2C8-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
3930,Nicardipine,2C8-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3931,Nicardipine,2C8-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3932,Nicotine,2C8-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3933,Nifedipine,2C8-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3934,Nilutamide,2C8-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
3935,Nilvadipine,2C8-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3936,Omeprazole,2C8-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3937,Oxybutynin,2C8-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
3938,Paclitaxel,2C8-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3939,Paracetamol,2C8-Substrate,CC(=O)NC1=CC=C(O)C=C1
3940,Paraoxon,2C8-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
3941,Paroxetine,2C8-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
3942,Pentamidine Isethionate,2C8-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
3943,Perphenazine,2C8-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3944,Phenazone,2C8-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3945,Phenelzine,2C8-Inhibitor,NNCCC1=CC=CC=C1
3946,Phenobarbital,2C8-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3947,Phenobarbital,2C8-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3948,Phenprocoumon,2C8-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3949,Phenytoin,2C8-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3950,Phenytoin,2C8-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3951,Pioglitazone,2C8-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3952,Pioglitazone,2C8-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3953,Piroxicam,2C8-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3954,Piroxicam,2C8-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3955,Pravastatin,2C8-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
3956,Primidone,2C8-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3957,Probenecid,2C8-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3958,Progesterone,2C8-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3959,Propafenone,2C8-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
3960,Propofol,2C8-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3961,Pyrimethamine,2C8-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
3962,Quinidine,2C8-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
3963,Raloxifene,2C8-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
3964,Repaglinide,2C8-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
3965,Retinol (vit A),2C8-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
3966,Retinol (vit A),2C8-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
3967,Rifampicin,2C8-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3968,Rifampicin,2C8-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3969,Rifampicin,2C8-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3970,Rifapentine,2C8-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
3971,Ritonavir,2C8-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3972,Ritonavir,2C8-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3973,Rofecoxib,2C8-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
3974,Rosiglitazone,2C8-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3975,Rosiglitazone,2C8-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3976,Rutoside,2C8-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
3977,Salmeterol,2C8-Inhibitor,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
3978,Saquinavir,2C8-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3979,Secobarbital,2C8-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
3980,Selegiline,2C8-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3981,Seratrodast,2C8-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3982,Simvastatin,2C8-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3983,Simvastatin,2C8-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3984,Ezetimibe,2C8-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
3985,Spironolactone,2C8-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
3986,Sulfadiazine,2C8-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
3987,Sulfafurazole,2C8-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
3988,Sulfafurazole,2C8-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
3989,Sulfamethoxazole,2C8-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3990,Sulfaphenazole,2C8-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
3991,Sulfinpyrazon,2C8-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
3992,Tamoxifen,2C8-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3993,Tazarotene,2C8-Substrate,CCOC(=O)C1=CC=C(N=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2
3994,Tegafur,2C8-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
3995,Tegaserod,2C8-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
3996,Temazepam,2C8-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3997,Terbinafine,2C8-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
3998,Terfenadine,2C8-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
3999,Testosterone,2C8-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4000,Tetrabenazine,2C8-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
4001,Thalidomide,2C8-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
4002,Theophylline,2C8-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4003,Thioridazine,2C8-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4004,Ticlopidine,2C8-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
4005,Tioconazole,2C8-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
4006,Tolbutamide,2C8-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4007,Tolbutamide,2C8-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4008,Torasemide,2C8-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
4009,Tretinoin,2C8-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4010,Tretinoin,2C8-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4011,Triazolam,2C8-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
4012,Trimethadione,2C8-Substrate,CN1C(=O)OC(C)(C)C1=O
4013,Trimethoprim,2C8-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4014,Trimethoprim,2C8-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4015,Troglitazone,2C8-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4016,Troglitazone,2C8-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4017,Troleandomycin,2C8-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
4018,Valproic Acid,2C8-Inhibitor,CCCC(CCC)C(O)=O
4019,Verapamil,2C8-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4020,Warfarin,2C8-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4021,Warfarin,2C8-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4022,Zafirlukast,2C8-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4023,Zafirlukast,2C8-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4024,Zidovudine,2C8-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4025,Zopiclone,2C8-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
4026,Latanoprost,Solute_carrier_organic_anion_transporter_family_member_2A1-Inhibitor,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2
4027,Latanoprost,Solute_carrier_organic_anion_transporter_family_member_2A1-Substrate,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2
4028,Aldosterone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4029,Aminogluthetimide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4030,Aminosalicylic Acid,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,NC1=CC(O)=C(C=C1)C(O)=O
4031,Angiotensinamide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4032,Benazepril,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(CC(O)=O)C2=O
4033,Desoxycortone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
4034,Eplerenone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
4035,Etomidate,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
4036,Glucose,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4037,Hydrocortisone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4038,Insulin (human),Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4039,Metoclopramide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4040,Mibefradil,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
4041,Valsartan,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
4042,Doxorubicin,Multidrug_resistance_associated_protein_7-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4043,Paclitaxel,Multidrug_resistance_associated_protein_7-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4044,Sulfinpyrazon,Multidrug_resistance_associated_protein_7-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4045,Calcitriol,Calcidiol_1_monooxygenase_25_OHD_1_alpha_hydroxylase_25_hydroxyvitamin_D3_1_alpha_hydroxylase_VD3_1A_hydroxylase_P450C1_alpha_50VD1_alpha-Inhibitor,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
4046,Lovastatin,CP4FN-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4047,Minoxidil,Prostacyclin_synthase_Prostaglandin_I2_synthase_PTGIS-Inhibitor,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
4048,Tranylcypromine,Prostacyclin_synthase_Prostaglandin_I2_synthase_PTGIS-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
4049,Androstanolone,Solute_carrier_family_22_member_8-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4050,Angiotensinamide,Solute_carrier_family_22_member_8-Inhibitor,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4051,Benzylpenicillin,Solute_carrier_family_22_member_8-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
4052,Benzylpenicillin,Solute_carrier_family_22_member_8-Inhibitor,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
4053,Cefazolin,Solute_carrier_family_22_member_8-Substrate,CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN4C=NN=N4)C3=O)C(O)=O)S1
4054,Cefotiam,Solute_carrier_family_22_member_8-Substrate,CN(C)CCN1N=NN=C1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CC4=CSC(N)=N4)C3=O)C(O)=O
4055,Celecoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4056,Chlorothiazide,Solute_carrier_family_22_member_8-Substrate,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
4057,Cidofovir,Solute_carrier_family_22_member_8-Substrate,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
4058,Ciprofloxacin,Solute_carrier_family_22_member_8-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4059,Ciprofloxacin,Solute_carrier_family_22_member_8-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4060,Estrone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
4061,Etoricoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
4062,Famotidine,Solute_carrier_family_22_member_8-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
4063,Fluvastatin,Solute_carrier_family_22_member_8-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
4064,Furosemide,Solute_carrier_family_22_member_8-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
4065,Gatifloxacin,Solute_carrier_family_22_member_8-Inhibitor,COC1=C(N2CCN[C@@H](C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)[C@H]4CC4
4066,Glutathione,Solute_carrier_family_22_member_8-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
4067,Hydrocortisone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4068,Ibuprofen,Solute_carrier_family_22_member_8-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
4069,Mercaptopurine,Solute_carrier_family_22_member_8-Substrate,S=C1NC=NC2=C1NC=N2
4070,Methotrexate,Solute_carrier_family_22_member_8-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4071,Phenolsulfonphthalein,Solute_carrier_family_22_member_8-Substrate,OC1=CC=C(C=C1)[C@@]2(OS(=O)(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4072,Prasterone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
4073,Pravastatin,Solute_carrier_family_22_member_8-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
4074,Probenecid,Solute_carrier_family_22_member_8-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4075,Ranitidine,Solute_carrier_family_22_member_8-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4076,Rofecoxib,Solute_carrier_family_22_member_8-Inhibitor,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4077,Rosuvastatin,Solute_carrier_family_22_member_8-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4078,Simvastatin,Solute_carrier_family_22_member_8-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4079,Sulfasalazine,Solute_carrier_family_22_member_8-Inhibitor,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
4080,Torasemide,Solute_carrier_family_22_member_8-Inhibitor,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
4081,Tryptophan,Solute_carrier_family_22_member_8-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
4082,Valdecoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
4083,Etretinate,26B-Substrate,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
4084,Abacavir,UGT-Substrate,NC1=NC2=C(N=CN2[C@H]3C[C@@H](CO)C=C3)C(N[C@H]4CC4)=N1
4085,Acarbose,UGT-Inhibitor,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
4086,Acetylsalicylic Acid,UGT-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
4087,Amitriptyline,UGT-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4088,Amitriptyline,UGT-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4089,Anastrozole,UGT-Substrate,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
4090,Androstanolone,UGT-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4091,Atazanavir,UGT-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4092,Atazanavir,UGT-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4093,Atorvastatin,UGT-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4094,Benfluorex,UGT-Inducer,C[C@@H](CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2
4095,Bucladesine,UGT-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
4096,Buprenorphine,UGT-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4097,Bupropion,UGT-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4098,Candesartan,UGT-Substrate,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
4099,Canrenone,UGT-Inhibitor,C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5
4100,Carbamazepine,UGT-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4101,Carbamazepine,UGT-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4102,Chenodeoxycholic Acid,UGT-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4103,Cicletanine,UGT-Substrate,CC1=NC=C2[C@H](OCC2=C1O)C3=CC=C(Cl)C=C3
4104,Cisplatin,UGT-Inducer,N[Pt](N)(Cl)Cl
4105,Clofibrate,UGT-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
4106,Clomipramine,UGT-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4107,Codeine,UGT-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
4108,Cyproheptadin,UGT-Substrate,CN1CCC(CC1)=C2/C3=C(C=CC=C3)C=CC4=C2C=CC=C4
4109,Dactinomycin,UGT-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
4110,Dasatinib,UGT-Inhibitor,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
4111,Dexamethasone,UGT-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4112,Diazepam,UGT-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4113,Diclofenac,UGT-Inducer,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4114,Diflunisal,UGT-Substrate,OC(=O)C1=C(O)C=CC(=C1)C2=C(F)C=C(F)C=C2
4115,Digitoxin,UGT-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4116,Disulfiram,UGT-Inducer,CCN(CC)C(=S)SSC(=S)N(CC)CC
4117,Enoxolone,UGT-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
4118,Epinephrine,UGT-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4119,Erlotinib,UGT-Inhibitor,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
4120,Esketamine,UGT-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4121,Eslicarbazepine,UGT-Substrate,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2
4122,Estradiol,UGT-Inhibitor,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4123,Estradiol,UGT-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4124,Estriol,UGT-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
4125,Estriol,UGT-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
4126,Ethanol,UGT-Inducer,CCO
4127,Etodolac,UGT-Substrate,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
4128,Ezetimibe,UGT-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
4129,Febuxostat,UGT-Substrate,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
4130,Fluconazole,UGT-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4131,Flurbiprofen,UGT-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
4132,Gefitinib,UGT-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
4133,Gemfibrozil,UGT-Substrate,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
4134,Hydrocodone,UGT-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
4135,Hydrocortisone,UGT-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4136,Hydromorphone,UGT-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
4137,Hydroxyprogesterone,UGT-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4138,Hymecromone,UGT-Inhibitor,CC1=CC(=O)OC2=C1C=CC(O)=C2
4139,Hymecromone,UGT-Inducer,CC1=CC(=O)OC2=C1C=CC(O)=C2
4140,Hymecromone,UGT-Substrate,CC1=CC(=O)OC2=C1C=CC(O)=C2
4141,Imipramine,UGT-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4142,Imipramine,UGT-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4143,Indinavir,UGT-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
4144,Indometacin,UGT-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4145,Indometacin,UGT-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4146,Irinotecan,UGT-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4147,Itraconazole,UGT-Substrate,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
4148,Ketamine,UGT-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4149,Labetalol,UGT-Substrate,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
4150,Lopinavir,UGT-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
4151,Losartan,UGT-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4152,Medroxyprogesterone,UGT-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
4153,Meprobamate,UGT-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
4154,Mercaptopurine,UGT-Substrate,S=C1NC=NC2=C1NC=N2
4155,Mitiglinide,UGT-Substrate,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O
4156,Naloxone,UGT-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
4157,Naproxen,UGT-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
4158,Nicotine,UGT-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
4159,Nicotine,UGT-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
4160,Niflumic Acid,UGT-Substrate,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
4161,Niflumic Acid,UGT-Inhibitor,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
4162,Nilotinib,UGT-Inhibitor,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
4163,Oleandomycin,UGT-Substrate,CO[C@@H]1C[C@@H](O[C@@H](C)[C@H]1O)O[C@H]2[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
4164,Oxazepam,UGT-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
4165,Oxymetazoline,UGT-Substrate,CC1=CC(=C(O)C(C)=C1CC2=NCCN2)C(C)(C)C
4166,Paracetamol,UGT-Substrate,CC(=O)NC1=CC=C(O)C=C1
4167,Phenobarbital,UGT-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4168,Phenol,UGT-Substrate,OC1=CC=CC=C1
4169,Phenolphthalein,UGT-Substrate,OC1=CC=C(C=C1)[C@@]2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4170,Phenolsulfonphthalein,UGT-Substrate,OC1=CC=C(C=C1)[C@@]2(OS(=O)(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4171,Phenylbutazone,UGT-Substrate,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
4172,Phenylbutazone,UGT-Inhibitor,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
4173,Phenytoin,UGT-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
4174,Pirprofen,UGT-Substrate,C[C@H](C(O)=O)C1=CC(Cl)=C(C=C1)N2CC=CC2
4175,Pitavastatin,UGT-Inhibitor,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
4176,Pitavastatin,UGT-Substrate,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
4177,Posaconazole,UGT-Substrate,[H][C@@](C)(O)[C@]([H])(CC)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@]2([H])CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1
4178,Probenecid,UGT-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4179,Probenecid,UGT-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4180,Raltegravir,UGT-Substrate,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
4181,Ranitidine,UGT-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4182,Repaglinide,UGT-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
4183,Riluzole,UGT-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
4184,Ritonavir,UGT-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4185,Saquinavir,UGT-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4186,Silymarin,UGT-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
4187,Sorafenib,UGT-Inhibitor,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
4188,Spironolactone,UGT-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
4189,Tamoxifen,UGT-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4190,Telmisartan,UGT-Substrate,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4191,Telmisartan,UGT-Inducer,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4192,Tiadenol,UGT-Inducer,OCCSCCCCCCCCCCSCCO
4193,Triclosan,UGT-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
4194,Trimipramine,UGT-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4195,Troglitazone,UGT-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4196,Valproic Acid,UGT-Substrate,CCCC(CCC)C(O)=O
4197,Valproic Acid,UGT-Inhibitor,CCCC(CCC)C(O)=O
4198,Vorinostat,UGT-Substrate,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
4199,Warfarin,UGT-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4200,Zidovudine,UGT-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4201,Dexamethasone,CP343-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4202,Ethosuximide,CP343-Substrate,CC[C@]1(C)CC(=O)NC1=O
4203,Oxazepam,CP343-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
4204,Phenelzine,CP343-Inhibitor,NNCCC1=CC=CC=C1
4205,Praziquantel,CP343-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
4206,Rifampicin,CP343-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4207,Rifapentine,CP343-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
4208,Testosterone,CP343-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4209,Zalcitabine,CP343-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
4210,Alprostadil,Multidrug_resistance_associated_protein_4-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
4211,Androstanolone,Multidrug_resistance_associated_protein_4-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4212,Cefmetazole,Multidrug_resistance_associated_protein_4-Inhibitor,CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O
4213,Celecoxib,Multidrug_resistance_associated_protein_4-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4214,Chlorothiazide,Multidrug_resistance_associated_protein_4-Inhibitor,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
4215,Ciprofloxacin,Multidrug_resistance_associated_protein_4-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4216,Cyclophosphamide,Multidrug_resistance_associated_protein_4-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
4217,Diclofenac,Multidrug_resistance_associated_protein_4-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4218,Dinoprostone,Multidrug_resistance_associated_protein_4-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
4219,Folic Acid,Multidrug_resistance_associated_protein_4-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
4220,Furosemide,Multidrug_resistance_associated_protein_4-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
4221,Indometacin,Multidrug_resistance_associated_protein_4-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4222,Irinotecan,Multidrug_resistance_associated_protein_4-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4223,Ketoprofen,Multidrug_resistance_associated_protein_4-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
4224,Mercaptopurine,Multidrug_resistance_associated_protein_4-Substrate,S=C1NC=NC2=C1NC=N2
4225,Methotrexate,Multidrug_resistance_associated_protein_4-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4226,Oseltamivir,Multidrug_resistance_associated_protein_4-Substrate,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
4227,Paracetamol,Multidrug_resistance_associated_protein_4-Inducer,CC(=O)NC1=CC=C(O)C=C1
4228,Prasterone,Multidrug_resistance_associated_protein_4-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
4229,Sulindac,Multidrug_resistance_associated_protein_4-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
4230,Telmisartan,Multidrug_resistance_associated_protein_4-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4231,Tioguanine,Multidrug_resistance_associated_protein_4-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
4232,Adenosine,Multidrug_resistance_associated_protein_5-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
4233,Fluorescein,Multidrug_resistance_associated_protein_5-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
4234,Fluorouracil,Multidrug_resistance_associated_protein_5-Inducer,FC1=CNC(=O)NC1=O
4235,Gemcitabine,Multidrug_resistance_associated_protein_5-Inducer,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F
4236,Gemcitabine,Multidrug_resistance_associated_protein_5-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F
4237,Irinotecan,Multidrug_resistance_associated_protein_5-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4238,Probenecid,Multidrug_resistance_associated_protein_5-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4239,Colestyramine,8B1-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
4240,Insulin (human),8B1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4241,Dextromethorphan,Cholesterol_24_hydroxylase-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
4242,Diclofenac,Cholesterol_24_hydroxylase-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4243,Phenacetin,Cholesterol_24_hydroxylase-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
4244,Progesterone,Cholesterol_24_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4245,Testosterone,Cholesterol_24_hydroxylase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4246,Amfetamine,2A6-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
4247,Amlodipine,2A6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
4248,Amobarbital,2A6-Inducer,CC[C@@]1(CCC(C)C)C(=O)NC(=O)NC1=O
4249,Artemisinin,2A6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
4250,Artesunate,2A6-Substrate,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
4251,Azelastine,2A6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
4252,Azithromycin,2A6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
4253,Buprenorphine,2A6-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4254,Bupropion,2A6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4255,Carbamazepine,2A6-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4256,Chloroform,2A6-Substrate,ClC(Cl)Cl
4257,Chloroxylenol,2A6-Substrate,CC1=CC(O)=CC(C)=C1Cl
4258,Chlorzoxazone,2A6-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
4259,Cinnarizin,2A6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
4260,Cisapride,2A6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
4261,Clofibrate,2A6-Inhibitor,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
4262,Clomethiazole,2A6-Substrate,CC1=C(CCCl)SC=N1
4263,Clomifene,2A6-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
4264,Clotrimazole,2A6-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4265,Clotrimazole,2A6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4266,Clozapine,2A6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
4267,Cocaine,2A6-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
4268,Cyclophosphamide,2A6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
4269,Desipramine,2A6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4270,Dexfenfluramine,2A6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
4271,Dexmedetomidine,2A6-Substrate,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
4272,Diethyl Ether,2A6-Substrate,CCOCC
4273,Diethyltoluamide,2A6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
4274,Disulfiram,2A6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
4275,Disulfiram,2A6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
4276,Dronabinol,2A6-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
4277,Eletriptan,2A6-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
4278,Entacapone,2A6-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
4279,Flunarizine,2A6-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
4280,Flunitrazepam,2A6-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
4281,Fluorouracil,2A6-Substrate,FC1=CNC(=O)NC1=O
4282,Fomepizole,2A6-Inhibitor,CC1=CNN=C1
4283,Formoterol,2A6-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
4284,Halothane,2A6-Substrate,FC(F)(F)[C@@H](Cl)Br
4285,Histamine,2A6-Inhibitor,NCCC1=CNC=N1
4286,Ifosfamide,2A6-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
4287,Indigo Carmine,2A6-Inhibitor,[O-]S(=O)(=O)C1=CC=C2NC(C(=O)C2=C1)=C3NC4=CC=C(C=C4C3=O)S([O-])(=O)=O
4288,Isoniazid,2A6-Inhibitor,NNC(=O)C1=CC=NC=C1
4289,Isopropanol,2A6-Inhibitor,CC(C)O
4290,Ketoconazole,2A6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4291,Letrozole,2A6-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
4292,Letrozole,2A6-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
4293,Levoverbenone,2A6-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
4294,Lidocain,2A6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4295,Medifoxamine,2A6-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
4296,Memantine,2A6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
4297,Menadione,2A6-Inhibitor,CC1=CC(=O)C2=C(C=CC=C2)C1=O
4298,Methoxsalen,2A6-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
4299,Methoxsalen,2A6-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
4300,Methoxyflurane,2A6-Substrate,COC(F)(F)C(Cl)Cl
4301,Metyrapone,2A6-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
4302,Miconazole,2A6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
4303,Nicotine,2A6-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
4304,Nicotine,2A6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
4305,Nicotinyl Alcohol (pyridylcarbinol),2A6-Substrate,OCC1=CC=CN=C1
4306,Nilvadipine,2A6-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
4307,Norfloxacin,2A6-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
4308,Orphenadrine (citrate),2A6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
4309,Paracetamol,2A6-Substrate,CC(=O)NC1=CC=C(O)C=C1
4310,Perazine,2A6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
4311,Phenacetin,2A6-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
4312,Phenazone,2A6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
4313,Phenobarbital,2A6-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4314,Phenobarbital,2A6-Inhibitor,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4315,Pilocarpine,2A6-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
4316,Pilocarpine,2A6-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
4317,Prednisolone,2A6-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
4318,Progesterone,2A6-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4319,Propofol,2A6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
4320,Rifampicin,2A6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4321,Rifampicin,2A6-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4322,Rifampicin,2A6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4323,Rosiglitazone,2A6-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4324,Roxatidine,2A6-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
4325,Selegiline,2A6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4326,Seratrodast,2A6-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
4327,Sevoflurane,2A6-Substrate,FCOC(C(F)(F)F)C(F)(F)F
4328,Sulconazole,2A6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
4329,Sulfaphenazole,2A6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
4330,Tamoxifen,2A6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4331,Tegafur,2A6-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
4332,Thalidomide,2A6-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
4333,Thiamazole,2A6-Inhibitor,CN1C=CNC1=S
4334,Tranylcypromine,2A6-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
4335,Tretinoin,2A6-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4336,Troleandomycin,2A6-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
4337,Trospium,2A6-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
4338,Valproic Acid,2A6-Substrate,CCCC(CCC)C(O)=O
4339,Zidovudine,2A6-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4340,Ketoconazole,51A-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4341,Meglutol,51A-Inhibitor,CC(O)(CC(O)=O)CC(O)=O
4342,Sertaconazole,51A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
4343,Terconazole,51A-Inhibitor,CC(C)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4344,Bupropion,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4345,Ciclosporin,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4346,Cimetidine,ATP_binding_cassette_sub_family_G_member_2-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
4347,Ciprofloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4348,Cladribine,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
4349,Daunorubicin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
4350,Dexamethasone,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4351,Diclofenac,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4352,Dipyridamole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
4353,Dipyridamole,ATP_binding_cassette_sub_family_G_member_2-Substrate,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
4354,Doxorubicin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4355,Doxycycline,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
4356,Estradiol,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4357,Estrone,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
4358,Etoposide,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
4359,Fluorouracil,ATP_binding_cassette_sub_family_G_member_2-Substrate,FC1=CNC(=O)NC1=O
4360,Folic Acid,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
4361,Folic Acid,ATP_binding_cassette_sub_family_G_member_2-Inducer,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
4362,Ganciclovir,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
4363,Gefitinib,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
4364,Gefitinib,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
4365,Glafenine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OC[C@@H](O)COC(=O)C1=C(NC2=C3C=CC(Cl)=CC3=NC=C2)C=CC=C1
4366,Glibenclamide,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
4367,Glutathione,ATP_binding_cassette_sub_family_G_member_2-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
4368,Grepafloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
4369,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Inducer,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4370,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4371,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4372,Insulin (human),ATP_binding_cassette_sub_family_G_member_2-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4373,Irinotecan,ATP_binding_cassette_sub_family_G_member_2-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4374,Itraconazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
4375,Ketoconazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4376,Lamivudine,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
4377,Leflunomide,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
4378,Lopinavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
4379,Menadione,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
4380,Metformin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN(C)C(=N)NC(N)=N
4381,Methotrexate,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4382,Methotrexate,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4383,Mitoxantrone,ATP_binding_cassette_sub_family_G_member_2-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
4384,Mitoxantrone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
4385,Nelfinavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
4386,Nicardipine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
4387,Nimodipine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
4388,Nitrofurantoin,ATP_binding_cassette_sub_family_G_member_2-Substrate,[O-][N+](=O)C1=CC=C(O1)C=NN2CC(=O)NC2=O
4389,Norfloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
4390,Omeprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
4391,Oxycodone,ATP_binding_cassette_sub_family_G_member_2-Inducer,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
4392,Oxygen,ATP_binding_cassette_sub_family_G_member_2-Inducer,O=O
4393,Pantoprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
4394,Pantoprazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
4395,Plicamycin,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
4396,Prazosin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
4397,Progesterone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4398,Progesterone,ATP_binding_cassette_sub_family_G_member_2-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4399,Propafenone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4400,Rabeprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
4401,Reserpine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
4402,Riboflavin (vit B2),ATP_binding_cassette_sub_family_G_member_2-Substrate,CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2
4403,Riluzole,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
4404,Ritonavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4405,Rosiglitazone,ATP_binding_cassette_sub_family_G_member_2-Inducer,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4406,Rosuvastatin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4407,Rutoside,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
4408,Saquinavir,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4409,Sirolimus,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
4410,Sulfasalazine,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
4411,Tacrolimus,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
4412,Topotecan,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
4413,Topotecan,ATP_binding_cassette_sub_family_G_member_2-Inducer,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
4414,Toremifene,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
4415,Alprazolam,Ileal_sodiumbile_acid_cotransporter-Inducer,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
4416,Budesonide,Ileal_sodiumbile_acid_cotransporter-Inducer,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
4417,Ciprofibrate,Ileal_sodiumbile_acid_cotransporter-Inducer,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
4418,Colestyramine,Ileal_sodiumbile_acid_cotransporter-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
4419,Dexamethasone,Ileal_sodiumbile_acid_cotransporter-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4420,Secretin,Ileal_sodiumbile_acid_cotransporter-Inducer,CC(C)C[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC2=NC=CN2)[C@H](C)O)[C@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O
4421,Tretinoin,Ileal_sodiumbile_acid_cotransporter-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4422,Acetylsalicylic Acid,Sulfotransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
4423,Acetylsalicylic Acid,Sulfotransferase-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
4424,Adenosine,Sulfotransferase-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
4425,Aminobenzoic Acid,Sulfotransferase-Substrate,NC1=CC=C(C=C1)C(O)=O
4426,Apomorphine,Sulfotransferase-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
4427,Bemiparin,Sulfotransferase-Substrate,C1=CC=C(C=C1)C=CC(=O)O
4428,Betamethason,Sulfotransferase-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4429,Budesonide,Sulfotransferase-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
4430,Calcitriol,Sulfotransferase-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
4431,Celecoxib,Sulfotransferase-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4432,Celecoxib,Sulfotransferase-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4433,Cholic Acid,Sulfotransferase-Substrate,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
4434,Clioquinol,Sulfotransferase-Inhibitor,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
4435,Clioquinol,Sulfotransferase-Substrate,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
4436,Corticotropin,Sulfotransferase-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
4437,Cortisone,Sulfotransferase-Inhibitor,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
4438,Diethyl Ether,Sulfotransferase-Inducer,CCOCC
4439,Digitoxin,Sulfotransferase-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4440,Ephedrin,Sulfotransferase-Substrate,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
4441,Epinephrine,Sulfotransferase-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4442,Epinephrine,Sulfotransferase-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4443,Estradiol,Sulfotransferase-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4444,Estradiol,Sulfotransferase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4445,Fluphenazine,Sulfotransferase-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4446,Galactose,Sulfotransferase-Substrate,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
4447,Hydrocortisone,Sulfotransferase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4448,Hydrocortisone,Sulfotransferase-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4449,Ibuprofen,Sulfotransferase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
4450,Insulin (human),Sulfotransferase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4451,Methotrexate,Sulfotransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4452,Methyldopa (levorotatory),Sulfotransferase-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4453,Minoxidil,Sulfotransferase-Substrate,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
4454,Naproxen,Sulfotransferase-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
4455,Paclitaxel,Sulfotransferase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4456,Pantoprazole,Sulfotransferase-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
4457,Paracetamol,Sulfotransferase-Substrate,CC(=O)NC1=CC=C(O)C=C1
4458,Pipamperone,Sulfotransferase-Inhibitor,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
4459,Progesterone,Sulfotransferase-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4460,Progesterone,Sulfotransferase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4461,Promegestone,Sulfotransferase-Inducer,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C
4462,Pseudoephedrine,Sulfotransferase-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
4463,Pyridoxal Phosphate,Sulfotransferase-Inhibitor,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1
4464,Ritodrine,Sulfotransferase-Substrate,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2
4465,Salicylic Acid,Sulfotransferase-Inhibitor,OC(=O)C1=C(O)C=CC=C1
4466,Sodium Citrate,Sulfotransferase-Inhibitor,OC(=O)CC(O)(CC(O)=O)C([O-])=O
4467,Sodium Salicylate,Sulfotransferase-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
4468,Sulindac,Sulfotransferase-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
4469,Tamoxifen,Sulfotransferase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4470,Tamoxifen,Sulfotransferase-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4471,Teicoplanin,Sulfotransferase-Substrate,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](Cc6ccc(Oc7cc4cc(Oc8ccc2cc8Cl)c7O[C@@H]9O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]9NC(=O)C)c(Cl)c6)NC(=O)[C@H](N)c%10ccc(O)c(Oc%11cc(O)cc5c%11)c%10)c%12ccc(O)c(c%12)c%13c(O[C@H]%14O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]%14O)cc(O)cc%13[C@H](NC3=O)C(=O)O
4472,Testosterone,Sulfotransferase-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4473,Tibolone,Sulfotransferase-Substrate,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
4474,Tibolone,Sulfotransferase-Inducer,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
4475,Triamcinolone,Sulfotransferase-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
4476,Triclosan,Sulfotransferase-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
4477,Warfarin,Sulfotransferase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4478,Warfarin,Sulfotransferase-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4479,Astemizole,Arachidonic_acid_epoxygenase-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
4480,Cocaine,Arachidonic_acid_epoxygenase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
4481,Ebastine,Arachidonic_acid_epoxygenase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
4482,Ebastine,Arachidonic_acid_epoxygenase-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
4483,Ergocalciferol,Arachidonic_acid_epoxygenase-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
4484,Masoprocol,Arachidonic_acid_epoxygenase-Inhibitor,C[C@H](CC1=CC=C(O)C(O)=C1)[C@@H](C)CC2=CC(O)=C(O)C=C2
4485,Terfenadine,Arachidonic_acid_epoxygenase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4486,Alprostadil,4F3-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
4487,Aldosterone,11B1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4488,Aminogluthetimide,11B1-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4489,Angiotensinamide,11B1-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4490,Cimetidine,11B1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
4491,Clotrimazole,11B1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4492,Corticotropin,11B1-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
4493,Desoxycortone,11B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
4494,Dexamethasone,11B1-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4495,Etomidate,11B1-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
4496,Fluconazole,11B1-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4497,Hydrocortisone,11B1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4498,Ketoconazole,11B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4499,Metoclopramide,11B1-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4500,Metyrapone,11B1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
4501,Mibefradil,11B1-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
4502,Miconazole,11B1-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
4503,Phenytoin,11B1-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
4504,Spironolactone,11B1-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
4505,Spironolactone,11B1-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
4506,Dinoprostone,4F2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
4507,Ebastine,4F2-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
4508,Fingolimod,4F2-Substrate,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
4509,Ketoconazole,4F2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4510,Retinol (vit A),4F2-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4511,Tocopherol (vit E),4F2-Substrate,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
4512,Acriflavinium Chloride,1A2-Substrate,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
4513,Albendazole,1A2-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
4514,Albendazole,1A2-Inhibitor,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
4515,Albendazole,1A2-Inducer,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
4516,Alitretinoin,1A2-Inhibitor,CC1=C(C=CC(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1
4517,Alosetron,1A2-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
4518,Aminogluthetimide,1A2-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4519,Aminophenazone,1A2-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
4520,Aminophylline,1A2-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4521,Amiodarone,1A2-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4522,Amiodarone,1A2-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4523,Amitriptyline,1A2-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4524,Amitriptyline,1A2-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4525,Amlodipine,1A2-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
4526,Anagrelide,1A2-Substrate,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
4527,Anastrozole,1A2-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
4528,Aprepitant,1A2-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
4529,Artemisinin,1A2-Inhibitor,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
4530,Ascorbic Acid (vit C),1A2-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
4531,Atropine,1A2-Inhibitor,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@@H](CO)C3=CC=CC=C3
4532,Azelastine,1A2-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
4533,Benoxaprofen,1A2-Inducer,C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C3=CC=C(Cl)C=C3)C=C1
4534,Benzydamine,1A2-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
4535,Bergapten,1A2-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
4536,Betacarotene,1A2-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
4537,Betaxolol,1A2-Substrate,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
4538,Bortezomib,1A2-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
4539,Bromazepam,1A2-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
4540,Bromocriptine,1A2-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
4541,Bupivacaine,1A2-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
4542,Buprenorphine,1A2-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4543,Bupropion,1A2-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4544,Caffeine,1A2-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
4545,Caffeine,1A2-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
4546,Capsaicin,1A2-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
4547,Carbamazepine,1A2-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4548,Carbamazepine,1A2-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4549,Carbamazepine,1A2-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4550,Carmustine,1A2-Substrate,ClCCNC(=O)N(CCCl)N=O
4551,Carvedilol,1A2-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
4552,Chinin,1A2-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
4553,Chinin,1A2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
4554,Chinin,1A2-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
4555,Chlorothiazide,1A2-Inducer,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
4556,Chlorpromazine,1A2-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4557,Chlorpromazine,1A2-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4558,Chlorpromazine,1A2-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4559,Chlorzoxazone,1A2-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
4560,Cilostazol,1A2-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
4561,Cimetidine,1A2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
4562,Cinacalcet,1A2-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
4563,Cinnarizin,1A2-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
4564,Ciprofloxacin,1A2-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4565,Cisapride,1A2-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
4566,Citalopram,1A2-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
4567,Clarithromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
4568,Clenbuterol,1A2-Substrate,CC(C)(C)NC[C@H](O)C1=CC(Cl)=C(N)C(Cl)=C1
4569,Clobetasol,1A2-Inhibitor,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
4570,Clomifene,1A2-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
4571,Clomipramine,1A2-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4572,Clopidogrel,1A2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
4573,Clotrimazole,1A2-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4574,Clozapine,1A2-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
4575,Clozapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
4576,Cocaine,1A2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
4577,Cyamemazine,1A2-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
4578,Cyclobarbital,1A2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
4579,Cyclobenzaprine,1A2-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4580,Cypermethrin,1A2-Substrate,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
4581,Dacarbazine,1A2-Inhibitor,CN(C)N=NC1=C(N=CN1)C(N)=O
4582,Dacarbazine,1A2-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
4583,Dactinomycin,1A2-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
4584,Daunorubicin,1A2-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
4585,Deanol,1A2-Substrate,CN(C)CCO
4586,Decamethrin,1A2-Substrate,CC1(C)[C@@H](C=C(/Br)Br)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
4587,Delavirdine,1A2-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
4588,Desipramine,1A2-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4589,Desloratadine,1A2-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
4590,Dexamethasone,1A2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4591,Dexfenfluramine,1A2-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
4592,Dexfenfluramine,1A2-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
4593,Dexmedetomidine,1A2-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
4594,Diazepam,1A2-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4595,Diazepam,1A2-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4596,Diclofenac,1A2-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4597,Diclofenac,1A2-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4598,Diethyltoluamide,1A2-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
4599,Dihydralazine,1A2-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
4600,Dihydralazine,1A2-Inhibitor,NNC1=NN=C(NN)C2=C1C=CC=C2
4601,Dinoprostone,1A2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
4602,Disulfiram,1A2-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
4603,Disulfiram,1A2-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
4604,Domperidone,1A2-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
4605,Dopamine,1A2-Inhibitor,NCCC1=CC(O)=C(O)C=C1
4606,Dopamine,1A2-Substrate,NCCC1=CC(O)=C(O)C=C1
4607,Doxepin,1A2-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
4608,Doxorubicin,1A2-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4609,Duloxetine,1A2-Substrate,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
4610,Efavirenz,1A2-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
4611,Enoxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
4612,Enoxolone,1A2-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
4613,Entacapone,1A2-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
4614,Epinephrine,1A2-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4615,Ergotamine,1A2-Substrate,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
4616,Erlotinib,1A2-Substrate,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
4617,Erythromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
4618,Erythromycin,1A2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
4619,Estradiol,1A2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4620,Estriol,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
4621,Estrone,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
4622,Ethanol,1A2-Substrate,CCO
4623,Ethinylestradiol,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
4624,Ethinylestradiol,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
4625,Etoposide,1A2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
4626,Etoricoxib,1A2-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
4627,Fenbendazole,1A2-Inducer,COC(=O)NC1=NC2=C(N1)C=CC(SC3=CC=CC=C3)=C2
4628,Flecainide,1A2-Substrate,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
4629,Fluconazole,1A2-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4630,Flunarizine,1A2-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
4631,Flunitrazepam,1A2-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
4632,Fluorouracil,1A2-Substrate,FC1=CNC(=O)NC1=O
4633,Fluoxetine,1A2-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
4634,Fluoxetine,1A2-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
4635,Fluphenazine,1A2-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4636,Flutamide,1A2-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
4637,Flutamide,1A2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
4638,Fluvastatin,1A2-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
4639,Fluvoxamine,1A2-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
4640,Fluvoxamine,1A2-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
4641,Frovatriptan,1A2-Substrate,CN[C@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O
4642,Gemfibrozil,1A2-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
4643,Granisetron,1A2-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
4644,Griseofulvin,1A2-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
4645,Griseofulvin,1A2-Substrate,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
4646,Guajazulen,1A2-Substrate,CC(C)C1=CC2=C(C)C=CC2=C(C)C=C1
4647,Haloperidol,1A2-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
4648,Hexobarbital,1A2-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
4649,Hydrochloric Acid,1A2-Inhibitor,Cl
4650,Idebenone,1A2-Substrate,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
4651,Imatinib,1A2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4652,Imipramine,1A2-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4653,Imipramine,1A2-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4654,Imipramine Oxide,1A2-Substrate,C[N+](C)([O-])CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4655,Imiquimod,1A2-Substrate,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
4656,Insulin (human),1A2-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4657,Ipriflavone,1A2-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
4658,Ipriflavone,1A2-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
4659,Irbesartan,1A2-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
4660,Isoniazid,1A2-Inhibitor,NNC(=O)C1=CC=NC=C1
4661,Ketoconazole,1A2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4662,Lansoprazole,1A2-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4663,Levobupivacaine,1A2-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
4664,Levofloxacin,1A2-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
4665,Lidocain,1A2-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4666,Lidocain,1A2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4667,Lomefloxacin,1A2-Substrate,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
4668,Lomefloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
4669,Lopinavir,1A2-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
4670,Losartan,1A2-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4671,Lumiracoxib,1A2-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
4672,Malathion,1A2-Substrate,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
4673,Maprotiline,1A2-Substrate,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
4674,Meclozin,1A2-Inhibitor,CC1=CC(CN2CCN(CC2)[C@@H](C3=CC=CC=C3)C4=CC=C(Cl)C=C4)=CC=C1
4675,Medrysone,1A2-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
4676,Melatonin,1A2-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
4677,Menadione,1A2-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
4678,Methadone,1A2-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4679,Methoxsalen,1A2-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
4680,Methoxyflurane,1A2-Substrate,COC(F)(F)C(Cl)Cl
4681,Methyldopa (levorotatory),1A2-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
4682,Mexiletine,1A2-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
4683,Mexiletine,1A2-Inhibitor,C[C@H](N)COC1=C(C)C=CC=C1C
4684,Mianserin,1A2-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
4685,Mibefradil,1A2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
4686,Miconazole,1A2-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
4687,Mirtazapine,1A2-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
4688,Mitobronitol,1A2-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
4689,Mitomycin,1A2-Inducer,CO[C@@]12[C@H](COC(N)=O)C3=C(N1C[C@@H]4N[C@H]24)C(=O)C(C)=C(N)C3=O
4690,Moclobemide,1A2-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
4691,Modafinil,1A2-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
4692,Modafinil,1A2-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
4693,Moracizine,1A2-Inhibitor,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
4694,Nabumetone,1A2-Substrate,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
4695,Naproxen,1A2-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
4696,Nelfinavir,1A2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
4697,Nevirapine,1A2-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
4698,Niclosamide,1A2-Inhibitor,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
4699,Nicotinamide,1A2-Inducer,NC(=O)C1=CC=CN=C1
4700,Nicotine,1A2-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
4701,Nicotine,1A2-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
4702,Nifedipine,1A2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
4703,Nilvadipine,1A2-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
4704,Nisoldipine,1A2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
4705,Nitrazepam,1A2-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
4706,Nitroprusside,1A2-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
4707,Norepinephrine,1A2-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
4708,Norfloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
4709,Nortriptyline,1A2-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4710,Ofloxacin,1A2-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
4711,Olanzapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
4712,Omeprazole,1A2-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
4713,Omeprazole,1A2-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
4714,Omeprazole,1A2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
4715,Ondansetron,1A2-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
4716,Ondansetron,1A2-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
4717,Orphenadrine (citrate),1A2-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
4718,Oxaliplatin,1A2-Substrate,N[C@@H]1CCCC[C@H]1N
4719,Palonosetron,1A2-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
4720,Pantoprazole,1A2-Inducer,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
4721,Pantoprazole,1A2-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
4722,Paracetamol,1A2-Substrate,CC(=O)NC1=CC=C(O)C=C1
4723,Paraoxon,1A2-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
4724,Paroxetine,1A2-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
4725,Pefloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(F)=C2
4726,Pentamidine Isethionate,1A2-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
4727,Pentoxifylline,1A2-Substrate,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
4728,Perazine,1A2-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
4729,Perazine,1A2-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
4730,Perphenazine,1A2-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4731,Perphenazine,1A2-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4732,Pethidine,1A2-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
4733,Phenacetin,1A2-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
4734,Phenazone,1A2-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
4735,Phenobarbital,1A2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4736,Phentermine,1A2-Inhibitor,CC(C)(N)CC1=CC=CC=C1
4737,Phenylephrine,1A2-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
4738,Phenylpropanolamine,1A2-Inhibitor,C[C@@H](N)[C@@H](O)C1=CC=CC=C1
4739,Pimozide,1A2-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
4740,Pipamperone,1A2-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
4741,Pirfenidone,1A2-Substrate,CC1=CN(C(=O)C=C1)C1=CC=CC=C1
4742,Prasterone,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
4743,Praziquantel,1A2-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
4744,Prednisone,1A2-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
4745,Primaquine,1A2-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
4746,Primaquine,1A2-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
4747,Primaquine,1A2-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
4748,Primidone,1A2-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
4749,Procarbazine,1A2-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
4750,Progesterone,1A2-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4751,Proguanil,1A2-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
4752,Promazine,1A2-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
4753,Propafenone,1A2-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4754,Propafenone,1A2-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4755,Propofol,1A2-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
4756,Propofol,1A2-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
4757,Propranolol,1A2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
4758,Propranolol,1A2-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
4759,Pyrazinamide,1A2-Substrate,NC(=O)C1=CN=CC=N1
4760,Quinidine,1A2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4761,Rabeprazole,1A2-Inducer,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
4762,Ranitidine,1A2-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4763,Ranitidine,1A2-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4764,Rasagiline,1A2-Substrate,C#CCNC1CCC2=CC=CC=C12
4765,Retinol (vit A),1A2-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4766,Retinol (vit A),1A2-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4767,Rifabutin,1A2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
4768,Rifampicin,1A2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4769,Rifampicin,1A2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4770,Riluzole,1A2-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
4771,Ritonavir,1A2-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4772,Ritonavir,1A2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4773,Ritonavir,1A2-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4774,Rofecoxib,1A2-Inhibitor,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4775,Rofecoxib,1A2-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4776,Ropinirole,1A2-Inhibitor,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
4777,Ropinirole,1A2-Substrate,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
4778,Ropivacaine,1A2-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
4779,Rosiglitazone,1A2-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4780,Roxithromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
4781,Salicylamide,1A2-Inhibitor,NC(=O)C1=C(O)C=CC=C1
4782,Secobarbital,1A2-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
4783,Selegiline,1A2-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4784,Selegiline,1A2-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4785,Sertraline,1A2-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
4786,Sorbitol,1A2-Inhibitor,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO
4787,Streptozocin,1A2-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
4788,Sulconazole,1A2-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
4789,Sulindac,1A2-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
4790,Sulpiride,1A2-Inhibitor,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
4791,Tacrine,1A2-Substrate,NC1=C2CCCCC2=NC3=C1C=CC=C3
4792,Tegafur,1A2-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
4793,Tegaserod,1A2-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
4794,Telithromycin,1A2-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
4795,Temafloxacin,1A2-Substrate,C[C@@H]1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=C(F)C=C(F)C=C4)C(O)=O
4796,Temafloxacin,1A2-Inhibitor,C[C@@H]1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=C(F)C=C(F)C=C4)C(O)=O
4797,Tenofovir Disoproxil,1A2-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
4798,Terbinafine,1A2-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
4799,Tetrabenazine,1A2-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
4800,Theobromine,1A2-Substrate,CN1C=NC2=C1C(=O)NC(=O)N2C
4801,Theophylline,1A2-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4802,Theophylline,1A2-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4803,Thiamazole,1A2-Inhibitor,CN1C=CNC1=S
4804,Thioridazine,1A2-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4805,Thioridazine,1A2-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4806,Tiabendazole,1A2-Inhibitor,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
4807,Tiabendazole,1A2-Substrate,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
4808,Tibolone,1A2-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
4809,Ticlopidine,1A2-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
4810,Tioconazole,1A2-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
4811,Tiotixene,1A2-Substrate,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
4812,Tizanidine,1A2-Substrate,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1
4813,Tocainide,1A2-Inhibitor,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
4814,Tolperisone,1A2-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
4815,Toremifene,1A2-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
4816,Tranylcypromine,1A2-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
4817,Treosulfan,1A2-Inhibitor,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O
4818,Triamterene,1A2-Inhibitor,NC1=NC2=C(N=C(C3=CC=CC=C3)C(N)=N2)C(N)=N1
4819,Triamterene,1A2-Substrate,NC1=NC2=C(N=C(C3=CC=CC=C3)C(N)=N2)C(N)=N1
4820,Trichloroethylene,1A2-Substrate,ClC=C(Cl)Cl
4821,Trifluoperazine,1A2-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4822,Trospium,1A2-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
4823,Tryptophan,1A2-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
4824,Valproic Acid,1A2-Inhibitor,CCCC(CCC)C(O)=O
4825,Verapamil,1A2-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4826,Vincamine,1A2-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
4827,Warfarin,1A2-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4828,Zafirlukast,1A2-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4829,Ziprasidone,1A2-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
4830,Zolmitriptan,1A2-Substrate,CN(C)CCC1=CNC2=C1C=C(C[C@H]3COC(=O)N3)C=C2
4831,Zolpidem,1A2-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
4832,Zolpidem,1A2-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
4833,Zotepine,1A2-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
4834,Amitriptyline,Sodium_dependent_noradrenaline_transporter-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4835,Atomoxetine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
4836,Cocaine,Sodium_dependent_noradrenaline_transporter-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
4837,Desipramine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4838,Dopamine,Sodium_dependent_noradrenaline_transporter-Substrate,NCCC1=CC(O)=C(O)C=C1
4839,Duloxetine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
4840,Metaraminol,Sodium_dependent_noradrenaline_transporter-Substrate,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1
4841,Methylphenidate,Sodium_dependent_noradrenaline_transporter-Substrate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
4842,Norepinephrine,Sodium_dependent_noradrenaline_transporter-Substrate,NC[C@@H](O)C1=CC(O)=C(O)C=C1
4843,Reboxetine,Sodium_dependent_noradrenaline_transporter-Inducer,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
4844,Sibutramine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
4845,Sodium Chloride,Sodium_dependent_noradrenaline_transporter-Inducer,[Na+].[Cl-]
4846,Tramadol,Sodium_dependent_noradrenaline_transporter-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
4847,Vorinostat,Sodium_dependent_noradrenaline_transporter-Inducer,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
4848,Angiotensinamide,21A-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4849,Hydroxyprogesterone,21A-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4850,Progesterone,21A-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4851,Acetylcysteine,Multidrug_resistance_protein_1-Inducer,CC(=O)N[C@H](CS)C(O)=O
4852,Ajmaline,Multidrug_resistance_protein_1-Substrate,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
4853,Aldosterone,Multidrug_resistance_protein_1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4854,Arsenic Trioxide,Multidrug_resistance_protein_1-Inhibitor,O=[As]1=[As](=O)O1
4855,Arsenic Trioxide,Multidrug_resistance_protein_1-Inducer,O=[As]1=[As](=O)O1
4856,Artemisinin,Multidrug_resistance_protein_1-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
4857,Atorvastatin,Multidrug_resistance_protein_1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4858,Atorvastatin,Multidrug_resistance_protein_1-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4859,Bromocriptine,Multidrug_resistance_protein_1-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
4860,Budesonide,Multidrug_resistance_protein_1-Inducer,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
4861,Carbamazepine,Multidrug_resistance_protein_1-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4862,Celecoxib,Multidrug_resistance_protein_1-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4863,Ciclosporin,Multidrug_resistance_protein_1-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4864,Ciclosporin,Multidrug_resistance_protein_1-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4865,Ciclosporin,Multidrug_resistance_protein_1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4866,Cisplatin,Multidrug_resistance_protein_1-Inducer,N[Pt](N)(Cl)Cl
4867,Clopidogrel,Multidrug_resistance_protein_1-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
4868,Colchicine,Multidrug_resistance_protein_1-Substrate,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
4869,Cytarabine,Multidrug_resistance_protein_1-Inducer,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
4870,Cytarabine,Multidrug_resistance_protein_1-Inhibitor,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
4871,Dactinomycin,Multidrug_resistance_protein_1-Inducer,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
4872,Daunorubicin,Multidrug_resistance_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
4873,Daunorubicin,Multidrug_resistance_protein_1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
4874,Dexamethasone,Multidrug_resistance_protein_1-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4875,Dexamethasone,Multidrug_resistance_protein_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4876,Diclofenac,Multidrug_resistance_protein_1-Inducer,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4877,Dicloxacillin,Multidrug_resistance_protein_1-Substrate,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4Cl
4878,Digitoxin,Multidrug_resistance_protein_1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4879,Digoxin,Multidrug_resistance_protein_1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4880,Digoxin,Multidrug_resistance_protein_1-Inducer,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4881,Diltiazem,Multidrug_resistance_protein_1-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
4882,Dimethyl Sulfoxide,Multidrug_resistance_protein_1-Inducer,CS(C)=O
4883,Dinoprostone,Multidrug_resistance_protein_1-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
4884,Dipyridamole,Multidrug_resistance_protein_1-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
4885,Docetaxel,Multidrug_resistance_protein_1-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
4886,Docetaxel,Multidrug_resistance_protein_1-Inducer,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
4887,Doxorubicin,Multidrug_resistance_protein_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4888,Doxorubicin,Multidrug_resistance_protein_1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4889,Doxorubicin,Multidrug_resistance_protein_1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4890,Epinephrine,Multidrug_resistance_protein_1-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4891,Epinephrine,Multidrug_resistance_protein_1-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4892,Epirubicin,Multidrug_resistance_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C(=O)C2=CC=C1
4893,Erythromycin,Multidrug_resistance_protein_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
4894,Etoposide,Multidrug_resistance_protein_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
4895,Etoposide,Multidrug_resistance_protein_1-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
4896,Ezetimibe,Multidrug_resistance_protein_1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
4897,Fenbufen,Multidrug_resistance_protein_1-Inducer,OC(=O)CCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2
4898,Fexofenadine,Multidrug_resistance_protein_1-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4899,Flucloxacillin,Multidrug_resistance_protein_1-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
4900,Fluorouracil,Multidrug_resistance_protein_1-Inducer,FC1=CNC(=O)NC1=O
4901,Folic Acid,Multidrug_resistance_protein_1-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
4902,G-strophanthin,Multidrug_resistance_protein_1-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
4903,Glutathione,Multidrug_resistance_protein_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
4904,Hydrocortisone,Multidrug_resistance_protein_1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4905,Hydroxycarbamide,Multidrug_resistance_protein_1-Inducer,NC(=O)NO
4906,Imatinib,Multidrug_resistance_protein_1-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4907,Indometacin,Multidrug_resistance_protein_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4908,Indometacin,Multidrug_resistance_protein_1-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4909,Indometacin,Multidrug_resistance_protein_1-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4910,Insulin (human),Multidrug_resistance_protein_1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4911,Irinotecan,Multidrug_resistance_protein_1-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4912,Ivermectin,Multidrug_resistance_protein_1-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
4913,Ketoconazole,Multidrug_resistance_protein_1-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4914,Loperamide,Multidrug_resistance_protein_1-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4915,Lopinavir,Multidrug_resistance_protein_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
4916,Losartan,Multidrug_resistance_protein_1-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4917,Metformin,Multidrug_resistance_protein_1-Inhibitor,CN(C)C(=N)NC(N)=N
4918,Methadone,Multidrug_resistance_protein_1-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4919,Mitomycin,Multidrug_resistance_protein_1-Substrate,CO[C@@]12[C@H](COC(N)=O)C3=C(N1C[C@@H]4N[C@H]24)C(=O)C(C)=C(N)C3=O
4920,Mitoxantrone,Multidrug_resistance_protein_1-Inducer,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
4921,Morphine,Multidrug_resistance_protein_1-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
4922,Nelfinavir,Multidrug_resistance_protein_1-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
4923,Oxycodone,Multidrug_resistance_protein_1-Inducer,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
4924,Paclitaxel,Multidrug_resistance_protein_1-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4925,Paclitaxel,Multidrug_resistance_protein_1-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4926,Paracetamol,Multidrug_resistance_protein_1-Inducer,CC(=O)NC1=CC=C(O)C=C1
4927,Prednisolone,Multidrug_resistance_protein_1-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
4928,Probenecid,Multidrug_resistance_protein_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4929,Quinidine,Multidrug_resistance_protein_1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4930,Rescinnamine,Multidrug_resistance_protein_1-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C=CC6=CC(OC)=C(OC)C(OC)=C6
4931,Reserpine,Multidrug_resistance_protein_1-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
4932,Reserpine,Multidrug_resistance_protein_1-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
4933,Retinol,Multidrug_resistance_protein_1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4934,Rifampicin,Multidrug_resistance_protein_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4935,Risperidone,Multidrug_resistance_protein_1-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
4936,Rosuvastatin,Multidrug_resistance_protein_1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4937,Saquinavir,Multidrug_resistance_protein_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4938,Saquinavir,Multidrug_resistance_protein_1-Inducer,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4939,Sirolimus,Multidrug_resistance_protein_1-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
4940,Tacrolimus,Multidrug_resistance_protein_1-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
4941,Talinolol,Multidrug_resistance_protein_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
4942,Tamoxifen,Multidrug_resistance_protein_1-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4943,Trabectedin,Multidrug_resistance_protein_1-Inhibitor,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
4944,Tretinoin,Multidrug_resistance_protein_1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4945,Trifluoperazine,Multidrug_resistance_protein_1-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4946,Tryptophan,Multidrug_resistance_protein_1-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
4947,Ursodeoxycholic Acid,Multidrug_resistance_protein_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4948,Valproic Acid,Multidrug_resistance_protein_1-Inducer,CCCC(CCC)C(O)=O
4949,Venlafaxine,Multidrug_resistance_protein_1-Inducer,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
4950,Verapamil,Multidrug_resistance_protein_1-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4951,Verapamil,Multidrug_resistance_protein_1-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4952,Verapamil,Multidrug_resistance_protein_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4953,Vinblastine,Multidrug_resistance_protein_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
4954,Vincamine,Multidrug_resistance_protein_1-Inhibitor,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
4955,Vincristine,Multidrug_resistance_protein_1-Inducer,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
4956,Vincristine,Multidrug_resistance_protein_1-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
4957,Yohimbin,Multidrug_resistance_protein_1-Inducer,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
4958,Bezafibrate,Multidrug_resistance_protein_3-Inducer,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
4959,Doxorubicin,Multidrug_resistance_protein_3-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4960,Morphine,Multidrug_resistance_protein_3-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
4961,Phenobarbital,Multidrug_resistance_protein_3-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4962,Retinol,Multidrug_resistance_protein_3-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4963,Simvastatin,Multidrug_resistance_protein_3-Inducer,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4964,Aldosterone,17A-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4965,Aminogluthetimide,17A-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4966,Aminophenazone,17A-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
4967,Androstanolone,17A-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4968,Dexamethasone,17A-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4969,Insulin (human),17A-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4970,Metoclopramide,17A-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4971,Progesterone,17A-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4972,[32P]Natriumphosphat,17A-Substrate,OP([O-])([O-])=O
4973,Aldosterone,11B2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4974,Aminogluthetimide,11B2-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4975,Aminosalicylic Acid,11B2-Inducer,NC1=CC(O)=C(C=C1)C(O)=O
4976,Angiotensinamide,11B2-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4977,Benazepril,11B2-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(CC(O)=O)C2=O
4978,Desoxycortone,11B2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
4979,Eplerenone,11B2-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
4980,Etomidate,11B2-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
4981,Glucose,11B2-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4982,Hydrocortisone,11B2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4983,Insulin (human),11B2-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4984,Metoclopramide,11B2-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4985,Mibefradil,11B2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
4986,Valsartan,11B2-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
4987,Acriflavinium Chloride,1A1-Substrate,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
4988,Albendazole,1A1-Inducer,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
4989,Alum,1A1-Substrate,[O-]S([O-])(=O)=O
4990,Alum,1A1-Inducer,[O-]S([O-])(=O)=O
4991,Amiloride,1A1-Inhibitor,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
4992,Amiodarone,1A1-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4993,Amlodipine,1A1-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
4994,Amodiaquine,1A1-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
4995,Arsenic Trioxide,1A1-Inhibitor,O=[As]1=[As](=O)O1
4996,Ascorbic Acid (vit C),1A1-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
4997,Atazanavir,1A1-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4998,Benidipine,1A1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
4999,Benoxaprofen,1A1-Inducer,C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C3=CC=C(Cl)C=C3)C=C1
5000,Benzydamine,1A1-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
5001,Betacarotene,1A1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
5002,Bezafibrate,1A1-Inducer,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
5003,Bortezomib,1A1-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5004,Caffeine,1A1-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5005,Capsaicin,1A1-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
5006,Chinin,1A1-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5007,Chinin,1A1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5008,Chloroquine,1A1-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
5009,Chlorothiazide,1A1-Inducer,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
5010,Chlorpromazine,1A1-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5011,Cinnarizin,1A1-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5012,Clenbuterol,1A1-Substrate,CC(C)(C)NC[C@H](O)C1=CC(Cl)=C(N)C(Cl)=C1
5013,Clobetasol,1A1-Inhibitor,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
5014,Clofibrate,1A1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5015,Clomifene,1A1-Inducer,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
5016,Clozapine,1A1-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5017,Cocaine,1A1-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5018,Colchicine,1A1-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5019,Colecalciferol,1A1-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
5020,Dacarbazine,1A1-Inhibitor,CN(C)N=NC1=C(N=CN1)C(N)=O
5021,Dacarbazine,1A1-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
5022,Dactinomycin,1A1-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
5023,Dantrolene,1A1-Inhibitor,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
5024,Daunorubicin,1A1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5025,Debrisoquine,1A1-Substrate,NC(=N)N1CCC2=C(C1)C=CC=C2
5026,Decamethrin,1A1-Substrate,CC1(C)[C@@H](C=C(/Br)Br)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
5027,Deferoxamine,1A1-Inhibitor,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
5028,Dexamethasone,1A1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5029,Diclofenac,1A1-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5030,Dicycloverine,1A1-Inducer,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
5031,Diethylstilbestrol,1A1-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
5032,Diosmectite,1A1-Inducer,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
5033,Diosmectite,1A1-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
5034,Diosmin,1A1-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
5035,Diosmin,1A1-Inducer,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
5036,Doxorubicin,1A1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5037,Dronabinol,1A1-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
5038,Enoxacin,1A1-Inducer,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
5039,Ergometrine,1A1-Inhibitor,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
5040,Erythromycin,1A1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5041,Estradiol,1A1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5042,Estriol,1A1-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
5043,Estriol,1A1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
5044,Estrone,1A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5045,Etacrynic Acid,1A1-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
5046,Ethanol,1A1-Inhibitor,CCO
5047,Ethinylestradiol,1A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5048,Fluconazole,1A1-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
5049,Flunarizine,1A1-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
5050,Fluorescein,1A1-Inducer,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
5051,Flutamide,1A1-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
5052,Fluvastatin,1A1-Inducer,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
5053,Fluvastatin,1A1-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
5054,Fluvoxamine,1A1-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
5055,G-strophanthin,1A1-Inhibitor,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
5056,Granisetron,1A1-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
5057,Haloperidol,1A1-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5058,Histamine,1A1-Inducer,NCCC1=CNC=N1
5059,Ipriflavone,1A1-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
5060,Isoprenaline,1A1-Inhibitor,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
5061,Itraconazole,1A1-Inducer,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
5062,Ketoconazole,1A1-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5063,Ketoconazole,1A1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5064,Lansoprazole,1A1-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
5065,Lentinan,1A1-Inhibitor,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]5O)[C@H]4O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
5066,Lindane,1A1-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
5067,Mebendazole,1A1-Inducer,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
5068,Mecamylamine,1A1-Inducer,CN[C@@]1(C)[C@H]2CC[C@H](C2)C1(C)C
5069,Melatonin,1A1-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
5070,Menadione,1A1-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
5071,Mercaptopurine,1A1-Substrate,S=C1NC=NC2=C1NC=N2
5072,"Mercury, Metallic",1A1-Inducer,[Hg]
5073,Methoxsalen,1A1-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
5074,Mibefradil,1A1-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5075,Mitobronitol,1A1-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
5076,Moracizine,1A1-Inhibitor,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
5077,Nicotine,1A1-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
5078,Nicotine,1A1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
5079,Nifedipine,1A1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5080,Nitrofurantoin,1A1-Substrate,[O-][N+](=O)C1=CC=C(O1)C=NN2CC(=O)NC2=O
5081,Nitroprusside,1A1-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
5082,Norfloxacin,1A1-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5083,Omeprazole,1A1-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5084,Omeprazole,1A1-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5085,Omeprazole,1A1-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5086,Oxaliplatin,1A1-Substrate,N[C@@H]1CCCC[C@H]1N
5087,Paracetamol,1A1-Substrate,CC(=O)NC1=CC=C(O)C=C1
5088,Perazine,1A1-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5089,Phenacetin,1A1-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5090,Phenobarbital,1A1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5091,Pipamperone,1A1-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
5092,Prasterone,1A1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5093,Prazosin,1A1-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
5094,Prednisone,1A1-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5095,Primaquine,1A1-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5096,Procarbazine,1A1-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
5097,Progesterone,1A1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5098,Propofol,1A1-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
5099,Propranolol,1A1-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5100,Propylthiouracil,1A1-Inducer,CCCC1=CC(=O)NC(=S)N1
5101,Pyridoxine (vit B6),1A1-Inducer,CC1=C(O)C(CO)=C(CO)C=N1
5102,Quassia,1A1-Inhibitor,COC1=C[C@@H](C)[C@@H]2C[C@@H]3OC(=O)C[C@H]4C(C)=C(OC)C(=O)[C@@H]([C@]34C)[C@@]2(C)C1=O
5103,Quinidine,1A1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5104,Rabeprazole,1A1-Inducer,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
5105,Raltegravir,1A1-Substrate,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
5106,Retigabine,1A1-Substrate,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
5107,Retinol,1A1-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5108,Retinol,1A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5109,Retinol (vit A),1A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5110,Riboflavin (vit B2),1A1-Substrate,CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2
5111,Rifampicin,1A1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5112,Riluzole,1A1-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
5113,Salicylamide,1A1-Inhibitor,NC(=O)C1=C(O)C=CC=C1
5114,Sildenafil,1A1-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
5115,Streptozocin,1A1-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
5116,Sulindac,1A1-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
5117,Tamoxifen,1A1-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5118,Testosterone,1A1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5119,Tetrabenazine,1A1-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
5120,Thalidomide,1A1-Inducer,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
5121,Theophylline,1A1-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5122,Theophylline,1A1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5123,Tiabendazole,1A1-Inducer,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
5124,Ticlopidine,1A1-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
5125,Tocainide,1A1-Inhibitor,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
5126,Toremifene,1A1-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
5127,Triclosan,1A1-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
5128,Troglitazone,1A1-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
5129,Tryptophan,1A1-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
5130,Zotepine,1A1-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
5131,Acetylcholin,NAT-Inhibitor,CC(=O)OCC[N+](C)(C)C
5132,Acetylsalicylic Acid,NAT-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
5133,Adenosine,NAT-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
5134,Allopurinol,NAT-Substrate,OC1=NC=NC2=C1C=NN2
5135,Amfetamine,NAT-Inducer,C[C@@H](N)CC1=CC=CC=C1
5136,Aminobenzoic Acid,NAT-Substrate,NC1=CC=C(C=C1)C(O)=O
5137,Aminobenzoic Acid,NAT-Inhibitor,NC1=CC=C(C=C1)C(O)=O
5138,Aminophylline,NAT-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5139,Androstanolone,NAT-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
5140,Apomorphine,NAT-Inhibitor,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
5141,Arbekacin,NAT-Substrate,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
5142,Ascorbic Acid (vit C),NAT-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
5143,Bergapten,NAT-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
5144,Bromocriptine,NAT-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
5145,Bucladesine,NAT-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
5146,Caffeine,NAT-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5147,Carbachol,NAT-Inhibitor,C[N+](C)(C)CCOC(N)=O
5148,Carmustine,NAT-Inhibitor,ClCCNC(=O)N(CCCl)N=O
5149,Cimetidine,NAT-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5150,Clonazepam,NAT-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
5151,Clonidine,NAT-Inhibitor,ClC1=CC=CC(Cl)=C1NC2=NCCN2
5152,Clozapine,NAT-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5153,Cocaine,NAT-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5154,Cocaine,NAT-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5155,Dactinomycin,NAT-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
5156,Desipramine,NAT-Inducer,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5157,Desipramine,NAT-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5158,Dexamfetamine,NAT-Inducer,C[C@H](N)CC1=CC=CC=C1
5159,Diazepam,NAT-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5160,Dihydralazine,NAT-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
5161,Dinoprostone,NAT-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
5162,Disulfiram,NAT-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
5163,Esketamine,NAT-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
5164,Fluoxetine,NAT-Inducer,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
5165,Folic Acid,NAT-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5166,Folic Acid,NAT-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5167,G-strophanthin,NAT-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
5168,Glycyrrhizic Acid,NAT-Inhibitor,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
5169,Haloperidol,NAT-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5170,Hydralazine,NAT-Substrate,NN=C1NN=CC2=C1C=CC=C2
5171,Hydrocortisone,NAT-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5172,Ibuprofen,NAT-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
5173,Ibuprofen,NAT-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
5174,Imipramine,NAT-Inducer,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5175,Indometacin,NAT-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5176,Indometacin,NAT-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5177,Insulin (human),NAT-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5178,Iproniazide,NAT-Inhibitor,CC(C)NNC(=O)C1=CC=NC=C1
5179,Isoprenaline,NAT-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
5180,Ketamine,NAT-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
5181,Ketoprofen,NAT-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
5182,Levodopa,NAT-Inducer,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
5183,Lindane,NAT-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
5184,Melatonin,NAT-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
5185,Melatonin,NAT-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
5186,Mercaptamine,NAT-Inhibitor,NCCS
5187,Mesalazine,NAT-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
5188,Metamizole Sodium,NAT-Substrate,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
5189,Methotrexate,NAT-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5190,Metoclopramide,NAT-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
5191,Netilmicin,NAT-Substrate,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O
5192,Nicotine,NAT-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
5193,Norepinephrine,NAT-Inducer,NC[C@@H](O)C1=CC(O)=C(O)C=C1
5194,Octopamine,NAT-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
5195,Oxedrine,NAT-Inhibitor,CNC[C@@H](O)C1=CC=C(O)C=C1
5196,Paclitaxel,NAT-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5197,Pargyline,NAT-Inducer,CN(CC#C)CC1=CC=CC=C1
5198,Phenazone,NAT-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
5199,Procainamide,NAT-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
5200,Salicylamide,NAT-Inhibitor,NC(=O)C1=C(O)C=CC=C1
5201,Sulfadiazine,NAT-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
5202,Sulfamethoxazole,NAT-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
5203,Sulfapyridine,NAT-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
5204,Sulindac,NAT-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
5205,Sultiame,NAT-Inducer,NS(=O)(=O)C1=CC=C(C=C1)N2CCCCS2(=O)=O
5206,Tamoxifen,NAT-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5207,Testosterone,NAT-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5208,Theophylline,NAT-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5209,Tobramycin,NAT-Substrate,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
5210,Trichloroethylene,NAT-Substrate,ClC=C(Cl)Cl
5211,Warfarin,NAT-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
5212,Doxorubicin,ATP_binding_cassette_sub_family_A_member_3-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5213,Imatinib,ATP_binding_cassette_sub_family_A_member_3-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5214,Methotrexate,ATP_binding_cassette_sub_family_A_member_3-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5215,Mitoxantrone,ATP_binding_cassette_sub_family_A_member_3-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
5216,Alfentanil,3A7-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
5217,Alprazolam,3A7-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
5218,Aminophenazone,3A7-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
5219,Amiodarone,3A7-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5220,Amlodipine,3A7-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5221,Aprepitant,3A7-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
5222,Aripiprazole,3A7-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
5223,Astemizole,3A7-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
5224,Atazanavir,3A7-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
5225,Atazanavir,3A7-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
5226,Atorvastatin,3A7-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
5227,Aztreonam,3A7-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
5228,Buspirone,3A7-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
5229,Caffeine,3A7-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5230,Carbamazepine,3A7-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5231,Cerivastatin,3A7-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
5232,Chinin,3A7-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5233,Chlorphenamine,3A7-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
5234,Ciclosporin,3A7-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5235,Ciclosporin,3A7-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5236,Cimetidine,3A7-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5237,Cisapride,3A7-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
5238,Clarithromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
5239,Clotiapine,3A7-Substrate,CN1CCN(CC1)C2=NC3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3
5240,Clotrimazole,3A7-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5241,Cocaine,3A7-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5242,Codeine,3A7-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
5243,Cortisone,3A7-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
5244,Cyclophosphamide,3A7-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
5245,Dapsone,3A7-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
5246,Dexamethasone,3A7-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5247,Dexamethasone,3A7-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5248,Dextromethorphan,3A7-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
5249,Dextropropoxyphene,3A7-Inducer,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
5250,Diazepam,3A7-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5251,Diltiazem,3A7-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
5252,Docetaxel,3A7-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
5253,Domperidone,3A7-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
5254,Doxylamin,3A7-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
5255,Eplerenone,3A7-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
5256,Erythromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5257,Estradiol,3A7-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5258,Estriol,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
5259,Ethinylestradiol,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5260,Ethosuximide,3A7-Substrate,CC[C@]1(C)CC(=O)NC1=O
5261,Ethylmorphine,3A7-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
5262,Felodipine,3A7-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
5263,Fentanyl,3A7-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
5264,Finasteride,3A7-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
5265,Fluvoxamine,3A7-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
5266,Glycyrrhizic Acid,3A7-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
5267,Glycyrrhizic Acid,3A7-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
5268,Haloperidol,3A7-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5269,Hydrocortisone,3A7-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5270,Ifosfamide,3A7-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
5271,Imatinib,3A7-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5272,Imipramine,3A7-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5273,Indinavir,3A7-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
5274,Indinavir,3A7-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
5275,Irinotecan,3A7-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5276,Ketoconazole,3A7-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5277,Lercanidipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
5278,Levacetylmethadol,3A7-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5279,Lidocain,3A7-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5280,Linopirdine,3A7-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
5281,Lovastatin,3A7-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5282,Methadone,3A7-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5283,Mibefradil,3A7-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5284,Midazolam,3A7-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
5285,Midazolam,3A7-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
5286,Mifepristone,3A7-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
5287,Nateglinide,3A7-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
5288,Nefazodone,3A7-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
5289,Nelfinavir,3A7-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5290,Nelfinavir,3A7-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5291,Neostigmine,3A7-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
5292,Nifedipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5293,Nisoldipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
5294,Nitrendipine,3A7-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
5295,Norethisterone,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
5296,Norfloxacin,3A7-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5297,Ondansetron,3A7-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
5298,Ornidazole,3A7-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
5299,Oxazepam,3A7-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
5300,Oxycodone,3A7-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
5301,Paclitaxel,3A7-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5302,Phenelzine,3A7-Inhibitor,NNCCC1=CC=CC=C1
5303,Phenobarbital,3A7-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5304,Phenytoin,3A7-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
5305,Pimozide,3A7-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
5306,Pleconaril,3A7-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
5307,Prasterone,3A7-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5308,Prasterone,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5309,Praziquantel,3A7-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
5310,Progesterone,3A7-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5311,Progesterone,3A7-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5312,Propranolol,3A7-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5313,Quetiapine,3A7-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
5314,Quinidine,3A7-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5315,Rifampicin,3A7-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5316,Rifapentine,3A7-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
5317,Risperidone,3A7-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
5318,Ritonavir,3A7-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5319,Ritonavir,3A7-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5320,Salmeterol,3A7-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
5321,Saquinavir,3A7-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5322,Sildenafil,3A7-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
5323,Simvastatin,3A7-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5324,Sirolimus,3A7-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5325,Tacrolimus,3A7-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
5326,Tamoxifen,3A7-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5327,Telithromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
5328,Terfenadine,3A7-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
5329,Testosterone,3A7-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5330,Trazodone,3A7-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
5331,Triamcinolone,3A7-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
5332,Triazolam,3A7-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
5333,Troglitazone,3A7-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
5334,Troglitazone,3A7-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
5335,Verapamil,3A7-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5336,Verapamil,3A7-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5337,Vincristine,3A7-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
5338,Zalcitabine,3A7-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
5339,Zaleplon,3A7-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
5340,Ziprasidone,3A7-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
5341,Zolpidem,3A7-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
5342,Caffeine,Proton_coupled_amino_acid_transporter_1-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5343,Cycloserine,Proton_coupled_amino_acid_transporter_1-Substrate,N[C@@H]1CONC1=O
5344,Glycine,Proton_coupled_amino_acid_transporter_1-Substrate,NCC(O)=O
5345,Oxitriptan,Proton_coupled_amino_acid_transporter_1-Inhibitor,N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O
5346,Vigabatrin,Proton_coupled_amino_acid_transporter_1-Substrate,N[C@@H](CCC(O)=O)C=C
5347,Retinol (vit A),2S1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5348,Bosentan,Bile_salt_export_pump-Inhibitor,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
5349,Bosentan,Bile_salt_export_pump-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
5350,Chenodeoxycholic Acid,Bile_salt_export_pump-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
5351,Ciclosporin,Bile_salt_export_pump-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5352,Colchicine,Bile_salt_export_pump-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5353,Estradiol,Bile_salt_export_pump-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5354,Glibenclamide,Bile_salt_export_pump-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
5355,Midecamycin,Bile_salt_export_pump-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
5356,Pravastatin,Bile_salt_export_pump-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
5357,Pravastatin,Bile_salt_export_pump-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
5358,Rifamycin,Bile_salt_export_pump-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5359,Troglitazone,Bile_salt_export_pump-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
5360,Alprostadil,Solute_carrier_organic_anion_transporter_family_member_3A1-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
5361,Acetazolamide,3A4-Inhibitor,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
5362,Adefovir Dipivoxil,3A4-Inhibitor,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C
5363,Ademetionine,3A4-Inhibitor,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
5364,Adinazolam,3A4-Substrate,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
5365,Albendazole,3A4-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
5366,Alfentanil,3A4-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
5367,Alfuzosin,3A4-Substrate,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)[C@H]3CCCO3
5368,Allylestrenol,3A4-Substrate,C[C@@]12CC[C@@H]3[C@H](CCC4=CCCC[C@@H]34)[C@@H]1CC[C@@]2(O)CC=C
5369,Almotriptan,3A4-Substrate,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
5370,Alosetron,3A4-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
5371,Alprazolam,3A4-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
5372,Ambroxol,3A4-Inhibitor,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
5373,Ambroxol,3A4-Substrate,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
5374,Aminogluthetimide,3A4-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
5375,Aminophenazone,3A4-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
5376,Aminophylline,3A4-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5377,Amiodarone,3A4-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5378,Amiodarone,3A4-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5379,Amitriptyline,3A4-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5380,Amitriptyline,3A4-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5381,Amlodipine,3A4-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5382,Amlodipine,3A4-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5383,Amprenavir,3A4-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
5384,Amprenavir,3A4-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
5385,Anastrozole,3A4-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
5386,Aprepitant,3A4-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
5387,Aprepitant,3A4-Inducer,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
5388,Aprepitant,3A4-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
5389,Argatroban,3A4-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
5390,Aripiprazole,3A4-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
5391,Arsenic Trioxide,3A4-Inhibitor,O=[As]1=[As](=O)O1
5392,Artemether,3A4-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
5393,Artemisinin,3A4-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
5394,Artemisinin,3A4-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
5395,Astemizole,3A4-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
5396,Astemizole,3A4-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
5397,Atazanavir,3A4-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
5398,Atazanavir,3A4-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
5399,Atenolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1
5400,Atomoxetine,3A4-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
5401,Atorvastatin,3A4-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
5402,Atorvastatin,3A4-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
5403,Azatadine,3A4-Inducer,CN1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=CC=C3
5404,Azelastine,3A4-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
5405,Azelastine,3A4-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
5406,Azithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
5407,Azithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
5408,Aztreonam,3A4-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
5409,Barnidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
5410,Barnidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
5411,Benidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
5412,Benzethonium,3A4-Inhibitor,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
5413,Benzocaine,3A4-Inhibitor,CCOC(=O)C1=CC=C(N)C=C1
5414,Benzydamine,3A4-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
5415,Bergapten,3A4-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
5416,Betamethason,3A4-Inhibitor,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5417,Bexarotene,3A4-Substrate,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
5418,Bexarotene,3A4-Inducer,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
5419,Bezafibrate,3A4-Substrate,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
5420,Bicalutamide,3A4-Substrate,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
5421,Bicalutamide,3A4-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
5422,Bifonazole,3A4-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
5423,Bisoprolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
5424,Bortezomib,3A4-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5425,Bortezomib,3A4-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5426,Bosentan,3A4-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
5427,Bosentan,3A4-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
5428,Brinzolamide,3A4-Substrate,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
5429,Bromazepam,3A4-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
5430,Bromocriptine,3A4-Substrate,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
5431,Bromocriptine,3A4-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
5432,Bromperidol,3A4-Substrate,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
5433,Brompheniramine,3A4-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
5434,Brotizolam,3A4-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(Br)=C4)N12
5435,Budesonide,3A4-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
5436,Bupivacaine,3A4-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5437,Buprenorphine,3A4-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
5438,Buprenorphine,3A4-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
5439,Bupropion,3A4-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
5440,Buspirone,3A4-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
5441,Busulfan,3A4-Substrate,CS(=O)(=O)OCCCCOS(C)(=O)=O
5442,Caffeine,3A4-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5443,Caffeine,3A4-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5444,Calcitriol,3A4-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
5445,Capsaicin,3A4-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
5446,Carbamazepine,3A4-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5447,Carbamazepine,3A4-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5448,Carbinoxamine,3A4-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
5449,Carboplatin,3A4-Inducer,N.N.O=C1O[Pt]OC(=O)C12CCC2
5450,Carvedilol,3A4-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
5451,Caspofungin,3A4-Inhibitor,CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN
5452,Cefalexin,3A4-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
5453,Celecoxib,3A4-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
5454,Cerivastatin,3A4-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
5455,Cerivastatin,3A4-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
5456,Cetirizine,3A4-Substrate,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
5457,Cevimeline,3A4-Substrate,CC1O[C@@]2(CS1)CN1CCC2CC1
5458,Chinin,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5459,Chinin,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5460,Chinin,3A4-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5461,Chloramphenicol,3A4-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
5462,Chlordiazepoxide,3A4-Substrate,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
5463,Chlormadinone,3A4-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5464,Chloroquine,3A4-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
5465,Chlorphenamine,3A4-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
5466,Chlorpromazine,3A4-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5467,Chlorpromazine,3A4-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5468,Chlorprothixene,3A4-Substrate,CN(C)CCC=C1/C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5469,Chlorzoxazone,3A4-Inhibitor,OC1=NC2=C(O1)C=CC(Cl)=C2
5470,Chlorzoxazone,3A4-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
5471,Cibenzoline,3A4-Substrate,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
5472,Ciclesonide,3A4-Substrate,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]3[C@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@H]4[C@@H](O)C[C@@]23C)[C@H]6CCCCC6
5473,Ciclosporin,3A4-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5474,Ciclosporin,3A4-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5475,Ciclosporin,3A4-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5476,Cilnidipine,3A4-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
5477,Cilostazol,3A4-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
5478,Cimetidine,3A4-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5479,Cinacalcet,3A4-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
5480,Ciprofibrate,3A4-Substrate,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
5481,Ciprofloxacin,3A4-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
5482,Cisapride,3A4-Inhibitor,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
5483,Cisapride,3A4-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
5484,Citalopram,3A4-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
5485,Clarithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
5486,Clarithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
5487,Clemastine,3A4-Inhibitor,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
5488,Clindamycin,3A4-Inhibitor,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
5489,Clindamycin,3A4-Substrate,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
5490,Clobazam,3A4-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5491,Clofazimine,3A4-Inhibitor,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
5492,Clofazimine,3A4-Substrate,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
5493,Clofenotane,3A4-Inducer,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
5494,Clofibrate,3A4-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5495,Clofibrate,3A4-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5496,Clomethiazole,3A4-Substrate,CC1=C(CCCl)SC=N1
5497,Clomifene,3A4-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
5498,Clomipramine,3A4-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
5499,Clonazepam,3A4-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
5500,Clopidogrel,3A4-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
5501,Clotiazepam,3A4-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
5502,Clotiazepam,3A4-Inhibitor,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
5503,Clotrimazole,3A4-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5504,Clotrimazole,3A4-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5505,Clozapine,3A4-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5506,Clozapine,3A4-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5507,Clozapine,3A4-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5508,Cocaine,3A4-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5509,Cocaine,3A4-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5510,Cocaine,3A4-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5511,Codeine,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
5512,Colchicine,3A4-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5513,Colchicine,3A4-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5514,Colchicine,3A4-Substrate,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5515,Cortisone,3A4-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
5516,Cyamemazine,3A4-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
5517,Cyclobarbital,3A4-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
5518,Cyclobenzaprine,3A4-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5519,Cyclophosphamide,3A4-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
5520,Cyclophosphamide,3A4-Inhibitor,ClCCN(CCCl)[P@]1(=O)NCCCO1
5521,Cyclophosphamide,3A4-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
5522,Cytarabine,3A4-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
5523,Danazol,3A4-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
5524,Dantrolene,3A4-Substrate,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
5525,Dapsone,3A4-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
5526,Daunorubicin,3A4-Inhibitor,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5527,Daunorubicin,3A4-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5528,Delavirdine,3A4-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
5529,Delavirdine,3A4-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
5530,Desipramine,3A4-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5531,Desogestrel,3A4-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
5532,Desvenlafaxine,3A4-Substrate,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
5533,Dexamethasone,3A4-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5534,Dexamethasone,3A4-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5535,Dexamethasone,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5536,Dexmedetomidine,3A4-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
5537,Dextromethorphan,3A4-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
5538,Dextropropoxyphene,3A4-Substrate,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
5539,Dextropropoxyphene,3A4-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
5540,Diazepam,3A4-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5541,Diazepam,3A4-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5542,Diclofenac,3A4-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5543,Diclofenac,3A4-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5544,Dicloxacillin,3A4-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4Cl
5545,Diethyltoluamide,3A4-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
5546,Digitoxin,3A4-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5547,Digoxin,3A4-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5548,Dihydralazine,3A4-Inhibitor,NNC1=NN=C(NN)C2=C1C=CC=C2
5549,Dihydralazine,3A4-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
5550,Dihydrocodeine,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
5551,Dihydroergotamine,3A4-Inhibitor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
5552,Dihydroergotamine,3A4-Substrate,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
5553,Dihydrostreptomycin,3A4-Substrate,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N
5554,Diltiazem,3A4-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
5555,Diltiazem,3A4-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
5556,Dimethyl Sulfoxide,3A4-Inhibitor,CS(C)=O
5557,Dimetotiazine,3A4-Inhibitor,C[C@@H](CN1C2=C(SC3=CC=C(C=C13)S(=O)(=O)N(C)C)C=CC=C2)N(C)C
5558,Diosmectite,3A4-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
5559,Diphenhydramine Methylbromide,3A4-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
5560,Dirithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
5561,Disopyramide,3A4-Substrate,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
5562,Disulfiram,3A4-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
5563,Disulfiram,3A4-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
5564,Docetaxel,3A4-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
5565,Docetaxel,3A4-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
5566,Dofetilide,3A4-Substrate,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2
5567,Dolasetron,3A4-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
5568,Domperidone,3A4-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
5569,Donepezil,3A4-Substrate,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
5570,Dorzolamide,3A4-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
5571,Doxazosin,3A4-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
5572,Doxepin,3A4-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
5573,Doxorubicin,3A4-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5574,Doxorubicin,3A4-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5575,Doxorubicin,3A4-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5576,Doxycycline,3A4-Substrate,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
5577,Doxycycline,3A4-Inhibitor,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
5578,Doxylamin,3A4-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
5579,Dutasteride,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
5580,Ebastine,3A4-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
5581,Econazole,3A4-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
5582,Efavirenz,3A4-Inducer,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
5583,Efavirenz,3A4-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
5584,Efavirenz,3A4-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
5585,Eletriptan,3A4-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
5586,Eletriptan,3A4-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
5587,Emetine,3A4-Substrate,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
5588,Emetine,3A4-Inhibitor,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
5589,Enalapril,3A4-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
5590,Entacapone,3A4-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
5591,Epinastine,3A4-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
5592,Epinephrine,3A4-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5593,Eplerenone,3A4-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
5594,Ergocalciferol,3A4-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
5595,Ergocalciferol,3A4-Inducer,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
5596,Ergometrine,3A4-Inhibitor,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
5597,Ergotamine,3A4-Substrate,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
5598,Ergotamine,3A4-Inhibitor,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
5599,Erlotinib,3A4-Substrate,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
5600,Erythromycin,3A4-Inducer,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5601,Erythromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5602,Erythromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5603,Escitalopram,3A4-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
5604,Esketamine,3A4-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
5605,Esomeprazole,3A4-Substrate,COC1=CC2=C([N-]C(=N2)S(=O)CC3=NC=C(C)C(OC)=C3C)C=C1
5606,Estazolam,3A4-Substrate,ClC1=CC2=C(C=C1)N3C=NN=C3CN=C2C4=CC=CC=C4
5607,Estradiol,3A4-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5608,Estramustine,3A4-Substrate,C[C@@]12CC[C@@H]3[C@H](CCC4=C3C=CC(OC(=O)N(CCCl)CCCl)=C4)[C@@H]1CC[C@@H]2O
5609,Estrone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5610,Eszopiclone,3A4-Substrate,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
5611,Ethanol,3A4-Substrate,CCO
5612,Ethanol,3A4-Inhibitor,CCO
5613,Ethanol,3A4-Inducer,CCO
5614,Ethinylestradiol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5615,Ethinylestradiol,3A4-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5616,Ethinylestradiol,3A4-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5617,Ethosuximide,3A4-Substrate,CC[C@]1(C)CC(=O)NC1=O
5618,Ethylmorphine,3A4-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
5619,Etizolam,3A4-Substrate,CCC1=CC2=C(S1)N3C(C)=NN=C3CN=C2C4=C(Cl)C=CC=C4
5620,Etonogestrel,3A4-Substrate,CC[C@@]12CC(=C)[C@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@@H]1CC[C@@]2(O)C#C
5621,Etoperidone,3A4-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
5622,Etoposide,3A4-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5623,Etoposide,3A4-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5624,Etoposide,3A4-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5625,Etoricoxib,3A4-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
5626,Etoricoxib,3A4-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
5627,Everolimus,3A4-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5628,Exemestane,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
5629,Famciclovir,3A4-Substrate,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O
5630,Felbamate,3A4-Inducer,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
5631,Felbamate,3A4-Substrate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
5632,Felodipine,3A4-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
5633,Felodipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
5634,Fenofibrate,3A4-Substrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
5635,Fentanyl,3A4-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
5636,Fentanyl,3A4-Inhibitor,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
5637,Fesoterodine,3A4-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
5638,Fexofenadine,3A4-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
5639,Finasteride,3A4-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
5640,Flosequinan,3A4-Substrate,COSC1=CN(C)C2=C(C=CC(F)=C2)C1=O
5641,Flucloxacillin,3A4-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
5642,Fluconazole,3A4-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
5643,Fluconazole,3A4-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
5644,Flunitrazepam,3A4-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
5645,Fluoxetine,3A4-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
5646,Fluoxetine,3A4-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
5647,Flurazepam,3A4-Substrate,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
5648,Flurithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5649,Flutamide,3A4-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
5650,Fluticasone,3A4-Substrate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
5651,Fluvastatin,3A4-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
5652,Fluvastatin,3A4-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
5653,Fluvoxamine,3A4-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
5654,Fosamprenavir,3A4-Inhibitor,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
5655,Fosamprenavir,3A4-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
5656,Fosphenytoin,3A4-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
5657,Fosphenytoin,3A4-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
5658,Fulvestrant,3A4-Substrate,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC4=CC(O)=CC=C34)[C@@H]1CC[C@@H]2O
5659,Galantamine,3A4-Substrate,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
5660,Gallopamil,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
5661,Gefitinib,3A4-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
5662,Gemfibrozil,3A4-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
5663,Gemfibrozil,3A4-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
5664,Gemfibrozil,3A4-Substrate,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
5665,Gepirone,3A4-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
5666,Glibenclamide,3A4-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
5667,Glibenclamide,3A4-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
5668,Glipizide,3A4-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
5669,Glycyrrhizic Acid,3A4-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
5670,Glycyrrhizic Acid,3A4-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
5671,Granisetron,3A4-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
5672,Griseofulvin,3A4-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
5673,Guanethidine,3A4-Inducer,NC(=N)NCCN1CCCCCCC1
5674,Halofantrine,3A4-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
5675,Haloperidol,3A4-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5676,Haloperidol,3A4-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5677,Halothane,3A4-Substrate,FC(F)(F)[C@@H](Cl)Br
5678,Hexobarbital,3A4-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
5679,Histamine,3A4-Inhibitor,NCCC1=CNC=N1
5680,Histamine,3A4-Substrate,NCCC1=CNC=N1
5681,Hydralazine,3A4-Inhibitor,NN=C1NN=CC2=C1C=CC=C2
5682,Hydrocodone,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
5683,Hydrocortisone,3A4-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5684,Hydrocortisone,3A4-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5685,Hydrocortisone,3A4-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5686,Hydrocortisone Aceponate,3A4-Substrate,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
5687,Hydromorphone,3A4-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
5688,Hydroquinone,3A4-Substrate,OC1=CC=C(O)C=C1
5689,Ifosfamide,3A4-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
5690,Ifosfamide,3A4-Inhibitor,ClCCN[P@@]1(=O)OCCCN1CCCl
5691,Ifosfamide,3A4-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
5692,Imatinib,3A4-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5693,Imatinib,3A4-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5694,Imipramine,3A4-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5695,Imipramine Oxide,3A4-Substrate,C[N+](C)([O-])CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5696,Imiquimod,3A4-Substrate,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
5697,Indinavir,3A4-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
5698,Indinavir,3A4-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
5699,Ipriflavone,3A4-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
5700,Ipriflavone,3A4-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
5701,Irbesartan,3A4-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
5702,Irinotecan,3A4-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5703,Irinotecan,3A4-Inhibitor,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5704,Isoniazid,3A4-Inhibitor,NNC(=O)C1=CC=NC=C1
5705,Isopropanol,3A4-Inhibitor,CC(C)O
5706,Isosorbide Dinitrate,3A4-Substrate,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
5707,Isosorbide Mononitrate,3A4-Substrate,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O
5708,Isotretinoin,3A4-Substrate,CC1=C(C=CC(C)=CC=CC(C)=C/C(O)=O)C(C)(C)CCC1
5709,Isradipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
5710,Isradipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
5711,Itraconazole,3A4-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
5712,Itraconazole,3A4-Substrate,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
5713,Ivabradine,3A4-Substrate,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
5714,Ivermectin,3A4-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
5715,Josamycin,3A4-Inhibitor,CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O
5716,Ketamine,3A4-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
5717,Ketobemidone,3A4-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
5718,Ketoconazole,3A4-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5719,Ketoconazole,3A4-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5720,Ketoconazole,3A4-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5721,Lacidipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)C=CC(=O)OC(C)(C)C)C(=O)OCC
5722,Lansoprazole,3A4-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
5723,Lansoprazole,3A4-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
5724,Lansoprazole,3A4-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
5725,Lercanidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
5726,Lercanidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
5727,Letrozole,3A4-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
5728,Levacetylmethadol,3A4-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5729,Levobupivacaine,3A4-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5730,Levofloxacin,3A4-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
5731,Levonorgestrel,3A4-Substrate,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
5732,Levothyroxine Sodium,3A4-Substrate,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
5733,Lidocain,3A4-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5734,Lidocain,3A4-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5735,Linopirdine,3A4-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
5736,Lisuride,3A4-Substrate,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
5737,Lomustine,3A4-Inhibitor,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
5738,Loperamide,3A4-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5739,Loperamide,3A4-Inhibitor,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5740,Lopinavir,3A4-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
5741,Lopinavir,3A4-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
5742,Loratadine,3A4-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
5743,Loratadine,3A4-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
5744,Loratadine,3A4-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
5745,Losartan,3A4-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
5746,Losartan,3A4-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
5747,Lovastatin,3A4-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5748,Lovastatin,3A4-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5749,Lynestrenol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
5750,Manidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
5751,Mebendazole,3A4-Substrate,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
5752,Medazepam,3A4-Substrate,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5753,Medifoxamine,3A4-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
5754,Medrogestone,3A4-Substrate,CC(=O)[C@@]1(C)CC[C@H]2[C@H]3C=C(C)C4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]12C
5755,Medroxyprogesterone,3A4-Inducer,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
5756,Medroxyprogesterone,3A4-Substrate,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
5757,Medrysone,3A4-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
5758,Mefloquine,3A4-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
5759,Mefloquine,3A4-Substrate,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
5760,Meloxicam,3A4-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
5761,Mepacrine,3A4-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
5762,Mephenytoin,3A4-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
5763,Mequitazine,3A4-Inhibitor,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
5764,Metamizole Sodium,3A4-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
5765,Metandienone,3A4-Substrate,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
5766,Metformin,3A4-Inhibitor,CN(C)C(=N)NC(N)=N
5767,Methadone,3A4-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5768,Methadone,3A4-Inhibitor,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5769,Methadone,3A4-Inducer,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5770,Methaqualone,3A4-Substrate,CC1=C(C=CC=C1)N2C(C)=NC3=C(C=CC=C3)C2=O
5771,Methazolamide,3A4-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
5772,Methoxsalen,3A4-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
5773,Methoxyflurane,3A4-Substrate,COC(F)(F)C(Cl)Cl
5774,Methylergometrine,3A4-Substrate,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
5775,Methylprednisolone,3A4-Substrate,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
5776,Methylprednisolone,3A4-Inhibitor,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
5777,Methylprednisolone Aceponate,3A4-Inducer,CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O
5778,Methyltestosterone,3A4-Substrate,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
5779,Metronidazole,3A4-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
5780,Metronidazole,3A4-Substrate,CC1=NC=C(N1CCO)[N+]([O-])=O
5781,Metyrapone,3A4-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
5782,Metyrapone,3A4-Inducer,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
5783,Mexiletine,3A4-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
5784,Mianserin,3A4-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
5785,Mibefradil,3A4-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5786,Mibefradil,3A4-Substrate,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5787,Miconazole,3A4-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
5788,Miconazole,3A4-Substrate,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
5789,Midazolam,3A4-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
5790,Midazolam,3A4-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
5791,Midecamycin,3A4-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
5792,Mifepristone,3A4-Inducer,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
5793,Mifepristone,3A4-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
5794,Mifepristone,3A4-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
5795,Miocamycin,3A4-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
5796,Miocamycin,3A4-Substrate,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
5797,Mirtazapine,3A4-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
5798,Mirtazapine,3A4-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
5799,Mitoxantrone,3A4-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
5800,Mizolastine,3A4-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
5801,Modafinil,3A4-Substrate,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
5802,Modafinil,3A4-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
5803,Modafinil,3A4-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
5804,Morphine,3A4-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
5805,Naloxone,3A4-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
5806,Nateglinide,3A4-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
5807,Nefazodone,3A4-Substrate,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
5808,Nefazodone,3A4-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
5809,Nelfinavir,3A4-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5810,Nelfinavir,3A4-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5811,Neostigmine,3A4-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
5812,Nevirapine,3A4-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
5813,Nevirapine,3A4-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
5814,Nevirapine,3A4-Inducer,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
5815,Nicardipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
5816,Nicardipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
5817,Nicardipine,3A4-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
5818,Nicotinamide,3A4-Inhibitor,NC(=O)C1=CC=CN=C1
5819,Nicotine,3A4-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
5820,Nifedipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5821,Nifedipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5822,Nifedipine,3A4-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5823,Nilvadipine,3A4-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
5824,Nimodipine,3A4-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
5825,Nisoldipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
5826,Nisoldipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
5827,Nitrazepam,3A4-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
5828,Nitrazepam,3A4-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
5829,Nitrendipine,3A4-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
5830,Nitrendipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
5831,Nitric Oxide,3A4-Inhibitor,N=O
5832,Nordazepam,3A4-Substrate,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
5833,Norethisterone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
5834,Norfloxacin,3A4-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5835,Nortriptyline,3A4-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5836,Noscapine,3A4-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
5837,Octopamine,3A4-Inhibitor,NC[C@H](O)C1=CC=C(O)C=C1
5838,Octopamine,3A4-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
5839,Olanzapine,3A4-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
5840,Oleandomycin,3A4-Inhibitor,CO[C@@H]1C[C@@H](O[C@@H](C)[C@H]1O)O[C@H]2[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
5841,Olopatadine,3A4-Substrate,CN(C)CCC=C1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2
5842,Omeprazole,3A4-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5843,Omeprazole,3A4-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5844,Omeprazole,3A4-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5845,Ondansetron,3A4-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
5846,Ondansetron,3A4-Inducer,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
5847,Ornidazole,3A4-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
5848,Orphenadrine (citrate),3A4-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
5849,Orphenadrine (citrate),3A4-Substrate,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
5850,Oxatomide,3A4-Substrate,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
5851,Oxatomide,3A4-Inhibitor,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
5852,Oxazepam,3A4-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
5853,Oxcarbazepine,3A4-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
5854,Oxiconazole,3A4-Inducer,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
5855,Oxomemazine,3A4-Inducer,C[C@H](CN(C)C)CN1C2=C(C=CC=C2)S(=O)(=O)C3=C1C=CC=C3
5856,Oxybutynin,3A4-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
5857,Oxybutynin,3A4-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
5858,Oxycodone,3A4-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
5859,Paclitaxel,3A4-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5860,Paclitaxel,3A4-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5861,Paclitaxel,3A4-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5862,Palonosetron,3A4-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
5863,Pantoprazole,3A4-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5864,Pantoprazole,3A4-Inducer,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5865,Paracetamol,3A4-Inhibitor,CC(=O)NC1=CC=C(O)C=C1
5866,Paracetamol,3A4-Substrate,CC(=O)NC1=CC=C(O)C=C1
5867,Paracetamol,3A4-Inducer,CC(=O)NC1=CC=C(O)C=C1
5868,Paraoxon,3A4-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
5869,Parecoxib,3A4-Substrate,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
5870,Paroxetine,3A4-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
5871,Pazopanib,3A4-Inhibitor,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
5872,Pentamidine Isethionate,3A4-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
5873,Pentoxyverine,3A4-Substrate,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
5874,Perazine,3A4-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5875,Perazine,3A4-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5876,Pergolide,3A4-Substrate,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
5877,Pergolide,3A4-Inhibitor,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
5878,Perhexiline,3A4-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
5879,Permethrin,3A4-Substrate,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
5880,Perphenazine,3A4-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
5881,Pethidine,3A4-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
5882,Pethidine,3A4-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
5883,Phenacetin,3A4-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5884,Phenazone,3A4-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
5885,Phenazone,3A4-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
5886,Phenelzine,3A4-Substrate,NNCCC1=CC=CC=C1
5887,Phenelzine,3A4-Inhibitor,NNCCC1=CC=CC=C1
5888,Phenobarbital,3A4-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5889,Phenoxybenzamine,3A4-Substrate,C[C@H](COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2
5890,Phenoxymethylpenicillin,3A4-Inducer,CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
5891,Phenprocoumon,3A4-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
5892,Phenylbutazone,3A4-Inducer,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
5893,Phenytoin,3A4-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
5894,Phenytoin,3A4-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
5895,Physostigmine,3A4-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
5896,Pilocarpine,3A4-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
5897,Pilocarpine,3A4-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
5898,Pimecrolimus,3A4-Substrate,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
5899,Pimozide,3A4-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
5900,Pimozide,3A4-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
5901,Pinacidil,3A4-Substrate,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
5902,Pioglitazone,3A4-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
5903,Pioglitazone,3A4-Inducer,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
5904,Pleconaril,3A4-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
5905,Podophyllotoxin,3A4-Substrate,COC1=CC(=CC(OC)=C1OC)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=C2C=C5OCOC5=C4
5906,Prasterone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5907,Pravastatin,3A4-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
5908,Pravastatin,3A4-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
5909,Prazepam,3A4-Substrate,ClC1=CC2=C(C=C1)N(C[C@H]3CC3)C(=O)CN=C2C4=CC=CC=C4
5910,Praziquantel,3A4-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
5911,Prednisolone,3A4-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5912,Prednisolone,3A4-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5913,Prednisone,3A4-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5914,Prednisone,3A4-Inhibitor,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5915,Prednisone,3A4-Substrate,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5916,Primaquine,3A4-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5917,Primaquine,3A4-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5918,Primidone,3A4-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
5919,Probenecid,3A4-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
5920,Prochlorperazine,3A4-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
5921,Progesterone,3A4-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5922,Progesterone,3A4-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5923,Progesterone,3A4-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5924,Proguanil,3A4-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
5925,Promazine,3A4-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
5926,Propafenone,3A4-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
5927,Propiverine,3A4-Inhibitor,CCCCC(C(=O)O[C@H]1CCN(C)CC1)(C2=CC=CC=C2)C3=CC=CC=C3
5928,Propofol,3A4-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
5929,Propofol,3A4-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
5930,Propranolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5931,Pyrazinamide,3A4-Substrate,NC(=O)C1=CN=CC=N1
5932,Pyridostigmine,3A4-Inducer,CN(C)C(=O)OC1=C[N+](C)=CC=C1
5933,Quazepam,3A4-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
5934,Quetiapine,3A4-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
5935,Quinidine,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5936,Quinidine,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5937,Quinidine,3A4-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5938,Quinupristin/dalfopristin,3A4-Inhibitor,CC[C@H]1NC(=O)[C@@H](NC(=O)C2=NC=CC=C2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@H]3CC(=O)[C@H](CS[C@@H]4CN5CC[C@@H]4CC5)CN3C(=O)[C@H](CC6=CC=C(C=C6)N(C)C)N(C)C(=O)[C@@H]7CCCN7C1=O)C8=CC=CC=C8
5939,Rabeprazole,3A4-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
5940,Rabeprazole,3A4-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
5941,Raloxifene,3A4-Substrate,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
5942,Raloxifene,3A4-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
5943,Ranitidine,3A4-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
5944,Reboxetine,3A4-Substrate,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
5945,Repaglinide,3A4-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
5946,Repaglinide,3A4-Inhibitor,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
5947,Retinol (vit A),3A4-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5948,Rifabutin,3A4-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
5949,Rifabutin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
5950,Rifampicin,3A4-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5951,Rifampicin,3A4-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5952,Rifampicin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5953,Rifapentine,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
5954,Rifaximin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C5=C4N=C6C=C(C)C=CN56
5955,Risperidone,3A4-Inhibitor,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
5956,Risperidone,3A4-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
5957,Ritonavir,3A4-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5958,Ritonavir,3A4-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5959,Ritonavir,3A4-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5960,Rivastigmine,3A4-Inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
5961,Rofecoxib,3A4-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
5962,Rokitamycin,3A4-Inhibitor,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
5963,Rokitamycin,3A4-Substrate,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
5964,Ropinirole,3A4-Substrate,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
5965,Ropivacaine,3A4-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5966,Roquinimex,3A4-Substrate,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O
5967,Rosuvastatin,3A4-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
5968,Rosuvastatin,3A4-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
5969,Roxithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
5970,Roxithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
5971,Rufinamide,3A4-Inducer,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
5972,Rupatadine,3A4-Substrate,CC1=CC(CN2CCC(CC2)=C3/C4=C(CCC5=C3N=CC=C5)C=C(Cl)C=C4)=CN=C1
5973,Rutoside,3A4-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
5974,Salbutamol,3A4-Inhibitor,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
5975,Salbutamol,3A4-Substrate,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
5976,Salmeterol,3A4-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
5977,Saquinavir,3A4-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5978,Saquinavir,3A4-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5979,Saxagliptin,3A4-Substrate,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2
5980,Selegiline,3A4-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
5981,Seratrodast,3A4-Inducer,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
5982,Seratrodast,3A4-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
5983,Sertindole,3A4-Substrate,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
5984,Sertraline,3A4-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
5985,Sertraline,3A4-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
5986,Sevoflurane,3A4-Substrate,FCOC(C(F)(F)F)C(F)(F)F
5987,Sibutramine,3A4-Substrate,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
5988,Sildenafil,3A4-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
5989,Sildenafil,3A4-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
5990,Silymarin,3A4-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
5991,Silymarin,3A4-Inducer,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
5992,Simvastatin,3A4-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5993,Simvastatin,3A4-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5994,Ezetimibe,3A4-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
5995,Sirolimus,3A4-Inhibitor,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5996,Sirolimus,3A4-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5997,Sodium Edetate,3A4-Substrate,[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
5998,Somatostatin,3A4-Inhibitor,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O
5999,Spiramycin,3A4-Substrate,CO[C@H]1[C@H](O)CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C
6000,Spironolactone,3A4-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
6001,Sufentanil,3A4-Substrate,CCC(=O)N(C1=CC=CC=C1)[C@]2(CCN(CCC3=CC=CS3)CC2)COC
6002,Sulconazole,3A4-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
6003,Sulfadiazine,3A4-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
6004,Sulfadimidine,3A4-Inducer,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
6005,Sulfamethoxazole,3A4-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
6006,Sulfamethoxazole,3A4-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
6007,Sulfanilamide,3A4-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
6008,Sulfinpyrazon,3A4-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
6009,Sulfinpyrazon,3A4-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
6010,Sulfinpyrazon,3A4-Inducer,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
6011,Tacrolimus,3A4-Inhibitor,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
6012,Tacrolimus,3A4-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
6013,Tadalafil,3A4-Substrate,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
6014,Talinolol,3A4-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
6015,Tamoxifen,3A4-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6016,Tamoxifen,3A4-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6017,Tamoxifen,3A4-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6018,Tamsulosin,3A4-Substrate,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
6019,Tasosartan,3A4-Substrate,CC1=NC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5)C(C)=N1
6020,Telithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
6021,Telithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
6022,Temazepam,3A4-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6023,Temozolomide,3A4-Inducer,CN1N=NC2=C(N=CN2C1=O)C(N)=O
6024,Teniposide,3A4-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
6025,Teniposide,3A4-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
6026,Terbinafine,3A4-Inducer,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
6027,Terbinafine,3A4-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
6028,Terfenadine,3A4-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6029,Terfenadine,3A4-Inducer,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6030,Terfenadine,3A4-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6031,Testosterone,3A4-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6032,Testosterone,3A4-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6033,Testosterone,3A4-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6034,Tetracycline,3A4-Inhibitor,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
6035,Tetracycline,3A4-Substrate,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
6036,Tetramethrin,3A4-Inducer,CC(C)=C/[C@@H]1[C@@H](C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C
6037,Theophylline,3A4-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6038,Thiamazole,3A4-Inhibitor,CN1C=CNC1=S
6039,Thiopental,3A4-Inhibitor,CCC[C@@H](C)[C@]1(CC)C(=O)NC(S)=NC1=O
6040,Thiotepa,3A4-Substrate,S=P(N1CC1)(N2CC2)N3CC3
6041,Tiagabine,3A4-Substrate,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
6042,Tibolone,3A4-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
6043,Ticlopidine,3A4-Substrate,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
6044,Tinidazole,3A4-Substrate,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
6045,Tioconazole,3A4-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
6046,Tiotropium Bromide,3A4-Substrate,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5
6047,Tirilazad,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN5CCN(CC5)C6=CC(=NC(=N6)N7CCCC7)N8CCCC8
6048,Tocopherol (vit E),3A4-Substrate,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
6049,Tocopherol (vit E),3A4-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
6050,Tofisopam,3A4-Inhibitor,CC[C@@H]1C(C)=NN=C(C2=CC(OC)=C(OC)C=C2)C3=C1C=C(OC)C(OC)=C3
6051,Tolterodine,3A4-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
6052,Topiramate,3A4-Inducer,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
6053,Topotecan,3A4-Inhibitor,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
6054,Topotecan,3A4-Inducer,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
6055,Toremifene,3A4-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
6056,Trabectedin,3A4-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
6057,Tramadol,3A4-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
6058,Tramadol,3A4-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
6059,Tranylcypromine,3A4-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
6060,Trazodone,3A4-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
6061,Treosulfan,3A4-Inhibitor,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O
6062,Triamcinolone,3A4-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
6063,Triazolam,3A4-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6064,Trichloroethylene,3A4-Substrate,ClC=C(Cl)Cl
6065,Trimethadione,3A4-Substrate,CN1C(=O)OC(C)(C)C1=O
6066,Trimethoprim,3A4-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
6067,Trimipramine,3A4-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6068,Trofosfamide,3A4-Substrate,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
6069,Troglitazone,3A4-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6070,Troglitazone,3A4-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6071,Troglitazone,3A4-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6072,Troleandomycin,3A4-Substrate,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
6073,Troleandomycin,3A4-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
6074,Tropisetron,3A4-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
6075,Trospium,3A4-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
6076,Valdecoxib,3A4-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
6077,Valproic Acid,3A4-Inhibitor,CCCC(CCC)C(O)=O
6078,Vardenafil,3A4-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
6079,Venlafaxine,3A4-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
6080,Venlafaxine,3A4-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
6081,Verapamil,3A4-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6082,Verapamil,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6083,Vinblastine,3A4-Inducer,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6084,Vinblastine,3A4-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6085,Vinblastine,3A4-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6086,Vincamine,3A4-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
6087,Vincristine,3A4-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6088,Vincristine,3A4-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6089,Vindesine,3A4-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
6090,Vinorelbine,3A4-Inhibitor,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
6091,Vinorelbine,3A4-Substrate,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
6092,Virginiamycin,3A4-Inducer,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
6093,Virginiamycin,3A4-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
6094,Voriconazole,3A4-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6095,Voriconazole,3A4-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6096,Warfarin,3A4-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6097,Yohimbin,3A4-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
6098,Zafirlukast,3A4-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
6099,Zalcitabine,3A4-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
6100,Zaleplon,3A4-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
6101,Zidovudine,3A4-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
6102,Ziprasidone,3A4-Inhibitor,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
6103,Ziprasidone,3A4-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
6104,Zolpidem,3A4-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
6105,Zomepirac,3A4-Substrate,CN1C(CC(O)=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2
6106,Zonisamide,3A4-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
6107,Zopiclone,3A4-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
6108,Zotepine,3A4-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
6109,Almotriptan,3A4-Inhibitor,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
6110,Avasimibe,3A4-Inhibitor,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
6111,Azamulin,3A4-Inhibitor,CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C
6112,Betamethasone,3A4-Inhibitor,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
6113,Calcium folinate,3A4-Inhibitor,C1C(N(C2=C(N1)N=C(N=C2[O-])N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Ca+2]
6114,Carbamazepine,3A4-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6115,Carvedilol,3A4-Inhibitor,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
6116,Cetirizine,3A4-Inhibitor,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
6117,Chloroquine,3A4-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
6118,Chlorpromazine,3A4-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6119,Chlorpyrifos,3A4-Inhibitor,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
6120,Cortisol,3A4-Inhibitor,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
6121,Coumarin,3A4-Inhibitor,C1=CC=C2C(=C1)C=CC(=O)O2
6122,Dalfopristin,3A4-Inhibitor,CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C
6123,Delapril,3A4-Inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2
6124,Desloratadine,3A4-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
6125,Digoxin,3A4-Inhibitor,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
6126,Dimethyl sulfoxide,3A4-Inhibitor,CS(=O)C
6127,Dirithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
6128,Disulfamide,3A4-Inhibitor,CC1=CC(=C(C=C1S(=O)(=O)N)S(=O)(=O)N)Cl
6129,Ditiocarb sodium,3A4-Inhibitor,CCN(CC)C(=S)[S-].[Na+]
6130,Drospirenone,3A4-Inhibitor,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
6131,Ebrotidine,3A4-Inhibitor,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
6132,Efonidipine,3A4-Inhibitor,CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5
6133,Eplerenone,3A4-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
6134,Famotidine,3A4-Inhibitor,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
6135,Fluphenazine,3A4-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
6136,Flutamide,3A4-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
6137,Gallopamil,3A4-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
6138,Gestodene,3A4-Inhibitor,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
6139,Grepafloxacin,3A4-Inhibitor,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
6140,Homochlorcyclizine,3A4-Inhibitor,CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
6141,Malathion,3A4-Inhibitor,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
6142,Methoxsalen,3A4-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
6143,Metoclopramide,3A4-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
6144,Nimodipine,3A4-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
6145,Oltipraz,3A4-Inhibitor,CC1=C(SSC1=S)C2=NC=CN=C2
6146,Onapristone,3A4-Inhibitor,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
6147,Orphenadrine,3A4-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
6148,Oxiconazole,3A4-Inhibitor,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
6149,Papaverine,3A4-Inhibitor,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
6150,Parathion,3A4-Inhibitor,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
6151,Perphenazine,3A4-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
6152,Phencyclidine,3A4-Inhibitor,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6153,Pilsicainide,3A4-Inhibitor,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
6154,Piroxicam,3A4-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
6155,Proadifen,3A4-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
6156,Quercetin,3A4-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
6157,Quinelorane,3A4-Inhibitor,CCCN1CCCC2C1CC3=CN=C(N=C3C2)N
6158,Quinine,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
6159,Quinupristin,3A4-Inhibitor,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
6160,Reboxetine,3A4-Inhibitor,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
6161,Remacemide,3A4-Inhibitor,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN
6162,Reserpine,3A4-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
6163,Rosiglitazone,3A4-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
6164,Selegiline,3A4-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
6165,Seratrodast,3A4-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
6166,Sertindole,3A4-Inhibitor,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
6167,Spironolactone,3A4-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
6168,Sulfaphenazole,3A4-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
6169,Sulfinpyrazone,3A4-Inhibitor,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
6170,Sulpiride,3A4-Inhibitor,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
6171,Tazanolast,3A4-Inhibitor,CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2
6172,Tecastemizole,3A4-Inhibitor,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
6173,Tegaserod,3A4-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
6174,Theophylline,3A4-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6175,Ticlopidine,3A4-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
6176,Timoprazole,3A4-Inhibitor,C1=CC=C2C(=C1)NC(=N2)S(=O)CC3=CC=CC=N3
6177,Trimethoprim,3A4-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
6178,Valdecoxib,3A4-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
6179,Valproic acid,3A4-Inhibitor,CCCC(CCC)C(=O)O
6180,Valspodar,3A4-Inhibitor,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
6181,Vindesine,3A4-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
6182,Zaltoprofen,3A4-Inhibitor,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
6183,Zileuton,3A4-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
6184,Zolpidem,3A4-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
6185,Aranidipine,3A4-Inhibitor,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
6186,Corticosterone,3A4-Inhibitor,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
6187,Domperidone,3A4-Inhibitor,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
6188,Glipizide,3A4-Inhibitor,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6189,Lilopristone,3A4-Inhibitor,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
6190,Norfluoxetine,3A4-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
6191,Pantoprazole,3A4-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
6192,Pioglitazone,3A4-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
6193,Prednisolone,3A4-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6194,Stiripentol,3A4-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
6195,Sulfamethizole,3A4-Inhibitor,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
6196,Ondansetron,-,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
6197,Acenocoumarol,3A4-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
6198,Alpidem,3A4-Substrate,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
6199,Aminopyrine,3A4-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
6200,Amoxapine,3A4-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
6201,Anastrozole,3A4-Substrate,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
6202,Apomorphine,3A4-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
6203,Atomoxetine,3A4-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
6204,Avitriptan,3A4-Substrate,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
6205,Azimilide,3A4-Substrate,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl
6206,Benzfetamine,3A4-Substrate,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
6207,Bepridil,3A4-Substrate,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
6208,Boldenone,3A4-Substrate,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C
6209,Bufuralol,3A4-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
6210,Carbaril,3A4-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
6211,Chlorpyrifos,3A4-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
6212,Cimetidine,3A4-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6213,Clofibric acid,3A4-Substrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
6214,Clotrimazole,3A4-Substrate,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6215,Cortisol,3A4-Substrate,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
6216,Cyproterone,3A4-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
6217,Diethylstilbestrol,3A4-Substrate,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
6218,Dronabinol,3A4-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
6219,Drospirenone,3A4-Substrate,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
6220,Ecabapide,3A4-Substrate,CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC
6221,Emedastine,3A4-Substrate,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
6222,Emivirine,3A4-Substrate,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2
6223,Ezlopitant,3A4-Substrate,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
6224,Flucloxacillin,3A4-Substrate,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
6225,Ganaxolone,3A4-Substrate,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C
6226,Gestodene,3A4-Substrate,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
6227,Glyceryl trinitrate,3A4-Substrate,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
6228,Iloperidone,3A4-Substrate,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
6229,Isosorbide dinitrate,3A4-Substrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
6230,Leflunomide,3A4-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
6231,Levothyroxine sodium,3A4-Substrate,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]
6232,Lidocaine,3A4-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
6233,Lilopristone,3A4-Substrate,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
6234,Lisofylline,3A4-Substrate,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
6235,Lumefantrine,3A4-Substrate,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O
6236,Methiocarb,3A4-Substrate,CC1=CC(=CC(=C1SC)C)OC(=O)NC
6237,Methylphenidate,3A4-Substrate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
6238,Metoclopramide,3A4-Substrate,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
6239,Mexazolam,3A4-Substrate,CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl
6240,Mizolastine,3A4-Substrate,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
6241,Montelukast,3A4-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
6242,Mosapride,3A4-Substrate,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
6243,Nefiracetam,3A4-Substrate,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
6244,Niludipine,3A4-Substrate,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCCC)C)C
6245,Nilvadipine,3A4-Substrate,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
6246,Orphenadrine,3A4-Substrate,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
6247,Oxodipine,3A4-Substrate,CCOC(=O)C1=C(NC(=C(C1C2=C3C(=CC=C2)OCO3)C(=O)OC)C)C
6248,Parathion,3A4-Substrate,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
6249,Phencyclidine,3A4-Substrate,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6250,Pimobendan,3A4-Substrate,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
6251,Pranidipine,3A4-Substrate,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
6252,Pregnenolone,3A4-Substrate,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
6253,Quercetin,3A4-Substrate,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
6254,Quinine,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
6255,Rebamipide,3A4-Substrate,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
6256,Resiquimod,3A4-Substrate,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
6257,Salicylic acid,3A4-Substrate,C1=CC=C(C(=C1)C(=O)O)O
6258,Sulfinpyrazone,3A4-Substrate,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
6259,Tauromustine,3A4-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
6260,Tazofelone,3A4-Substrate,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2
6261,Tecastemizole,3A4-Substrate,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
6262,Terguride,3A4-Substrate,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
6263,Tipranavir,3A4-Substrate,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
6264,Tolcapone,3A4-Substrate,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
6265,Tretinoin,3A4-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
6266,Trimetrexate,3A4-Substrate,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
6267,Valspodar,3A4-Substrate,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
6268,Zatosetron,3A4-Substrate,CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C
6269,Zileuton,3A4-Substrate,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
6270,Chenodeoxycholic acid,3A4-Substrate,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
6271,Corticosterone,3A4-Substrate,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
6272,Dextrorphan,3A4-Substrate,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
6273,Dipotassium clorazepate,3A4-Substrate,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O.[OH-].[K+].[K+]
6274,Ergometrine,3A4-Substrate,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
6275,Manidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
6276,Onapristone,3A4-Substrate,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
6277,Perospirone,3A4-Substrate,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
6278,Ranolazine,3A4-Substrate,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
6279,Vanoxerine,3A4-Substrate,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
6280,Vesnarinone,3A4-Substrate,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC
6281,Yohimbine,3A4-Substrate,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
6282,Acetylsalicylic Acid,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
6283,Aminophenazone,S_mephenytoin_4_hydroxylase-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
6284,Amiodarone,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
6285,Amitriptyline,S_mephenytoin_4_hydroxylase-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6286,Amitriptyline,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6287,Amlodipine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6288,Amodiaquine,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
6289,Amprenavir,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6290,Atorvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
6291,Bezafibrate,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
6292,Bortezomib,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
6293,Brompheniramine,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
6294,Buprenorphine,S_mephenytoin_4_hydroxylase-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
6295,Bupropion,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
6296,Caffeine,S_mephenytoin_4_hydroxylase-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6297,Capsaicin,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
6298,Carbamazepine,S_mephenytoin_4_hydroxylase-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6299,Carbamazepine,S_mephenytoin_4_hydroxylase-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6300,Carbinoxamine,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
6301,Cefaloridine,S_mephenytoin_4_hydroxylase-Substrate,[O-]C(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)C[N+]4=CC=CC=C4
6302,Cerivastatin,S_mephenytoin_4_hydroxylase-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6303,Cerivastatin,S_mephenytoin_4_hydroxylase-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6304,Chinin,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6305,Chloramphenicol,S_mephenytoin_4_hydroxylase-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
6306,Chloroquine,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
6307,Ciclosporin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6308,Cimetidine,S_mephenytoin_4_hydroxylase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6309,Cisapride,S_mephenytoin_4_hydroxylase-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
6310,Clopidogrel,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
6311,Clotrimazole,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6312,Clozapine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6313,Cocaine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6314,Colchicine,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6315,Colchicine,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6316,Colecalciferol,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
6317,Cyamemazine,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
6318,Cyclophosphamide,S_mephenytoin_4_hydroxylase-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
6319,Cyclophosphamide,S_mephenytoin_4_hydroxylase-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
6320,Dapsone,S_mephenytoin_4_hydroxylase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
6321,Delavirdine,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
6322,Dexamethasone,S_mephenytoin_4_hydroxylase-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6323,Dexmedetomidine,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
6324,Dextromethorphan,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
6325,Dextropropoxyphene,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
6326,Diazepam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6327,Diclofenac,S_mephenytoin_4_hydroxylase-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
6328,Diclofenac,S_mephenytoin_4_hydroxylase-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
6329,Diltiazem,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6330,Diltiazem,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6331,Disulfiram,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
6332,Dolasetron,S_mephenytoin_4_hydroxylase-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
6333,Domperidone,S_mephenytoin_4_hydroxylase-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
6334,Dorzolamide,S_mephenytoin_4_hydroxylase-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
6335,Efavirenz,S_mephenytoin_4_hydroxylase-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
6336,Entacapone,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
6337,Eprosartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
6338,Estradiol,S_mephenytoin_4_hydroxylase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6339,Etoposide,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6340,Felodipine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
6341,Fenofibrate,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
6342,Fluconazole,S_mephenytoin_4_hydroxylase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6343,Fluorouracil,S_mephenytoin_4_hydroxylase-Substrate,FC1=CNC(=O)NC1=O
6344,Fluoxetine,S_mephenytoin_4_hydroxylase-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
6345,Fluoxetine,S_mephenytoin_4_hydroxylase-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
6346,Fluphenazine,S_mephenytoin_4_hydroxylase-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
6347,Flurbiprofen,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
6348,Flurbiprofen,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
6349,Fluvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6350,Fluvastatin,S_mephenytoin_4_hydroxylase-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6351,Fluvoxamine,S_mephenytoin_4_hydroxylase-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
6352,Formoterol,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
6353,Fosamprenavir,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6354,Fosphenytoin,S_mephenytoin_4_hydroxylase-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
6355,Fosphenytoin,S_mephenytoin_4_hydroxylase-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
6356,Gemfibrozil,S_mephenytoin_4_hydroxylase-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6357,Gemfibrozil,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6358,Glimepiride,S_mephenytoin_4_hydroxylase-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
6359,Glipizide,S_mephenytoin_4_hydroxylase-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6360,Griseofulvin,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
6361,Halofantrine,S_mephenytoin_4_hydroxylase-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
6362,Halothane,S_mephenytoin_4_hydroxylase-Substrate,FC(F)(F)[C@@H](Cl)Br
6363,Hydrocortisone,S_mephenytoin_4_hydroxylase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6364,Ibuprofen,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
6365,Ibuprofen,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
6366,Ifosfamide,S_mephenytoin_4_hydroxylase-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
6367,Ifosfamide,S_mephenytoin_4_hydroxylase-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
6368,Imatinib,S_mephenytoin_4_hydroxylase-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6369,Imatinib,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6370,Indinavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6371,Indometacin,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
6372,Indometacin,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
6373,Ipriflavone,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
6374,Irbesartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
6375,Irbesartan,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
6376,Isoniazid,S_mephenytoin_4_hydroxylase-Inhibitor,NNC(=O)C1=CC=NC=C1
6377,Ketamine,S_mephenytoin_4_hydroxylase-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
6378,Ketobemidone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
6379,Ketoconazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6380,Ketoprofen,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
6381,Lansoprazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6382,Lansoprazole,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6383,Leflunomide,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
6384,Leflunomide,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
6385,Lidocain,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
6386,Loperamide,S_mephenytoin_4_hydroxylase-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6387,Loratadine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
6388,Losartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
6389,Losartan,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
6390,Lovastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6391,Medroxyprogesterone,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
6392,Mefenamic Acid,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
6393,Mefenamic Acid,S_mephenytoin_4_hydroxylase-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
6394,Meloxicam,S_mephenytoin_4_hydroxylase-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
6395,Meloxicam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
6396,Mephenytoin,S_mephenytoin_4_hydroxylase-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
6397,Methadone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6398,Metronidazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
6399,Mirtazapine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
6400,Mometasone,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
6401,Montelukast,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
6402,Morphine,S_mephenytoin_4_hydroxylase-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
6403,Naloxone,S_mephenytoin_4_hydroxylase-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
6404,Naproxen,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
6405,Nicardipine,S_mephenytoin_4_hydroxylase-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6406,Nicardipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6407,Nicotine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
6408,Nifedipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6409,Nilutamide,S_mephenytoin_4_hydroxylase-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
6410,Nilvadipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
6411,Omeprazole,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6412,Oxybutynin,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
6413,Paclitaxel,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6414,Paracetamol,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)NC1=CC=C(O)C=C1
6415,Paraoxon,S_mephenytoin_4_hydroxylase-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
6416,Paroxetine,S_mephenytoin_4_hydroxylase-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
6417,Pentamidine Isethionate,S_mephenytoin_4_hydroxylase-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
6418,Perphenazine,S_mephenytoin_4_hydroxylase-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
6419,Phenazone,S_mephenytoin_4_hydroxylase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
6420,Phenelzine,S_mephenytoin_4_hydroxylase-Inhibitor,NNCCC1=CC=CC=C1
6421,Phenobarbital,S_mephenytoin_4_hydroxylase-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6422,Phenobarbital,S_mephenytoin_4_hydroxylase-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6423,Phenprocoumon,S_mephenytoin_4_hydroxylase-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6424,Phenytoin,S_mephenytoin_4_hydroxylase-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6425,Phenytoin,S_mephenytoin_4_hydroxylase-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6426,Pioglitazone,S_mephenytoin_4_hydroxylase-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
6427,Pioglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
6428,Piroxicam,S_mephenytoin_4_hydroxylase-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
6429,Piroxicam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
6430,Pravastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6431,Primidone,S_mephenytoin_4_hydroxylase-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
6432,Probenecid,S_mephenytoin_4_hydroxylase-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6433,Progesterone,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6434,Propafenone,S_mephenytoin_4_hydroxylase-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
6435,Propofol,S_mephenytoin_4_hydroxylase-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
6436,Pyrimethamine,S_mephenytoin_4_hydroxylase-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
6437,Quinidine,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6438,Raloxifene,S_mephenytoin_4_hydroxylase-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
6439,Repaglinide,S_mephenytoin_4_hydroxylase-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
6440,Retinol (vit A),S_mephenytoin_4_hydroxylase-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6441,Retinol (vit A),S_mephenytoin_4_hydroxylase-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6442,Rifampicin,S_mephenytoin_4_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6443,Rifampicin,S_mephenytoin_4_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6444,Rifampicin,S_mephenytoin_4_hydroxylase-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6445,Rifapentine,S_mephenytoin_4_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
6446,Ritonavir,S_mephenytoin_4_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6447,Ritonavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6448,Rofecoxib,S_mephenytoin_4_hydroxylase-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
6449,Rosiglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
6450,Rosiglitazone,S_mephenytoin_4_hydroxylase-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
6451,Rutoside,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
6452,Salmeterol,S_mephenytoin_4_hydroxylase-Inhibitor,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
6453,Saquinavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6454,Secobarbital,S_mephenytoin_4_hydroxylase-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
6455,Selegiline,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
6456,Seratrodast,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
6457,Simvastatin,S_mephenytoin_4_hydroxylase-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6458,Simvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6459,Ezetimibe,S_mephenytoin_4_hydroxylase-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
6460,Spironolactone,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
6461,Sulfadiazine,S_mephenytoin_4_hydroxylase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
6462,Sulfafurazole,S_mephenytoin_4_hydroxylase-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
6463,Sulfafurazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
6464,Sulfamethoxazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
6465,Sulfaphenazole,S_mephenytoin_4_hydroxylase-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
6466,Sulfinpyrazon,S_mephenytoin_4_hydroxylase-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
6467,Tamoxifen,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6468,Tazarotene,S_mephenytoin_4_hydroxylase-Substrate,CCOC(=O)C1=CC=C(N=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2
6469,Tegafur,S_mephenytoin_4_hydroxylase-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
6470,Tegaserod,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
6471,Temazepam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6472,Terbinafine,S_mephenytoin_4_hydroxylase-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
6473,Terfenadine,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6474,Testosterone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6475,Tetrabenazine,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
6476,Thalidomide,S_mephenytoin_4_hydroxylase-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
6477,Theophylline,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6478,Thioridazine,S_mephenytoin_4_hydroxylase-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
6479,Ticlopidine,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
6480,Tioconazole,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
6481,Tolbutamide,S_mephenytoin_4_hydroxylase-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
6482,Tolbutamide,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
6483,Torasemide,S_mephenytoin_4_hydroxylase-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
6484,Tretinoin,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
6485,Tretinoin,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
6486,Triazolam,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6487,Trimethadione,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)OC(C)(C)C1=O
6488,Trimethoprim,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
6489,Trimethoprim,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
6490,Troglitazone,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6491,Troglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6492,Troleandomycin,S_mephenytoin_4_hydroxylase-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
6493,Valproic Acid,S_mephenytoin_4_hydroxylase-Inhibitor,CCCC(CCC)C(O)=O
6494,Verapamil,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6495,Warfarin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6496,Warfarin,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6497,Zafirlukast,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
6498,Zafirlukast,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
6499,Zidovudine,S_mephenytoin_4_hydroxylase-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
6500,Zopiclone,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
6501,Acebutolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
6502,Carbamide,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,NC(N)=O
6503,Celiprolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)(C)C)C=C1
6504,Ciclosporin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6505,Clarithromycin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
6506,Enalapril,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
6507,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6508,Estrone,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
6509,Fexofenadine,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6510,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6511,G-strophanthin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
6512,Imatinib,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6513,Levofloxacin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
6514,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
6515,Mifepristone,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6516,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6517,Probenecid,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6518,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6519,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6520,Rifamycin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6521,Ritonavir,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6522,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
6523,Saquinavir,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6524,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
6525,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
6526,Talinolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
6527,Telmisartan,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
6528,Unoproston,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O
6529,Valsartan,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
6530,Fluorouracil,ATP_binding_cassette_transporter_sub_family_C_member_11-Inducer,FC1=CNC(=O)NC1=O
6531,Methotrexate,ATP_binding_cassette_transporter_sub_family_C_member_11-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
6532,Methotrexate,ATP_binding_cassette_transporter_sub_family_C_member_11-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
6533,Prasterone,ATP_binding_cassette_transporter_sub_family_C_member_11-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
6534,Aldosterone,3A5-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
6535,Alfentanil,3A5-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
6536,Alprazolam,3A5-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
6537,Amiodarone,3A5-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
6538,Amitriptyline,3A5-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6539,Amlodipine,3A5-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6540,Amprenavir,3A5-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6541,Aprepitant,3A5-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
6542,Argatroban,3A5-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
6543,Aripiprazole,3A5-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
6544,Astemizole,3A5-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
6545,Atazanavir,3A5-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6546,Atazanavir,3A5-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6547,Atorvastatin,3A5-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
6548,Aztreonam,3A5-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
6549,Beclometasone,3A5-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6550,Buspirone,3A5-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
6551,Caffeine,3A5-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6552,Carbamazepine,3A5-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6553,Carbamazepine,3A5-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6554,Cerivastatin,3A5-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6555,Chinin,3A5-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6556,Chloroquine,3A5-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
6557,Chlorphenamine,3A5-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
6558,Chlorpromazine,3A5-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6559,Ciclosporin,3A5-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6560,Ciclosporin,3A5-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6561,Ciclosporin,3A5-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6562,Cimetidine,3A5-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6563,Cisapride,3A5-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
6564,Clarithromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
6565,Clopidogrel,3A5-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
6566,Cocaine,3A5-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6567,Cocaine,3A5-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6568,Codeine,3A5-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6569,Cortisone,3A5-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
6570,Cyclobarbital,3A5-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
6571,Dapsone,3A5-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
6572,Daunorubicin,3A5-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
6573,Dexamethasone,3A5-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6574,Dexamethasone,3A5-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6575,Dextromethorphan,3A5-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
6576,Diazepam,3A5-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6577,Diethyltoluamide,3A5-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
6578,Diltiazem,3A5-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6579,Diltiazem,3A5-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6580,Disulfiram,3A5-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
6581,Docetaxel,3A5-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
6582,Domperidone,3A5-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
6583,Doxorubicin,3A5-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6584,Doxylamin,3A5-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
6585,Dutasteride,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
6586,Eplerenone,3A5-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
6587,Erythromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6588,Erythromycin,3A5-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6589,Estradiol,3A5-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6590,Estrone,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
6591,Ethinylestradiol,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6592,Ethosuximide,3A5-Substrate,CC[C@]1(C)CC(=O)NC1=O
6593,Etoposide,3A5-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6594,Etoposide,3A5-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6595,Felodipine,3A5-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
6596,Fentanyl,3A5-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
6597,Finasteride,3A5-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
6598,Fluconazole,3A5-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6599,Fluconazole,3A5-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6600,Flutamide,3A5-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
6601,Fluvoxamine,3A5-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
6602,Glycyrrhizic Acid,3A5-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6603,Glycyrrhizic Acid,3A5-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6604,Granisetron,3A5-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
6605,Halofantrine,3A5-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
6606,Haloperidol,3A5-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6607,Hydrocortisone,3A5-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6608,Ifosfamide,3A5-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
6609,Imatinib,3A5-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6610,Imatinib,3A5-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6611,Indinavir,3A5-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6612,Indinavir,3A5-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6613,Irinotecan,3A5-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
6614,Ketoconazole,3A5-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6615,Ketoconazole,3A5-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6616,Ketoconazole,3A5-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6617,Lercanidipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
6618,Levacetylmethadol,3A5-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6619,Lidocain,3A5-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
6620,Linopirdine,3A5-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
6621,Losartan,3A5-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
6622,Lovastatin,3A5-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6623,Mepacrine,3A5-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
6624,Mephenytoin,3A5-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
6625,Methadone,3A5-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6626,Mibefradil,3A5-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
6627,Midazolam,3A5-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6628,Mifepristone,3A5-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6629,Mifepristone,3A5-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6630,Modafinil,3A5-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
6631,Modafinil,3A5-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
6632,Nateglinide,3A5-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
6633,Nefazodone,3A5-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
6634,Nelfinavir,3A5-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6635,Nelfinavir,3A5-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6636,Neostigmine,3A5-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
6637,Nicardipine,3A5-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6638,Nifedipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6639,Nimodipine,3A5-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
6640,Nisoldipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
6641,Nitrendipine,3A5-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
6642,Norethisterone,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6643,Norfloxacin,3A5-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
6644,Octopamine,3A5-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
6645,Omeprazole,3A5-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6646,Omeprazole,3A5-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6647,Omeprazole,3A5-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6648,Ondansetron,3A5-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
6649,Ornidazole,3A5-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
6650,Oxazepam,3A5-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
6651,Oxcarbazepine,3A5-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
6652,Oxybutynin,3A5-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
6653,Oxycodone,3A5-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
6654,Paclitaxel,3A5-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6655,Paracetamol,3A5-Inducer,CC(=O)NC1=CC=C(O)C=C1
6656,Paracetamol,3A5-Substrate,CC(=O)NC1=CC=C(O)C=C1
6657,Paraoxon,3A5-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
6658,Pethidine,3A5-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
6659,Phenelzine,3A5-Inhibitor,NNCCC1=CC=CC=C1
6660,Phenelzine,3A5-Substrate,NNCCC1=CC=CC=C1
6661,Phenobarbital,3A5-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6662,Phenytoin,3A5-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6663,Physostigmine,3A5-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
6664,Pimozide,3A5-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
6665,Pleconaril,3A5-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
6666,Pravastatin,3A5-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6667,Praziquantel,3A5-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
6668,Prednisolone,3A5-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6669,Prednisolone,3A5-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6670,Progesterone,3A5-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6671,Propranolol,3A5-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
6672,Quetiapine,3A5-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
6673,Ranitidine,3A5-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
6674,Reserpine,3A5-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
6675,Rifampicin,3A5-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6676,Rifampicin,3A5-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6677,Rifampicin,3A5-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6678,Rifapentine,3A5-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
6679,Risperidone,3A5-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
6680,Ritonavir,3A5-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6681,Ritonavir,3A5-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6682,Ritonavir,3A5-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6683,Rosuvastatin,3A5-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
6684,Salmeterol,3A5-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
6685,Saquinavir,3A5-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6686,Saquinavir,3A5-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6687,Sildenafil,3A5-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
6688,Simvastatin,3A5-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6689,Sirolimus,3A5-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
6690,Spironolactone,3A5-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
6691,Sulfasalazine,3A5-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
6692,Tacrolimus,3A5-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
6693,Tamoxifen,3A5-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6694,Tegafur,3A5-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
6695,Telithromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
6696,Teniposide,3A5-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
6697,Terfenadine,3A5-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6698,Testosterone,3A5-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6699,Thalidomide,3A5-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
6700,Tocopherol (vit E),3A5-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
6701,Trazodone,3A5-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
6702,Triamcinolone,3A5-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
6703,Triazolam,3A5-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6704,Troglitazone,3A5-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6705,Troglitazone,3A5-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6706,Vardenafil,3A5-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
6707,Verapamil,3A5-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6708,Verapamil,3A5-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6709,Vinblastine,3A5-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6710,Vincristine,3A5-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6711,Zalcitabine,3A5-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
6712,Zaleplon,3A5-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
6713,Ziprasidone,3A5-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
6714,Zolpidem,3A5-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
6715,Zonisamide,3A5-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
6716,Zotepine,3A5-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
6717,Bezafibrate,7A1-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
6718,Ciprofibrate,7A1-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
6719,Colestyramine,7A1-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
6720,Ezetimibe,7A1-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
6721,Fenofibrate,7A1-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
6722,Gemfibrozil,7A1-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6723,Glucose,7A1-Inducer,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
6724,Insulin (human),7A1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
6725,Metyrapone,7A1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
6726,Retinol (vit A),7A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6727,Rifampicin,7A1-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6728,Ritonavir,7A1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6729,Ursodeoxycholic Acid,7A1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
6730,Astemizole,2J2-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
6731,Cocaine,2J2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6732,Ebastine,2J2-Inhibitor,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
6733,Ebastine,2J2-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
6734,Ergocalciferol,2J2-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
6735,Masoprocol,2J2-Inhibitor,C[C@H](CC1=CC=C(O)C(O)=C1)[C@@H](C)CC2=CC(O)=C(O)C=C2
6736,Terfenadine,2J2-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6737,Ethanol,Choline_transporter_like_protein_2-Substrate,CCO
6738,Enflurane,2F1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
6739,Ketoconazole,2F1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6740,Phenol,2F1-Substrate,OC1=CC=CC=C1
6741,Rifampicin,2F1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
